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I.	Summary		Correct	 development	 of	 the	 placenta	 is	 crucial	 for	 the	 growth	 of	 the	 embryo	 and	 the	health	of	both	mother	and	child.	Using	mainly	the	mouse	as	a	model	system,	a	cohort	of	transcription	 factors	 (TFs)	have	been	 implicated	 in	 the	specification	of	 trophectoderm	lineage	 progenitors,	 which	 gives	 rise	 to	 the	 placenta.	 These	 progenitors	 are	 the	 first	differentiated	cells	that	emerge	in	the	embryo,	and	therefore	their	specification	involves	mechanisms	that	dissolve	pluripotency.	Importantly,	the	network	configuration	of	these	transcription	factors	has	not	been	entirely	clarified,	and	so	is	the	degree	of	conservation	in	 the	 human.	 Moreover,	 it	 is	 not	 well	 understood	 how	 pluripotency	 is	 terminated	during	the	commitment	of	trophectoderm	progenitors,	and	how	this	is	regulated	on	the	epigenetic	level.		To	address	these	questions	I	employed	an	in	vitro	differentiation	system	that	is	based	on	human	 embryonic	 stem	 cells	 (ESCs),	 and	 treatment	 with	 BMP4.	 This	 stimulates	 the	differentiation	of	the	cells	into	a	trophoblast	fate.	To	analyze	the	underlying	mechanisms	of	 this	 specification,	 I	 first	 optimized	 a	 purification	 modality	 for	 investigating	 the	intrinsic	properties	of	these	progenitor	cells.	This	utilizes	an	antibody	that	is	specific	to	APA	 (CD249,	 Ly-51,	 ENPEP),	 a	 surface	 marker	 of	 trophoblast	 progenitors,	 and	 cell	purification	 via	 fluorescence	 activated	 cell	 sorting	 (FACS).	 Based	 on	 this,	 I	 employed	global	 transcriptomic	 and	 epigenomic	 approaches	 as	well	 as	 functional	 approaches	 to	analyze	 the	 underlying	 mechanisms	 of	 trophectoderm	 specification	 and	 pluripotency	shutdown.		Using	 this	 approach	 I	 first	 showed	 the	 close	 homology	 of	 the	 in	 vitro	 derived	 APA+	trophoblast	 progenitors	 to	 human	 trophectoderm	 progenitors	 in	 blastocysts.	 I	 then	went	on	 to	discover	 a	 gene	 regulatory	network	 that	 governs	 the	differentiation	of	 the	human	ESC-derived	trophoblast	progenitors.	It	consists	of	the	four	transcription	factors	GATA2,	GATA3,	TFAP2A	 (AP2-α)	 and	TFAP2C	 (AP2-γ),	which	 I	 collectively	named	 the	TrophEctoderm	four,	or	in	short	–	the	TEtra.	I	found	that	the	TEtra	regulate	in	concert	both	 repression	 of	 pluripotency	 and	 activation	 of	 trophoblast	 specific	 genes.	 I	 also	discovered	 genome	wide	 distribution	 of	 the	 TEtra	 network,	 proven	 some	 of	 its	 main	
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components	 in	 functional	assays,	and	characterized	 important	epigenetic	 features	 that	regulate	the	specification	of	human	trophectoderm	progenitors.		The	 implications	 of	 my	 work	 are	 broad	 and	 include	 an	 important	 foundation	 for	understanding	 in	 a	 great	 detail	 the	 mechanisms	 underlying	 human	 placental	development	and	numerous	pathologies	related	to	placental	dysfunction	which	 impact	the	health	of	mother	and	child.	Furthermore,	I	point	out	important	features	of	regulation	of	 pluripotency	 dissolvent	 and	 TE	 specification	 that	 could	 be	 unique	 to	 the	 human.	Finally,	 I	discover	 features	of	epigenetic	 turnover	that	are	pertinent	 for	understanding	processes	undelaying	gene	regulation	in	development.			 	
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I.	Zusammenfassung		Während	der	Schwangerschaft	 ist	die	korrekte	Entwicklung	der	Plazenta	essenziell	 für	das	 Wachstum	 des	 Embryos	 und	 die	 Gesundheit	 von	 Mutter	 und	 Kind.	 Versuche	 an	Mäusen	 ermöglichten	 die	 Identifikation	 eines	 Netzwerks	 an	 Transkriptionsfaktoren	(TF),	 das	 der	 Entstehung	 von	 Trophectoderm-	 (Vorläuferzellen	 der	 Plazenta)	 und	spezialisierten	Plazenta-Zellen	in	Mäusen	zugrunde	liegt.	Da	Trophectoderm-Zellen	die	ersten	 differenzierten	 Zellen	 des	 Embryos	 ausmachen	 geht	 ihre	 Entwicklung	 Hand	 in	Hand	 mit	 der	 Abschaltung	 von	 Pluripotenz-Genen.	 Die	 Charakterisierung	 dieses	Netzwerks	 an	 TF	 ist	 jedoch	 noch	 nicht	 komplett	 ausgereift	 und	 es	 ist	 nicht	 klar,	 ob	dieses	 auch	 im	 Menschen	 für	 die	 Entwicklung	 der	 Plazenta	 und	 das	 Ende	 der	Pluripotenz	wichtig	sind	und	welchen	Einfluss	Epigenetik	auf	diese	Prozesse	hat.			Um	 diese	 Fragen	 zu	 beantworten	 habe	 ich	 ein	 in	 vitro	 Differenzierungsprotokoll,	 bei	dem	 ich	 humane	 Embryonale	 Stammzellen	 (ESZ)	 mit	 dem	 Morphogen	 BMP4	differenziere,	 benutzt.	 Um	 die	 Homogenität	 der	 Population	 von	 Trophoblast-Vorläuferzellen	sicherzustellen	habe	ich	die	Technik	fluorescence	activated	cell	sorting	(FACS)	 benutzt	 um	 Vorläuferzellen	 entsprechend	 der	 Expression	 des	Oberflächenantigens	 APA	 (CD249,	 Ly-51,	 ENPEP)	 anzureichern.	 Diese	 Zellen	 habe	 ich	dann	für	die	Analyse	von	Transkriptom	und	Epigenom	als	auch	für	funktionelle	Assays	benutzt	 um	 die	 grundlegenden	 Mechanismen	 der	 humanen	 Plazentaentwicklung	 zu	entziffern.			Hierdurch	 konnte	 ich	 zeigen,	 dass	 diese	 in	 vitro	 differenzierten	 Zellen	 zum	 Großteil	homolog	sind	zu	in	vivo	Trophectoderm-Zellen.	Außerdem	konnte	ich	ein	Netzwerk		von	TF	 identifizieren,	 das	 der	 Entwicklung	 von	 humanen	ESZ	 in	 frühe	Vorläuferzellen	 der	Plazenta	zugrunde	liegt.	Dieses	besteht	aus	den	vier	TF	GATA2,	GATA3,	TFAP2A	(AP2-α)	und	 TFAP2C	 (AP2-γ),	 die	 gleichzeitig	 Pluripotenz-Gene	 ab-	 und	 Trophoblast–Gene	anschalten	 können.	 Schließlich	 habe	 ich	 die	 Verteilung	 dieser	 4	 TF	 über	 das	 gesamte	Genom	 während	 dieser	 Differenzierung	 untersucht,	 durch	 Manipulation	 des	 Genoms	gewisse	 Bestandteile	 dieses	 Netzwerks	 auf	 deren	 Bedeutung	 geprüft	 und	 zentrale	
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epigenetische	 Merkmale	 charakterisiert,	 welche	 die	 Entwicklung	 von	 humanen	Plazenta-Vorläuferzellen	regulieren.		Die	 Ergebnisse	 dieser	 Arbeit	 zeigen	 die	 detaillierten	 Mechanismen,	 die	 für	 die	 frühe	Plazentaentwicklung	beim	Menschen	verantwortlich	sind.	 	
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II.	Introduction	
Trophectoderm	and	placental	development			
Generation	of	defined	cell	types	in	the	preimplantation	embryo			The	 fertilization	 of	 the	 mammalian	 oocyte	 leads	 to	 the	 formation	 of	 an	 embryo	consisting	of	totipotent	cells	called	the	morula.	During	the	partitioning	of	the	morula	and	the	 formation	 of	 the	 blastocyst	 distinct	 cell	 types	 can	 be	 identified	 for	 the	 first	 time	during	 development.	 This	 includes	 a	 group	 of	 pluripotent	 cells	 named	 the	 inner	 cell	mass	(ICM),	and	multipotent	cells	of	the	trophectoderm	(TE).	The	ICM	further	gives	rise	to	the	primitive	endoderm	(PE)	and	the	epiblast	that	forms	the	soma	and	the	germ	line	(Figure	 II-1).	 At	 this	 stage	 the	 blastocyst	 implants	 in	 the	 uterus.	 The	 gene	 networks	underlying	 the	 cell-commitment	processes	over	 time	have	been	 studied	extensively	 in	the	mouse	using	chiefly	classical	approaches	of	gene	gain–	and	loss–of–function.	It	is	not	well	 understood	 to	what	 degree	 the	molecular	 processes	 that	were	 elaborated	 in	 the	mouse	are	conserved	in	our	own	development.	Because	it	is	not	anticipated	that	human	embryos	 will	 become	 available	 for	 analysis	 by	 gene	 manipulation	 due	 to	 ethical	restrictions,	this	gap	can	only	be	filled	using	in	vitro	cell	based	models.																																												
Figure	II-1:	Mouse	embryo	development	up	to	the	blastocyst	stage	The	 fertilized	 egg	 develops	 via	 cell	 divisions	 into	 2-,	 4-,	 8-cell	 and	 morula	 stage	embryo.	It	is	not	until	the	early	blastocyst	stage	that	defined	cell	types	emerge,	namely	first,	 the	 trophectoderm	 (TE)	 and	 the	 inner	 cell	 mass	 (ICM),	 and	 subsequently	 the	epiblast	(EPI)	and	the	primitive	endoderm	(PE)	(Yamanaka	et	al.,	2006).		
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The	first	specification		Depletion	or	rearrangement	of	 totipotent	cells	 in	mouse	preimplantation	embryo	have	shown	that	there	 is	plasticity	 in	the	cells	 that	can	compensate	 for	these	manipulations	until	the	16-32-cell	stage	(Bedzhov	et	al.,	2014).	This	led	to	the	hypothesis	that	it	is	the	position	 of	 the	 cells	 between	 the	 8-	 and	 32-cell	 stage	 that	 determines	 the	 lineage	outcome:	inner	and	outer	cells	into	the	ICM	and	the	TE,	respectively	(Figure	II-2A).	This	view	 has	 been	 challenged	 by	 depletion	 of	 the	 cell	 polarity	 genes	Par3	 and	 aPKC	 that	skewed	lineage	ratio	in	favor	of	ICM	cells,	indicating	that	it	is	not	only	the	position	of	the	cells	that	determine	the	lineage	outcome	(Plusa	et	al.,	2005).	It	has	also	been	proposed	that	 there	exists	a	developmental	bias	 in	 the	blastomeres	of	 the	2-cell	 stage	 (Gardner,	2001;	 Piotrowska	 et	 al.,	 2001;	 Piotrowska	 and	 Zernicka-Goetz,	 2001).	 Although	 time-lapse	microscopy	observations	initially	rejected	the	view	that	the	two-cell	blastomeres	are	distinct	 from	each	other	with	 regard	 to	 the	 ICM	and	TE	outcome	 (Motosugi	 et	 al.,	2005),	more	 recently	experiments	using	genetically	 labeled	cells	have	emphasized	 the	existence	 of	 a	 developmental	 bias	 (Tabansky	 et	 al.,	 2013).	 Another	 model	 reconciles	these	observations	by	explaining	that	the	differences	in	cell	polarity	predispose	cells	in	2-,	4-	and	8-cell	stage	embryos	to	give	rise	to	the	ICM	or	TE	(Johnson	and	Ziomek,	1981).	This	relies	on	observations	that	at	these	stages	the	cells	have	apical-basal	polarity,	and	depending	 on	 the	 plane	 of	 division,	 the	 cells	 either	 give	 rise	 to	 one	 polar	TE	 and	 one	apolar	ICM	cell	or	to	two	polar	TE	cells.	This	model	is	in	agreement	with	the	increased	production	of	ICM	cells	upon	the	loss	of	cell	polarity	(Sutherland	et	al.,	1990)	(Figure	II-2B).		
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	The	gene	network	governing	the	bifurcation	of	the	ICM	and	the	TE	has	been	extensively	studied	in	the	mouse.	The	most	prominent	transcriptional	regulators	 implicated	 in	the	formation	 of	 the	 ICM	 are	Oct4	 (Nichols	 et	 al.,	 1998),	Nanog	 (Mitsui	 et	 al.,	 2003a)	 and	
Sox2	(Avilion	et	al.,	2003),	whereas	Cdx2	(Niwa	et	al.,	2005;	Strumpf	et	al.,	2005),	Gata3	(Ralston	et	al.,	2010)	and	Eomes	(Russ	et	al.,	2000)	are	important	for	the	TE.	The	latter	are	restricted	to	cells	of	the	8-16	cell	stage	embryo	that	are	destined	to	become	TE	cells.	
Tead4	 was	 shown	 to	 regulate	 Cdx2,	 and	 its	 depletion	 leads	 to	 the	 earliest	 embryonic	lethality	due	to	TE	defect	(Yagi	et	al.,	2007;	Nishioka	et	al.,	2008).	Surprisingly,	Tead4	is	not	only	expressed	in	the	outer	cells	that	are	designated	to	become	TE,	but	also	in	inner	cells	that	become	the	ICM	(Nishioka	et	al.,	2008).	The	phenotypic	specificity	in	TE	cells	is	explained	 by	 the	 nuclear	 accumulation	 of	 Yap	 and	 Taz,	 the	 two	 transcriptional	 co-
Figure	II-2:	Models	of	TE/ICM	specification		Primary	models	addressing	the	regulation	of	TE	and	ICM	cell	location.	(A)	The	inside-outside	 model	 proposes	 that	 the	 position	 of	 the	 cells	 determines	 the	 outcome.	 In	contrast,	the	cell	polarity	model	(B)	suggests	that	the	mode	of	cleavage	determines	the	outcome:	if	cells	divide	symmetrically	relative	to	their	axis,	two	outside	polar	emerge	(Ba),	 and	 if	cells	divide	asymmetrically	 this	 leads	 to	 the	emergence	of	one	polar	and	one	apolar	cell,	outside	and	inside,	respectively	(Bb)	(Yamanaka	et	al.,	2006).		
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activators	of	Tead4,	which	are	also	vital	for	TE	development	(Nishioka	et	al.,	2009).	Both	factors	are	 found	in	the	nucleus	of	 the	TE-destined	outer	cells	and	 in	the	cytoplasm	of	the	inner	cells.	What	controls	Yap	and	Taz	localization	in	general	and	specifically	in	TE	cells	are	kinases	of	the	Hippo	pathway:	the	asymmetry	in	cell-cell	contact	in	outer	cells	results	 in	 the	 accumulation	 of	 the	 polarity	 proteins	 Par6	 and	 aPKC	 (Bedzhov	 et	 al.,	2014),	 which	 inhibit	 the	 Hippo	 pathway.	 As	 a	 result	 unphosphorylated	 Yap	 and	 Taz	translocate	to	the	nucleus.	In	contrast,	in	ICM	cells	the	Hippo	pathway	kinases,	Lats1	and	
Lats2	 are	 active;	 they	 phosphorylate	 Yap	 and	 Taz,	 leading	 to	 cytoplasmic	 localization	and	thereby	prevention	of	Tead4-mediated	transcription	(Nishioka	et	al.,	2009)	(Figure	II-3).	 Cellular	 polarity	 also	 governs	 TE	 specification	 by	 regulation	 of	 Cdx2	 mRNA	localization	to	the	apical	side.	This	generates	inside	cells	 lacking	Cdx2	(Skamagki	et	al.,	2013).		
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	Nevertheless,	Cdx2	is	not	vital	or	alone	promoting	TE	development,	because	expression	of	Cdx2	but	not	Oct4	is	variable	 in	the	cells	of	the	morula	(Dietrich	and	Hiiragi,	2007),	and	the	 initial	TE	separation	 is	not	affected	by	depletion	of	maternal	and	zygotic	Cdx2	(Wu	et	al.,	2010).		
Second	specification	and	implantation		The	arrangement	of	 the	mouse	pluripotent	epiblast,	which	 is	surrounded	by	a	 layer	of	PE	cells,	 is	mediated	by	selective	apoptosis	and	cell	migration	of	epiblast	and	PE	cells.	Time-laps	 microscopy	 and	 tracking	 of	 ICM	 cells	 from	 mouse	 early	 to	 late	 blastocyst	showed	that	the	precursors	of	epiblast	and	PE	are	intermingled	within	the	ICM	(Chazaud	et	al.,	2006;	Plusa	et	al.,	2008;	Meilhac	et	al.,	2009).	With	regard	to	the	mechanism,	cells	of	the	PE	and	the	epiblast	were	shown	to	become	established	by	unique	transcriptional	programs	 that	 can	 already	 be	 detected	 at	 the	 early	 blastocyst	 (Chazaud	 et	 al.,	 2006;	Kurimoto	et	al.,	2006):	Nanog	(Chambers	et	al.,	2003;	Mitsui	et	al.,	2003a)	and	Sox2	for	the	 epiblast	 (Avilion	 et	 al.,	 2003),	 and	 endodermal	 genes	 such	 as	 Gata6,	 Gata4	(Koutsourakis	et	al.,	1999)	or	Sox17	(Niakan	et	al.,	2010)	for	the	PE.	As	the	mechanisms	governing	the	specification	of	epiblast	and	PE	cells	are	not	 the	 focus	of	my	work,	 they	are	not	covered	here	but	can	be	found	elsewhere	(Bedzhov	et	al.,	2014).		These	 events	 take	 place	 concomitantly	with	 the	 translocation	 of	 the	 blastocyst	 to	 the	uterus	 where	 it	 implants	 in	 the	 endometrium	 by	 hatching,	 a	 process	 that	 involves	breakdown	on	the	zona	pellucida	membrane.	The	cells	of	the	epiblast	further	give	rise	to	the	 fetus,	 the	TE	 contributes	 to	 the	placenta	 and	 the	PE	 to	 the	 yolk	 sac	 (Gardner	 and	Johnson,	1973;	Papaioannou	et	al.,	1975;	Gardner	and	Rossant,	1979;	Gardner,	1985).	
Figure	II-3:	Factors	involved	in	the	first	cell	specification	in	mouse	Cells	of	the	morula	exhibit	different	features.	The	outside	cells	have	asymmetric	cell-cell	contacts	and	form	the	TE,	whereas	the	inside	cells	have	symmetrical	cell-cell	contact	and	form	 cells	 of	 the	 ICM.	 In	 the	 mouse	 it	 was	 suggested	 that	 in	 outside	 cells	 Amot	 and	Lats1/2,	kinases	of	the	Hippo	pathway	are	inactive	and	Yap/Taz	can	go	to	the	nucleus	of	the	cell.	This	leads	to	activation	of	Tead4	and	Cdx2,	which	strengthens	the	TE	identity	of	outside	 cells.	 On	 inside,	 ICM,	 cells	 activity	 of	 Amot	and	 Lats1/2	 leads	 to	 repression	of	Yap/Taz	 and	 Tead4	 is	 not	 switched	 on	 in	 the	 nucleus.	 Therefore,	 the	 pluripotency	program	is	maintained	by	expression	of	Oct4	(Bedzhov	et	al.,	2014).		
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Human	and	mouse	preimplantation	embryos	compared		While	mouse	and	human	preimplantation	blastocysts	are	morphologically	similar,	there	are	some	important	differences:	mouse	and	human	blastocyst	form	around	E	day	3-3.5	and	 5,	 respectively,	 and	 implantation	 takes	 place	 at	 E	 day	 4-4.5	 and	 7-9,	 respectively	(with	 another	 round	 of	 cell	 division	 in	 the	 human)	 (Hertig	 et	 al.,	 1959;	 Finn	 and	McLaren,	 1967;	Norwitz	 et	 al.,	 2001;	 Cockburn	 and	Rossant,	 2010).	 Known	molecular	differences	 include	 timing	of	CDX2	expression,	 the	key	TE	TF,	which	 is	detected	 in	 the	human	only	after	the	formation	of	the	blastocyst	(Niakan	and	Eggan,	2013).	Conversely,	GATA3	expression	is	more	pronounced	in	human	TE,	probably	it	serves	to	compensate	for	the	late	CDX2	expression	(Deglincerti	et	al.,	2016).	Differences	in	expression	patterns	also	 exist	 between	 human	 and	mouse	 blastocysts.	 For	 example,	 OCT4	 is	 ubiquitously	expressed	 in	all	 cells	of	 the	human	blastocyst	at	E	day	5-7,	whereas	 in	 the	mouse	 it	 is	restricted	 to	 the	 ICM.	 Moreover,	 in	 contrast	 to	 the	 mouse,	 PE	 and	 ICM	 cells	 are	 not	sorted	 at	 E	 day	 6	 in	 the	 human	 (O'Leary	 et	 al.,	 2012;	 Roode	 et	 al.,	 2012;	 Niakan	 and	Eggan,	2013;	Deglincerti	et	al.,	2016).			Finally,	 interestingly	TE	cells	that	are	 isolated	from	the	human	blastocyst	can	still	give	rise	 to	 pluripotent	 cells	 in	 vitro	 (De	 Paepe	 et	 al.,	 2013),	 which	 indicates	 that	 human	blastocyst	cells	are	more	plastic	than	the	cells	of	the	murine	blastocyst.			
Chorion	and	placenta	development		After	 implantation,	 the	 blastocyst	 committed	TE	 cells	 develop	 into	 an	 extraembryonic	tissue	named	the	chorion,	the	primary	precursor	of	the	placenta.	The	placenta	forms	the	interface	 between	 the	 mother	 and	 the	 fetus,	 which	 is	 important	 for	 the	 exchange	 of	nutrients,	 waste	 products	 and	 gases,	 and	 for	 the	 prevention	 of	 immune	 response	towards	 the	 fetus.	 The	 placenta	 is	 also	 regulating	 the	 hormone	 regimens	 that	 are	necessary	 for	 fetal	 growth	 (Rossant	 and	 Cross,	 2001).	 Perturbations	 of	 chorion	development	and	placental	dysfunction	are	 implicated	 in	 fetal	 growth	 retardation	and	abnormalities	that	can	also	impact	the	health	of	the	mother.		
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Mouse	placental	development		The	attachment	of	the	blastocyst	to	the	maternal	endometrium	is	mediated	by	mural	TE,	the	TE	that	surrounds	the	blastocyst	cavity	opposite	of	the	ICM.	The	mural	TE	cells	then	undergo	DNA	endoreplication	without	cell	division,	a	process	that	leads	to	the	formation	of	 trophoblast	 giant	 cells.	 These	 cells	 remodel	 the	 vascular	 system	 and	 promote	angiogenic	 processes	which	 are	 crucial	 for	 generating	 the	 vascular	 infrastructure	 that	regulate	nutrient,	gas	and	waste	product	exchange	between	the	fetus	and	the	maternal	tissues	(Rossant	and	Cross,	2001;	Simmons	et	al.,	2007).	Polar	TE,	which	reside	adjacent	to	 the	 ICM,	 proliferate	 and	 generate	 structures	 named	 the	 extraembryonic	 ectoderm	(ExE)	and	the	ectoplacental	cone	(Figure	II-4).		
	
The	cone	grows	by	expansion	of	a	population	of	trophoblast	progenitor	cells	in	the	ExE	region.	This	 relies	on	several	TFs,	 like	Elf5,	 a	TF	 that	 regulates	 the	expression	of	Cdx2	and	 Eomes	 (Donnison	 et	 al.,	 2005;	 Ng	 et	 al.,	 2008)	 or	 Ets2	 (Georgiades	 and	 Rossant,	2006;	Polydorou	and	Georgiades,	2013)	(see	section	“The	transcriptional	network	of	TE	development”).	Around	 E	 day	 8.5	 the	 extra	 embryonic	 allantois	 tissue,	 which	 is	 mesoderm	 derived,	makes	 contact	with	 the	 chorionic	 ExE.	 This	 perpetuates	 the	 folding	 of	 the	 ExE	which	
Figure	II-4:	Morphology	of	the	late	mouse	blastocyst	Mouse	TE	progenitors	form	the	extraembryonic	ectoderm,	the	ectoplacental	cone	and	trophoblast	giant	cells.	The	PE	gives	rise	to	the	yolk	sac.	Adapted	from	(Rossant,	2015).		
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creates	villous	branching	structures	named	the	placental	labyrinth.	This	tissue	consists	of	 several	 layers	 of	 labyrinthine	 trophoblasts	 and	 it	 is	 structurally	 supported	 by	spongiotrophoblast	 cells	 that	 are	 derived	 from	 the	 ectoplacental	 cone.	 Fused	cytotrophoblasts	 cells	 named	 syncytiotrophoblasts	 form	 at	 the	 tip	 of	 the	 elongating	branches	of	 the	villous	 tree	 (Cross	 et	 al.,	 2003).	To	 support	 the	 transport	of	nutrients	and	the	exchange	of	gas	and	waste	products,	sinuses	develop	in	the	spongiotrophoblast	tissue,	 a	 process	 leading	 to	 invasion	 of	 maternal	 blood	 to	 the	 placenta	 (Rossant	 and	Cross,	2001)	(Figure	II-5).	Key	TFs	that	are	involved	in	these	processes	include	glial	cell	missing	1	(Gcm1),	which		drives	 the	 branching	 and	 the	 differentiation	 of	 syncytiotrophoblasts	 (Basyuk	 et	 al.,	1999;	 Anson-Cartwright	 et	 al.,	 2000;	 Schreiber	 et	 al.,	 2000),	 and	 TF	 AP-2γ	 (Tfap2c)	which	promotes	the	formation	of	the	labyrinth	(Werling	and	Schorle,	2002).		
	
Human	placental	development		Our	 knowledge	 regarding	 human	 placental	 development	 is	 based	 primarily	 on	hysterectomies.	 Compared	 with	 the	 mouse,	 where	 trophoblast	 giant	 cells	 mediate	implantation	and	invasion	of	the	mouse	blastocyst	into	the	uterus,	in	the	human	this	is	established	by	invasive	extravillious	trophoblast	cells.	Common	to	these	cell	types	is	that	they	are	both	polyploid	(Berezowsky	et	al.,	1995;	Zybina	and	Zybina,	1996;	MacAuley	et	
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al.,	 1998).	The	 chorionic	 villi	 of	 the	human	placenta	 are	 functionally	 equivalent	 to	 the	labyrinth	of	the	mouse	placenta.	In	both	species	these	villi/	labyrinth	are	covered	with	syncytiotrophoblasts	 that	 are	 in	 contact	with	 the	maternal	 blood	 (Rossant	 and	 Cross,	2001)	 and	 produce	 hormones	 like	 chorionic	 gonadotropin	 (CG),	 which	 is	 involved	 in	placentation	 through	 activities	 such	 as	 maintaining	 angiogenesis	 of	 the	 uterine	vasculature	and	promoting	differentiation	of	cytotrophoblasts	into	syncytiotrophoblasts	(Shi	et	al.,	1993;	Rao	and	Alsip,	2001;	Zygmunt	et	al.,	2002)	(Figure	II-6).		
		
There	exist	 some	key	differences	between	 the	species	 in	 relation	 to	TE	and	blastocyst	implantation.	This,	for	example	include	that	while	the	mouse	blastocyst	attaches	to	the	uterus	at	the	mural	part	of	the	TE,	the	human	blastocyst	makes	its	contact	through	the	polar	 TE	 (Herzog,	 1909).	 Another	 difference	 is	 that	 during	 early	 implantation	 the	blastocyst	 is	 rapidly	 engulfed	 by	 the	 expanding	 decidua	 (the	 uterine	 stroma)	 in	 the	mouse	while	during	human	implantation	the	TE	cells	are	highly	invasive	and	invade	the	uterine	stoma	(Hertig	and	Rock,	1973;	Enders,	1976).	Furthermore,	it	is	thought	that	the	mouse	yolk	sac	plays	an	important	role	in	nourishing	the	embryo	before	the	placenta	is	developed,	 while	 in	 the	 human	 invasive	 trophoblasts	 rather	 than	 the	 yolk	 sac	 are	important	in	this	respect	(Rossant,	2015).		
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Trophoblast	stem	cells		In	the	mouse,	all	the	cell	types	of	the	placenta	are	thought	to	originate	from	multipotent	precursor	cells	that	exist	initially	in	the	polar	TE	and	later	in	the	ExE.	It	is	thought	that	the	 renewal	 of	 these	 progenitors	 relies	 on	 FGF	 signaling	 because	 Fgfr2	 is	 specifically	expressed	in	TE	cells	and	the	ligand	FGF-4	is	expressed	in	the	adjacent	ICM	cells	in	late	mouse	blastocysts	(Yuan	et	al.,	1995;	Arman	et	al.,	1998).		The	 information	 about	 the	 involvement	 of	 FGF4	 in	 TE	 renewal	 has	 facilitated	 the	culturing	of	mouse	trophoblast	stem	cells	(TSCs).	Such	cultures	have	been	established	so	far	 from	 mouse	 blastocysts	 and	 ExEs,	 which	 was	 dissociated	 from	 the	 early-streak	around	day	6.5	post	coitus	(Tanaka	et	al.,	1998;	Uy	et	al.,	2002).	In	vitro	TSCs	are	able	to	renew	at	the	presence	of	Fgf4	and	can	produce	various	cell	types	of	the	chorioallantoic	placenta	 including	 spongiotrophoblast,	 syncytiotrophoblast	 and	 giant	 cells.	 When	implanted	into	blastocysts	TSCs	contribute	to	the	ExE,	ectoplacental	cone	and	giant	cells,	but	not	to	the	cells	of	the	epiblast,	PE	or	other	extraembryonic	tissues	that	are	derived	from	the	ICM	(Tanaka	et	al.,	1998).	Several	TFs	contribute	to	the	establishment	or	the	maintenance	of	TSCs,	including	Cdx2,	
Gata3,	Eomes,	Tfap2c,	Elf5,	Ets2	and	Esrrb	(Latos	and	Hemberger,	2014).	The	functional	importance	 of	 these	 factors	 was	 recently	 confirmed	 by	 reports	 showing	 that	 ectopic	expression	 of	 combinations	 of	 these	 factors,	Tfap2c,	Gata3,	Eomes	 and	Myc	 or	Tfap2c,	
Gata3,	 Eomes	 and	 Ets2,	 convert	 mouse	 fibroblasts	 into	 trophoblast	 stem-like	 cells	(Benchetrit	et	al.,	2015;	Kubaczka	et	al.,	2015).	 Importantly,	derivation	of	human	TSCs	or	 cells	 that	 have	 similar	 self-renewal	 /	 differentiation	 features	 has	 not	 yet	 been	reported	to	date.		
The	transcriptional	network	of	TE	development		The	putative	network	of	TFs	that	underlies	mouse	TE	development	seems	to	comprise	of	three	 primary	 layers,	 involved	 in	 the	 specification,	 reinforcement	 and	 further	differentiation,	 respectively	 (Senner	 and	 Hemberger,	 2010)	 (Figure	 II-7).	 Tead4	 and	
Cdx2	 are	 atop	 of	 this	 network	 (Nishioka	 et	 al.,	 2008)	 and	 regulate	Eomes	 and	Tfap2c,	which	subsequently	regulate	Gata3,	Elf5	and	Ets2.	This	classification	is	primarily	based	on	 the	 severity	 of	 the	 respective	 phenotypes	 resulting	 from	 gene	 inactivation:	 loss	 of	
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Tead4	results	 in	 the	 earliest	 known	 lethality	due	 to	 a	developmental	 failure	of	 the	TE	(Yagi	et	al.,	2007;	Nishioka	et	al.,	2008),	and	Cdx2	depleted	blastocysts	 fail	 to	 implant,	but	not	to	specify	TE	precursors	(Strumpf	et	al.,	2005).	Deletion	of	Eomes	leads	to	a	later	impairment	 of	 TE	 differentiation	 and	 developmental	 arrest	 at	 E4.5	 (Russ	 et	 al.,	 2000;	Strumpf	 et	 al.,	 2005).	 Similarly,	 deletion	of	Elf5	 produces	 embryos	 that	 lack	Cdx2	 and	Eomes	expression,	do	not	form	the	ExE	and	no	TSCs	can	be	derived	from	these	embryos	(Donnison	et	al.,	2005;	Ng	et	al.,	2008).	Tfap2c	depletion	leads	to	death	at	days	7	to	9	of	embryonic	 development	 (Werling	 and	 Schorle,	 2002),	 and	 knockout	 of	 Ets2	 leads	 to	developmental	 impairments	of	TE	cells	(Georgiades	and	Rossant,	2006;	Polydorou	and	Georgiades,	 2013).	 Finally,	 Gata3	 seems	 to	 play	 an	 important	 role	 because	overexpression	 of	 Gata3	 in	 mouse	 embryonic	 stem	 cells	 generates	 trophoblast	committed	 cells,	 overexpression	 in	TSCs	promotes	 their	 differentiation	 (Ralston	 et	 al.,	2010)	 and	 it	 is	 part	 of	 the	 cocktail	 that	 converts	 mouse	 fibroblasts	 into	 trophoblast	stem-like	cells	(Benchetrit	et	al.,	2015;	Kubaczka	et	al.,	2015).	
	
	
Comparison	 of	 human	 TE,	 human	 embryonic	 stem	 cells	 (ESCs,	 described	 below)	 and	cells	 of	 the	 adult	 placenta	 resulted	 in	 a	 list	 of	 16	TFs	 induced	 in	 the	TE	 and	 placenta	compared	to	human	ESC,	 including	TFs	that	have	been	shown	to	be	involved	in	mouse	trophoblast	 development	 like	 GATA3,	 TFAP2C	 and	 GCM1	 and	 some	 that	 are	 still	 not	connected	with	mouse	trophoblast	or	TE	development	(Bai	et	al.,	2012).	However,	the	connectivity	of	the	network	is	still	largely	unknown.	
Figure	II-7:	A	putative	transcription	circuit	of	mouse	trophoblast	development		The	dashed	 lines	 indicate	 putative	 connections	between	Eomes,	Gata3,	Elf5	 and	Ets2	with	Tcfap2c	(Senner	and	Hemberger,	2010).		
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Human	pluripotent	stem	cells		Human	 pluripotent	 stem	 cells	 (PSCs),	 in	 the	 form	 of	 ESCs	 that	 are	 derived	 from	blastocyst-stage	 embryos,	 or	 induced	 pluripotent	 stem	 cells	 (iPSCs)	 produced	 by	reprograming	 of	 somatic	 cells	 using	 a	 cohort	 of	 pluripotency	 TFs,	 can	 be	maintained	indefinitely	 in	vitro.	Human	ESCs	/	 iPSCs	 can	differentiate	 into	derivatives	of	 all	 three	germ	layers,	the	meso-,	endo-	and	ectoderm.	Interestingly,	as	early	as	the	first	report	of	human	ESCs,	 it	was	noted	 that	differentiation	 into	progeny	 resembling	 cells	 of	 the	TE	lineage	takes	place,	but	with	a	low	efficiency	(Thomson	et	al.,	1998).	This	is	despite	the	fact	 that	 the	 gene	 network	 regulating	 human	 PSCs	 was	 found	 similar	 to	 that	 of	 the	mouse,	including	OCT4,	NANOG	and	SOX2	(Nichols	et	al.,	1998;	Boyer	et	al.,	2005;	Wang	et	 al.,	 2012).	Moreover,	 it	was	 shown	 that	 in	human	ESCs	OCT4	and	SOX2	 can	 form	a	complex	 and	 bind	 to	 their	 own	 and	 to	 the	 NANOG	 promoter	 to	 activate	 their	 gene	expression.	 These	 three	 factors	 also	 bind	 genes,	 as	 TFAP2C,	 important	 for	developmental	processes	and	can	contribute	to	their	silencing	in	human	ESCs	(Boyer	et	al.,	 2005).	 Therefore,	 OCT4,	 SOX2	 and	 NANOG	 are	 considered	 the	 key	 responsible	players	for	maintenance	of	the	pluripotent	state	and	restriction	of	differentiation.	
	
OCT4		As	 Oct4	 can	 antagonize	 Cdx2	 expression,	 its	 regulation	 is	 relevant	 for	 ICM	 and	 TE	specification,	and	 is	elaborated	here	 in	detail.	During	mouse	development,	Oct4	mRNA	and	protein	is	first	detected	in	the	oocyte	(Scholer	et	al.,	1989;	Rosner	et	al.,	1990;	Yeom	et	 al.,	 1991;	 Palmieri	 et	 al.,	 1994).	 During	 the	 8-cell	 stage,	 Oct4	 mRNA	 and	 protein	expression	 increases	 again	 (Yeom	 et	 al.,	 1991;	 Palmieri	 et	 al.,	 1994),	 and	 becomes	restricted	to	pluripotent	cells	upon	the	partitioning	of	the	ICM	and	the	TE.	Importantly,	although	Oct4	is	vital	for	renewal	of	ICM	cells,	it	is	not	necessary	for	specification	of	the	pluripotent	 cells	 (Frum	et	 al.,	 2013;	Wu	 et	 al.,	 2013).	 Later,	Oct4	 is	 expressed	 only	 in	specific	 tissues	of	 the	epiblast,	 and	 finally	 is	detected	only	 in	 the	primodial	germ	cells	(PGCs)	(Yeom	et	al.,	1996),	which	give	rise	to	the	gametes	(Figure	II-8).		
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Several	regulatory	regions	exist	in	the	OCT4	locus,	including	the	proximal	promoter	and	proximal	 and	distal	 enhancers.	Within	 the	 enhancers	 there	 are	 four	 elements	 that	 are	conserved	between	mouse,	bovine	and	human,	indicating	a	common	mode	of	regulation	(Nordhoff	 et	 al.,	 2001).	 The	 distal	 enhancer	 regulates	 the	 expression	 of	 Oct4	 in	pluripotent	/	embryonic	germ	cells	whereas	the	proximal	enhancer	is	active	in	epiblast	cells	 (Yeom	et	 al.,	 1996;	Tesar	et	 al.,	 2007).	This	 regulation	 involves	proteins	 that	 can	positively	 or	 negatively	 influence	 Oct4	 expression	 by	 binding	 to	 different	 regulatory	elements	 (Wu	 and	 Scholer,	 2014).	 For	 example,	 the	 binding	 of	 Cdx2	 to	 the	 distal	
Figure	II-8:	Expression	of	Oct4	during	the	mouse	life	cycle		Oct4	(green)	is	expressed	in	the	oocyte,	the	cells	of	the	ICM,	in	the	epiblast	and	finally	in	PGCs	(Wu	and	Scholer,	2014).		
	18	
enhancer	downregulates	Oct4	in	mouse	TE	cells	(Niwa	et	al.,	2005).	Conversely,	binding	of	pluripotency	factors	as	Nanog,	Sox2	or	Oct4	itself	to	the	enhancer	regions	induces	its	expression	(Wu	and	Scholer,	2014)	(Figure	II-9).	
	
Transcriptional	processes	in	response	to	Bone	Morphogenic	Protein	(BMP)	4	
in	human	ESCs			BMP4	 is	 a	 TGF-beta	 superfamily	 ligand	 that	 binds	 to	 type	 I	 and	 II	 BMP	 receptors	(Allendorph	et	al.,	2006).	Binding	of	the	ligand	promotes	phosphorylation	and	activation	of	the	receptor	regulated	SMADs	(R-SMAD),	SMAD1/5/8,	that	associate	with	a	common	mediator	 SMAD	 (Co-SMAD),	 SMAD4.	 This	 heteromeric	 complex	 translocates	 into	 the	nucleus	where	it	regulates	gene	expression	(Mukhopadhyay	et	al.,	2008;	Morikawa	et	al.,	2011)	(Figure	II-10).		
Figure	II-9:	Transcriptional	regulation	of	mouse	Oct4		A	 schematic	 overview	 of	 the	 Oct4	 gene.	 TFs	 and	 the	 respective	 binding	 sites	 that	regulate	Oct4	are	indicated	on	top.	Green	and	red	labels	indicate	positive	and	negative	influence.	CR=	conserved	region;	Sp1=	GC-rich	site	recognized	by	TFs	of	the	Sp1/Sp3	family;	HRE=	hormone	response	element	(Wu	and	Scholer,	2014).		
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In	 the	 mouse	 16-cell	 stage	 blastocysts	 components	 of	 the	 BMP	 pathway	 are	 already	differentially	expressed	in	inside	and	outside	cells,	with	inside	cells	expressing	mRNA	of	BMP	 ligands	 Bmp4	 and	 Bmp7,	 whereas	 outside	 cells	 show	 mRNA	 expression	 of	 the	receptor	BmprII.	Further	manipulation	of	4	cell	stage	mouse	embryos,	using	dominant	negative	 forms	of	Smad4	and	BmprII,	 led	 to	 impaired	 formation	of	TE	and	PE,	but	not	epiblast	 cells	 at	 E4.5	 (Graham	 et	 al.,	 2014).	 However,	 embryos	 depleted	 of	 Smad4	 or	BmprII	 develop	 past	 the	 implantation	 stage,	 but	 show	 abnormalities	 in	 the	extraembryonic	tissues	and	cannot	gastrulate	(Beppu	et	al.,	2000;	Chu	et	al.,	2004).	BMP	signaling	 plays	 also	 an	 important	 role	 in	 the	mouse	 post-implantation	 embryo	 during	the	 formation	 of	 the	 node	 and	 the	 primitive	 streak	 and	 it	 coordinates	 the	 left-right	asymmetry	 and	 patterning	 in	 the	mouse	 (Winnier	 et	 al.,	 1995;	 Fujiwara	 et	 al.,	 2002).	Further	it	plays	central	parts	in	formation	of	PGCs	and	mesoderm	(Lawson	et	al.,	1993;	Winnier	et	al.,	1995).		
BMP4-mediated	trophoblast	differentiation	of	human	ESCs			Human	 tumor	 cell	 lines	 derived	 from	 choriocarcinoma,	 such	 as	 JAR	 or	 JEG3,	 primary	cytotrophoblast	 cultures	 and	 immortalized	 extravillous	 cytotrophoblasts	 are	 classical	
Figure	II-10:	The	BMP	pathway	(Shore	and	Kaplan,	2010)		
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models	for	investigating	trophoblast	physiology	(Ringler	and	Strauss,	1990).	Yet,	these	systems	cannot	recapitulate	the	emergence	of	differentiated	trophoblast	cell	types	from	progenitor	 cells	 (Genbacev	 et	 al.,	 2013).	 The	 derivation	 of	 human	 ESCs	 and	 later	 of	human	iPSCs	revolutionized	this	aspect	because	it	turned	out	that	human	PSCs	have	an	intrinsic	 tendency	 to	 differentiate	 into	 trophoblast-like	 progeny	 by	 exposure	 to	 BMP	ligands	(Xu	et	al.,	2002).	Human	ESCs	treated	with	BMP4	(Telugu	et	al.,	2013)	or	with	a	combination	of	BMP4,	an	Activin	A	 inhibitor	and	a	FGF2	 inhibitor	 (Amita	et	al.,	2013)	could	 mimic	 the	 invasive	 behavior	 of	 some	 trophoblast	 cells.	 The	 phenotypes	 noted	include	 rapid	 flatting	 of	 the	 cells,	 emergence	 of	 syncytium-like	 cells,	 production	 of	placental	 hormones,	 expression	 of	 typical	 early	 trophoblasts	 genes	 and	 reduction	 of	pluripotency	genes	(Xu	et	al.,	2002;	Das	et	al.,	2007;	Marchand	et	al.,	2011;	Drukker	et	al.,	2012;	Ezashi	et	al.,	2012;	Sudheer	et	al.,	2012;	Amita	et	al.,	2013).		This	trophoblast	phenomenon	was	received	initially	with	a	surprise,	as	human	ESCs	are	thought	to	represent	a	developmental	stage	past	the	segregation	of	the	ICM	and	TE.	The	trophoblast	 nature	 of	 these	 cells	 was	 therefore	 challenged	 by	 a	 classification	 system	used	to	classify	in	vivo	first	trimester	trophoblasts.	The	in	vitro	differentiated	cells	fulfill	some,	but	not	all	criteria.	They	express	the	tested	trophoblast	specific	proteins	(KRT7,	TFAP2C	and	GATA3),	their	ELF5	promoter	gets	de-methylated,	but	the	expression	of	the	microRNA	 cluster	 C19MC,	 which	 is	 highly	 expressed	 in	 first	 trimester	 trophoblast,	 is	only	weakly	expressed	in	the	BMP4,	Activin	A	inhibitor	and	FGF2	inhibitor	treated	cells.	Further	 they	 do	 not	 express	 the	 placenta	 specific	 HLA-G,	 which	 induces	 immune	tolerance	during	pregnancy	(Lee	et	al.,	2016).	Moreover,	it	was	disputed	that	human	ESCs	derived	trophoblast	progeny	emerges	from	TE	fates	cells:	Bernardo	and	colleagues	treated	human	ESCs	with	combinations	of	BMP4,	FGF2	 and	Activin	 in	 chemically	 defined	medium.	Using	BMP4	+	FGF2,	which	does	not	resemble	the	culture	conditions	used	before	by	others,	BRACHYURY	(BRA),	a	mesoderm	associated	 TF,	 as	well	 as	 CDX2,	 the	 trophoblast	 associated	 TF,	were	 upregulated.	 The	BRA	upregulation	was	dependent	on	FGF2.	In	contrast	to	previous	studies	cells	treated	with	BMP4	alone	did	only	result	in	low	amounts	of	KRT7+	cells	(4-8%	of	all	cells	at	day	7	of	 differentiation)	 and	 no	 de–methylation	 of	 ELF5.	 RT-PCR	 of	 the	 sorted	 KRT7+	 cells	revealed	 high	 expression	 of	 the	 trophoblast	 associated	 genes	 GCM1,	 ELF5	 and	 HCGA,	which	encodes	for	hCG,	but	also	of	mesoderm	associated	genes	ISL1	and	FLK1	in	KRT7+	compared	 to	 KRT7-	 cells.	 Therefore	 they	 conclude	 that	 this	 differentiation	 route	represents	an	extraembryonic	mesoderm	rather	than	a	trophoblast	pathway	(Bernardo	
	21	
et	al.,	2011).	However,	a	newer	study	shows	that	treatment	of	human	ESCs	with	BMP4	also	 leads	to	expression	of	 target	genes	 including	WNTs,	which	promote	expression	of	mesoderm	genes.	This	creates	a	mixture	of	trophoblast	and	mesodermal,	WNT	induced,	cells,	rather	than	extraembryonic	mesoderm,	as	the	addition	of	a	WNT	inhibitor	leads	to	the	formation	of	trophoblast	cells	only	(Kurek	et	al.,	2015).				
Human	PSC	derived	trophoblast	progenitors		Understanding	 of	 developmental	 processes	 using	 human	 ESCs	 is	 hindered	 by	 the	emergence	of	heterogeneous	progeny.	The	differentiation	of	human	ESCs	with	different	factors	 can	 lead	 to	 the	 emergence	 of	mixed	 populations	 of	 cells	with	 different	 nature	(Gifford	et	al.,	2013).	In	our	case	BMP4	not	only	produces	trophoblast	cells,	but	also	cells	with	other	specifications,	e.g.	mesoderm	(Bernardo	et	al.,	2011;	Kurek	et	al.,	2015).	This	complicates	 the	 identification	 of	 ground	 laying	 mechanisms	 during	 one	 specific	developmental	process,	as	 the	unwanted	side	products	can	blur	the	real	drivers	of	 the	differentiation.		This	 can	 be	 circumvented	 by	 using	 antibodies	 against	 surface	 antigens	 expressed	 by	unique	progenitor	populations.	Aminopeptidase	A	(APA,	also	known	as	CD249,	Ly-51),	encoded	 by	 the	 ENPEP	 gene,	 was	 shown	 to	 be	 a	 suitable	 candidate	 to	 sort	 purified	trophoblast	 progenitors	 from	 BMP4	 differentiated	 cells,	 as	 APA+	 but	 not	 APA-	 cells	develop	into	placental	structures,	shown	by	expression	of	the	placental	specific	proteins	STS,	the	placental	alkaline	phosphatase	(PLAP)	and	human	placental	lactogen	(HPL)	and	others,	when	implanted	into	mice	(Drukker	et	al.,	2012).	Furthermore	APA	was	shown	to	be	present	on	the	surface	of	human	syncytiotrophoblast	cells	(Ito	et	al.,	2003)	and	it	was	also	found	to	be	involved	in	the	regulation	of	maternal	blood	pressure	in	the	mouse	(Mitsui	et	al.,	2003b).		
	
Chromatin	associated	histone	turnover	in	development	and	
differentiation		
The	molecular	basis	of	tissue	formation	is	the	expression	of	unique	sets	of	genes	from	the	genome,	which	is	uniform	in	all	cell	types.	Epigenetics	is	the	discipline	that	deals	with	the	mechanisms	of	gene	regulation	that	are	heritable	over	cell	and	organismal	
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generations	without	changes	in	the	DNA	sequence.	Some	of	the	best-characterized	epigenetic	mechanisms	are	biochemical	modifications	of	histone	tails	and	additions	of	methyl	groups	to	DNA.	
Nucleosome	architecture	and	the	histone	code			The	 eukaryotic	 DNA	 is	 compressed	 in	 the	 form	 of	 a	 polymer	 named	 chromatin	(Paweletz,	2001).	Two	forms	of	chromatin	are	distinguished	by	their	density,	known	as	eu-	 and	 heterochromatin	 during	 interphase	 that	 correspond	 to	 open	 and	 closed	configurations	of	chromatin.	The	nucleosome	 is	 the	basic	unit	of	 the	chromatin,	which	consist	of	a	histone	octamer	containing	 two	copies	histone	H2A,	H2B,	H3	and	H4	with	146bp	of	DNA	wrapped	around	it,	and	the	histone	tails	reaching	outside	of	this	structure	(Luger	et	al.,	1997)	(Figure	II-11).	
	
The	structure	of	the	chromatin	is	determined	by	several	key	factors,	including	variants	of	 the	 core	 histone	 proteins	 encoded	 by	 different	 genes	 and	 producing	 chromatin	 of	different	 densities.	 This	 influences	 the	 recruitment	 of	 activating	 or	 repressing	 factors.	For	 example,	 histone	 H3.3,	 a	 variant	 of	 H3,	 is	 found	 in	 transcriptionally	 active	 loci,	whereas	histone	H2AZ,	a	variant	of	H2A,	recruits	 the	heterochromatin	specific	protein	HP1α	and	thereby	promotes	the	maintenance	of	heterochromatin	(Sarma	and	Reinberg,	2005).	 Another	 process	 that	 changes	 the	 nucleosome	 distribution	 and	 position	 is	chromatin	 remodeling,	mediated	by	nucleosome	sliding	or	nucleosome	eviction	which	enhances	 accessibility	 of	 regulatory	 sequences	 (Cairns,	 2007).	Modification	 of	 specific	
Figure	II-11:	The	structure	of	the	nucleosome		DNA	that	 is	wrapped	around	the	histone	octameres,	consisting	of	each	two	copies	of	histones	 H2A,	 H2B,	 H3	 and	 H4.	 Red	 lines	 indicate	 histone	 tails	 projecting	 from	 the	nucleosome	(Marks	et	al.,	2001).		
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residues	on	histone	tails,	called	posttranslational	modifications	(PTM),	can	further	affect	the	chromatin	structure	and	accessibility	of	the	DNA	for	TFs.	The	addition	or	removal	of	these	 reversible	 PTMs	 can	 lead	 to	 activation	 or	 repression	 of	 a	 specific	 DNA	 locus	(Jenuwein	and	Allis,	2001).	Many	 different	 histone	 modifications	 have	 been	 reported	 and	 best	 characterized	 are	those	involving	histone	methylation,	acetylation	and	phosphorylation	(Figure	II-12).	The	recognition,	 establishment	 and	 removal	 of	 PTMs	 depend	 on	 specific	 proteins,	 called	readers,	writers	and	erasers.			
Methylated	histone	tails			
Figure	II-12:	Post-translational	modifications	of	histone	tails	A	 simplified	diagram	of	methylation,	 acetylation,	phosphorylation	and	ubiquitination	marks	of	histone	tails.	The	amino	acid	residues	of	the	histone	tails	H2A,	H2B,	H3	and	H4	are	shown.	The	numbers	 indicate	the	position	of	the	respective	amino	acid	in	 the	histone	 tail.	 Ph=	 phosphorylation;	 ac=	 acetylation;	 ub1=	 ubiquitination;	 me=	methylation	(Bhaumik	et	al.,	2007).		
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Histone	 methylation	 takes	 place	 on	 lysine	 and	 arginine	 residues	 of	 the	 histone	 tails	(Shilatifard,	 2006;	 Kouzarides,	 2007).	 While	 arginines	 are	 mono-	 or	 dimethylated,	lysines	can	be	mono-,	di-	and	trimethylated.	The	most	prominent	and	best-characterized	methylation	marks	are	on	 lysine	4,	9,	27,	36	and	79	of	histone	H3	and	at	 lysine	20	of	histone	 H4.	 These	 histone	 marks	 have	 been	 studied	 extensively	 with	 respect	 to	transcriptional	regulation.		
Acetylated	histone	tails		Acetylation	 of	 specific	 lysines	 on	 histone	 tails	 leads	 to	 neutralization	 of	 their	 positive	charge	 and	 alters	 the	 DNA-histone	 interaction	 leading	 to	 a	 more	 open	 chromatin	conformation.	 This	makes	 the	DNA	more	 accessible	 for	 proteins	 like	 TFs	 (Shahbazian	and	 Grunstein,	 2007).	 The	 writers	 of	 histone	 acetylation	 are	 called	 histone	 acetyl	transferases	(HATs)	and	the	erasers	histone	deacetylases	(HDACs).	Many	transcriptional	coactivators,	 such	 as	 p300	 have	 an	 intrinsic	 HAT	 activity,	 whereas	 transcriptional	corepressor	complexes	contain	HDAC	subunits	 (Denslow	and	Wade,	2007;	Shahbazian	and	Grunstein,	2007).		
Phosphorylated	histone	tails		Serine	and	threonine	residues	of	histone	tails	can	be	phosphorylated.	Phosphorylation	of	 these	amino	acids	 is	 involved	 in	DNA	repair,	mitosis	and	activation	of	 transcription	(Rossetto	 et	 al.,	 2012).	 Transcriptional	 activation	 is	 mediated	 by	 a	 crosstalk	 of	phosphorylation	marks	with	enzymes	that	can	acetylate	histone	tail	residues	next	to	the	phosphorylation	sites,	promote	removal	of	the	methylation	mark	of	H3K9me3	or	inhibit	the	 removal	 of	 methylation	 at	 the	 H3K4	 position.	 All	 these	 events	 lead	 to	 an	 open	transcriptionally	active	chromatin	configuration	(Lau	and	Cheung,	2011).		
	
DNA	methylation			The	methylation	of	the	fifth	position	of	the	cytosine	nucleoside	is	conserved	throughout	the	animal	kingdom	(Feng	et	al.,	2010),	and	most	of	the	methylation	in	mammals	takes	place	in	C-phosphate-G	dinucleotides	(CpGs)(Ramsahoye	et	al.,	2000;	Ziller	et	al.,	2011).	At	 least	 three	 enzymes	 catalyze	 DNA	methylation	 in	 humans:	 DNMT1	 is	 ubiquitously	
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expressed	and	maintain	 the	methylation	marks	during	cell	division,	 and	DNMT3A	and	DNMT3B	 are	 developmentally	 regulated	 and	 carry	 out	 de-novo	methylation	 (Li	 et	 al.,	1992;	Okano	et	al.,	1999).	In	the	human	genome,	which	is	overall	depleted	of	CpGs,	there	are	around	28	million	CpG	sites	of	which	60-80%	are	constitutively	methylated.	Out	of	these,	less	than	10%	are	located	in	so	called	CpG	islands,	which	are	regions	with	a	high	CpG	 content.	 These	 regions	 are	mostly	 unmethylated	 and	 located	 at	 the	 promoters	 of	developmental	 and	 housekeeping	 genes	 (Deaton	 and	 Bird,	 2011).	 Enzymes,	 namely	TET1,	 TET2	 and	 TET3	 can	 remove	 the	 methylation	 mark	 of	 the	 CpG	 by	hydroxymethylating	 the	 CpG	 base	 and	 therefore	 reverting	 the	 effect	 of	 the	 before	methylated	CpG	(Tahiliani	et	al.,	2009;	Guo	et	al.,	2011).	CpG	hydroxymethylation	exists	mainly	 in	 the	brain	and	PSC,	both	 in	humans	and	mice	 (Kriaucionis	and	Heintz,	2009;	Tahiliani	et	al.,	2009;	Pastor	et	al.,	2011;	Szulwach	et	al.,	2011).		
	
Epigenetic	profiles	of	PSCs		Electron	microscopy	of	heterochromatin	domains	and	DNaseI	or	Micrococcal	nuclease	(MNase)	digestion,	which	allow	the	detection	of	open	chromatin,	showed	that	in	mouse	and	 human	 ESCs	 the	 chromatin	 state	 is	 more	 open	 than	 in	 somatic	 cells,	 meaning	 it	harbors	less	heterochromatin	(Park	et	al.,	2004;	Efroni	et	al.,	2008;	Schaniel	et	al.,	2009;	Ahmed	et	al.,	2010)	(Figure	II-13).			
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Figure	 II-13:	 Schematic	 illustration	 of	
different	chromatin	regions.		The	 upper	 pane	 shows	 condensed,	transcriptional	 inactive	 heterochromatin	marked	 with	 histone	 H3K27	 tri-methylation	marks.	The	 middle	 pane	 shows	 open,	transcriptional	 active	 euchromatin	marked	with	histone	H3K4	tri-methylation	marks.	The	 lower	 pane	 shows	 bivalent	 domains	that	are	marked	by	histone	H3K4	and	K27	tri-methylation	 marks	 at	 the	 same	position,	 which	 poises	 them	 for	transcriptional	activation	or	repression.	
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Transcriptionally	inactive	heterochromatin	in	PSCs	is	characterized	by	repressive	H3K9	di-	 and	 trimethylation	marks	 (H3K9me2,	H3K9me3),	 found	at	 repetitive	elements	 like	centromeres	 (Peters	et	al.,	2001;	Lehnertz	et	al.,	2003)	or	by	 trimethylation	of	H3K27	(H3K27me3)	at	facultative	heterochromatin	regions	(Boyer	et	al.,	2006;	Lee	et	al.,	2006;	Mikkelsen	et	al.,	2007).	In	the	same	cells,	genes	in	transcriptionally	active	euchromatin	are	marked	by	H3K4me3	at	their	promoter	regions	(Bernstein	et	al.,	2006;	Mikkelsen	et	al.,	 2007)	 and	 by	H3K27	 acetylation,	 H3K4me1	 and	 the	 presence	 of	 the	HAT	 p300	 at	their	 respective	 enhancer	 region	 (Rada-Iglesias	 et	 al.,	 2011).	 Moreover,	 actively	transcribed	genes	contain	H3K36me3	marks	in	the	gene	body	(Kolasinska-Zwierz	et	al.,	2009).	 This	 active	 histone	 modification	 combination,	 comprising	 of	 H3K4me1,	H3K4me3,	 H3K27	 acetylation	 and	 H3K36me3	 distributed	 in	 different	 regions	 around	the	gene,	is	present	in	pluripotency	and	housekeeping	genes	in	mouse	and	human	PSCs.	Mouse	and	human	PSCs	also	feature	a	unique	category	of	histone	modifications	named	the	 bivalent	 domains	 characterized	 by	 co-occupancy	 of	 H3K4me3	 activating	 and	H3K27me3	 repressing	marks	 (Bernstein	 et	 al.,	 2006;	Mikkelsen	 et	 al.,	 2007).	 Bivalent	domains	are	associated	with	promoters	of	developmental	genes	 that	contain	high	CpG	regions	in	PSC	but	bivalent	domains	are	found	rarely	in	differentiated	cells	(Watanabe	et	al.,	2013).	The	conceptual	framework	states	that	it	is	the	existence	of	bivalent	domains	that	 allows	 developmental	 genes	 to	 be	 rapidly	 silenced	 or	 activated	 during	differentiation	by	loss	of	the	activating	H3K4me3	mark	or	by	removal	of	the	repressing	H3K27me3	mark,	 respectively	 (Pan	 et	 al.,	 2007;	 Pasini	 et	 al.,	 2010).	 This	 concept	 has	been	debated	initially	by	researchers	who	argued	that	the	existence	of	bivalent	domains	could	be	 explained	by	 analysis	 of	mixture	of	 cells	 harboring	 activating	 and	 repressive	marks	at	the	same	respective	loci.	This	concern	has	been	dismissed	by	sequential	ChIP	assays	 for	H3K4me3	and	 then	 for	H3K27me3	(or	vice	versa)	 that	confirmed	 that	both	marks	 could	 be	 detected	 at	 the	 same	 region	 (Pan	 et	 al.,	 2007;	 De	 Gobbi	 et	 al.,	 2011).	Moreover,	 analysis	 of	 mononucleosomes	 in	 conjunction	 to	 sequential	 ChIP	 in	 mouse	ESCs	 revealed	 that	 H3K4me3	 and	 H3K27me3	 can	 co-exist	 on	 the	 same	 nucleosome	(Voigt	et	al.,	2012).	Importantly,	there	is	a	correlation	between	the	presence	of	high	and	medium	CpG	promoters	and	the	presence	of	bivalent	domains	in	mouse	and	human	ESC.	Furthermore,	practically	all	promoters	that	are	CpG	rich	lack	DNA	methylation	marks	in	human	 and	mouse	 PSC	 (Weber	 et	 al.,	 2007;	 Fouse	 et	 al.,	 2008;	Meissner	 et	 al.,	 2008;	Mohn	et	al.,	2008).		Promoters	with	a	 low	percentage	of	CpGs	are	 less	well	 studied	as	 they	are	 found	at	 a	
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very	 small	 part	 of	 the	 human	 genes.	 Only	 around	 6,5%	 of	 these	 low	 CpG	 promoters	harbor	H3K4me3	marks	 and	do	 not	 show	 any	H3K27me3	mark	 in	mouse	ESCs.	 	 Low	CpG	genes	have	also	been	associated	with	highly	tissue	specific	functions	(Mikkelsen	et	al.,	 2007)	 and	 harbor	 DNA	 methylation	 marks	 in	 human	 ESC.	 During	 human	 ESC	differentiation	 the	DNA	methylation	 levels	 of	 these	 low	CpG	 genes	 anti-correlate	with	gene	expression	(Xie	et	al.,	2013).		During	differentiation	of	ESCs	it	was	shown	that	pluripotency	genes	acquire	repressive	marks,	 both,	 histone	 modifications	 and	 DNA	 methylation,	 whereas	 genes,	 that	 are	important	 during	 this	 differentiation	 state	 loose	 the	 repressive	 H3K27me3	mark	 and	acquire	additional	activating	H3K4me3	marks.	On	the	contrary,	if	the	gene	is	not	needed	during	this	developmental	step	it	looses	the	activating	H3K4me3	mark	and	gets	silenced	(Christophersen	and	Helin,	2010).		Taken	 together,	 all	 these	 epigenetic	 events	 contribute	 to	 the	 establishment	 of	 unique	gene	expression	patterns	in	specialized	cell	types	resulting	from	PSC	without	changes	in	the	DNA	sequence.		 	
	28	
III.	Aims	of	the	study		My	 interest	 lies	 in	 the	 first	 differentiation	 event	 of	 human	 development	 –	 the	specification	of	TE	progenitors.	I	have	set	the	primary	objective	to	utilize	human	PSCs	as	a	model	and	novel	surface	markers	defined	by	the	Drukker	lab	for	purifying	trophoblast	progenitors	as	a	basis	for	my	analysis.	Because	of	the	ethical	ban	on	research	of	human	embryos	as	well	as	the	minute	quantity	of	chromatin	in	mouse	embryos,	this	human	PSC	progenitor-progeny	 system	 is	 both	 essential	 and	 uniquely	 tailored	 to	 break	 grounds	understanding	 the	 cell	 intrinsic	 molecular	 properties	 that	 drive	 the	 specification	 of	human	TE	progenitors.	The	specific	aims	of	my	work	include:		
1.	 To	 resolve	 the	 uncertainty	 concerning	 the	 lineage	 correspondence	 of	 human	
PSC-derived	trophoblast	progeny		There	 exists	 uncertainty	 regarding	 the	 lineage	 correspondence	 of	 BMP4-treated	 PSC	progeny	 that	 exhibits	 trophoblast	 features,	 including	 expression	 of	 the	 trophoblast	specific	genes	KRT7,	CDX2,	GATA3,	GCM1,	ELF5	and	others,	production	of	 the	placental	hormone	human	Chorionic	Gonadotropin	 (hCG),	presentation	of	 the	placental	 immune	regulator	HLA-G,	 and	 exhibiting	demethylation	of	 the	ELF5	 promoter	 (Xu	 et	 al.,	 2002;	Amita	et	al.,	2013;	Lichtner	et	al.,	2013;	Lee	et	al.,	2016).	These	properties	are	regarded	by	many	as	evidence	 for	a	TE	decent	of	 the	cells	(Roberts	et	al.,	2014)	however,	other	investigators	claimed	that	the	expression	of	genes	that	are	characteristic	to	mesoderm	progeny,	which	includes	blood,	muscle,	and	bone	tissues,	such	as	ISL1	and	FLK1	and	the	absence	of	KRT7	at	the	day	7	after	differentiation,	indicates	that	the	trophoblast	progeny	emerges	 from	 mesoderm	 precursors	 (Bernardo	 et	 al.,	 2011).	 What	 complicates	concluding	 the	 lineage	 classification	using	 the	 existing	data	 is	 the	 fact	 that	BMP4	also	induces	 the	 expression	 of	 WNT3	 during	 the	 differentiation	 process	 leading	 to	heterogeneous	cultures	consisting	of	trophoblast	and	mesoderm	cell	populations	as	our	lab	has	shown	in	collaboration	(Kurek	et	al.,	2015).	However,	this	is	still	not	a	proof	of	the	TE	decent	of	BMP4-induced	trophoblast	progeny.	To	resolve	this	issue	I	have	set	to	address	the	following	questions:		
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a. Does	 the	 gene	 cohort	 expressed	 in	 progenitors	 during	 the	 differentiation	 of	human	PSC	support	mesoderm	classification?	b. Does	 the	 gene	 cohort	 expressed	 in	 progenitors	 during	 the	 differentiation	 of	human	PSC	support	trophoblast	classification?	c. What	is	the	lineage	correspondence	of	the	non-trophoblast	progenitors	emerging	during	the	differentiation	of	human	PSCs?		d. Does	 the	gene	cohort	expressed	 in	BMP4	 induced	purified	 trophoblast	progeny	from	human	PSCs	correspond	to	blastocyst	stage	human	TE	progeny?		My	 experimental	 approach	 included	 global	 transcriptomic	 and	 tissue	 classification	bioinformatics	 methods	 coupled	 to	 culturing	 of	 bulk	 human	 PSCs	 and	 cell	 sorting	modalities	 of	 differentiated	 derivative	 populations.	 Furthermore,	 I	 used	 existing	transcriptomic	datasets	of	human	blastocyst-stage	TE	as	a	basis	for	comparison	to	the	in	
vitro	generated	trophoblast	progenitors.		
2.	 To	 explain	 the	 genetic	 mechanism	 that	 drives	 trophoblast	 specification	 of	
human	PSCs	
	Previous	 studies	 have	 identified	 TFs	 that	 are	 highly	 expressed	 following	 BMP4	treatment	of	human	PSCs	(Xu	et	al.,	2002;	Marchand	et	al.,	2011;	Sudheer	et	al.,	2012).	Nevertheless	they	were	not	placed	in	the	context	of	a	TF	network	that	explains	the	mode	of	trophoblast	formation.	I	reason	that	this	is	due	to	two	primary	causes:		1.	 Cellular	 heterogeneity:	 studies	 from	 our	 lab	 and	 others	 have	 shown	 that	 there	 is	 a	high	 degree	 of	 lineage	 heterogeneity	 in	 early	 differentiating	 human	 PSC	 cultures	(Drukker	et	al.,	2012;	Kurek	et	al.,	2015).	Cell	purification	therefore	has	to	be	applied	for	analyzing	 the	 intrinsic	 properties	 of	 cell	 lineages,	 a	 principle	 that	 has	 been	demonstrated	 in	 defining	 the	 populations	 of	 the	 hematopoietic	 system,	 the	 nervous	system	and	others	(Hoppe	et	al.,	2014).		2.	 Post	 lineage	 commitment	 analysis:	 previous	 studies	 of	 human	 PSC	 differentiation	towards	trophoblast	lineages	mainly	focused	on	analyzing	cultures	that	already	contain	trophoblasts,	 which	 are	 therefore	 not	 compatible	 with	 attempts	 to	 analyze	 the	mechanism	leading	to	 trophoblast	specification	 from	human	PSCs.	 I	have	therefore	set	the	following	questions	for	identifying	the	TF	network	that	underlie	human	trophoblast	specification:	
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a. What	are	the	key	TFs	upregulated	by	BMP4	treatment	prior	to	the	emergence	of	committed	trophoblast	progenitors	from	human	PSCs,	and	do	they	correspond	to	mouse	TE	key	genes?	b. What	are	 the	 trajectory	 categories	of	 the	upregulated	TFs	and	do	 they	 indicate	layers	of	a	putative	TF	network?	c. Is	 there	 a	 correspondence	 between	 the	 key	 putative	 TFs	 upregulated	 before	trophoblast	progenitors	and	TFs	enriched	in	purified	trophoblast	progenitors?	d. What	is	the	connectivity	of	the	putative	trophoblast	TF	network?	e. Does	 reduction	 of	 early	 key	 trophoblast	 TF	 candidates	 perturb	 trophoblast	progenitor	specification	and	the	putative	network?	f. How	does	the	trophoblast	TF	network	relate	to	downregulated	genes	during	the	process	of	trophoblast	progenitor	specification			To	 address	 these	 questions	 I	 have	 used	 the	 above-mentioned	 approaches,	 and	 in	addition	I	determined	the	bound	human	genomic	loci	of	key	putative	TFs	for	identifying	the	connectivity	of	the	TE	TF	network.	Moreover,	I	used	functional	knock-out	assays	for	proving	the	network	connectivity.		
3.	 To	 decipher	 epigenetic	 mechanisms	 that	 underlie	 trophoblast	 specification	
from	human	PSCs			Analysis	of	a	spectrum	of	histone	modifications	of	bulk	cultures	of	human	ESCs	treated	by	BMP4	(Xie	et	al.,	2013)	did	not	yield	a	significant	insight	into	epigenetic	mechanisms	underlying	 trophoblast	 commitment.	 I	 reason	 that	 this	 is	 due	 to	 the	 above-mentioned	confounding	 effects	 of	 lineage	 and	 stage	 heterogeneity.	 To	 identify	 epigenetic	chromatin-related	mechanisms	that	play	key	roles	during	this	differentiation	process	 I	have	set	to	address	the	following	questions:		 a. What	is	the	turnover	of	the	activating	and	repressing	histone	modifications	of	key	genes	in	trophoblast	progenitors	and	their	precursors?	b. What	 is	 the	 turnover	 of	 DNA	 methylation	 marks	 of	 key	 genes	 in	 trophoblast	progenitors	and	their	precursors?	
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c. Can	transcriptional	reduction	and	induction	of	key	pluripotency	and	TE	genes	be	explained	 by	 changes	 in	 histone	 configurations	 and	 DNA	 methylation	 marks	during	trophoblast	progenitors	commitment?		To	 address	 the	 questions	 related	 to	 the	 histone	 modification	 and	 DNA	 methylation	turnover	I	analyzed	the	genome-wide	distribution	of	the	H3K4me3	modification,	which	is	 correlated	 with	 transcribed	 chromatin,	 the	 H3K27me3	 modification,	 which	 is	correlated	 with	 non-transcribed	 chromatin,	 and	 of	 CpG	 methylation	 in	 purified	undifferentiated	cells	and	trophoblast	progenitors.	I	have	correlated	this	chromatin	data	with	transcriptomic	data	for	gaining	a	holistic	view	of	the	regulation	governing	human	TE	 specification,	 Finally,	 this	 combinatorial	 analysis	 enabled	 me	 to	 define	 a	 human	trophoblast	chromatin	signature	similar	to	the	one	identified	for	the	cardiac	progeny	of	human	PSC	(Paige	et	al.,	2012).					 	
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IV.	Material	and	Methods	
Material		
Cell	culture	 Article	number	 Vendor	2-Mercaptoethanol	 31350-010	 Life	Technologies	Accutase	 A6964-100ML	 Sigma-Aldrich	B27	Supplement,	minus	insulin-10	mL	 A1895601	 Life	Technologies	Collagenase,	type	IV	 17104019	 Life	Technologies	DMEM	 21969035	 Life	Technologies	DMEM/F12	 11320074	 Life	Technologies	DMSO	 D5879-100ml	 Sigma-Aldrich	Gelatin	powdered,	pure	Ph.	Eur.,	NF	 A1693,0500	 AppliChem	GlutaMAX,	100X	 35050038	 Life	Technologies	HyClone™	Fetal	Bovine	Serum	(South	America),	Research	Grade	 SV30160.03	(LOT	Nr	RZB35918)	 GE	Healthcare	Knockout-Serum	Replacement	(KSR)	 10828028	 Thermo	Fisher	Scientific	Matrigel-Matrix	 FALC354230	 Schubert&Weiss	MEM	Non-Essential	Amino	Acids	Solution	(100X)	(NEAA)	 11140050	 Thermo	Fisher	Scientific	Millex-GP	Syringe	Filter	Unit,	0.22	µm,	polyethersulfone,	33	mm,	gamma	sterilized	 SLGP033RS	 Merck	Millipore	mTESR1	 5850	 Stemcell	Technologies	PBS,	1x	 14190094	 Life	Technologies	Penicillin-Streptomycin	 15070063	 Life	Technologies	Recombinant	Human	BMP-4	Protein	 314-BP	 R&D	Systems	Recombinant	Human	FGF-basic	(154	a.a.)(bFGF)	 100-18B	 Peprotech	RPMI-1640	medium	 21875034	 Life	Technologies	Trypsin-EDTA	(0.25%),	phenol	red	 25200056	 Thermo	Fisher	Scientific	Y-27632	dihydrochloride	(ROCK	inhibitor)	 1254/10	 R&D	Systems	µ-Slide	8	Well,	ibidi-treat	 80826	 Ibidi	
	
Human	Chorionic	Gonadotropin		 Article	number	 Vendor	AccuLite®	CLIA	 8575-300	 Monobind	PREGNANCY	TESTS	 720-0723	 VWR			
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ChIP-Seq	 Article	number	 Vendor	16%	Formaldehyde	(w/v),	Methanol-free	10	x	10	mL	 10321714	 Thermo	Fisher	Scientific	AbSurance	Histone	H3	Antibody	Specificity	Array		 16-667	 Merk	Millipore	Agencourt®	AMPure®	XP,	60	mL	 A63881	 Beckman	Coulter	Albumin	from	bovine	serum	(BSA)	 A9647-10G	 Sigma-Aldrich	ChIP-IT	high	sensitivity	kit	 53040	 Active	Motif	Clarity	Western	ECL	Substrate,	200	ml	 170-5060	 Bio-Rad	Laboratories	Dynabeads(R)	Protein	A	for	Immunoprecipitation	 10001D	 Life	Technologies	EDTA	Dinatriumsalz	Dihydrat	>99%	250g	 X986.1	 Carl	Roth	EGTA	 3054.1	 Carl	Roth	Glycine	 23391,02	 Serva	HEPES,	1M	Buffer	Solution	20x100ml	 15630122	 Life	Technologies	HiSeq®	Rapid	SBS	Kit	v2	(50	Cycle)		 FC-402-4022	 Illumina	HiSeq®	Rapid	SR	Cluster	Kit	v2		 GD-402-4002	 Illumina	NEBNext®	ChIP-Seq	Library	Prep	Reagent	Set	for	Illumina®	 E6200	S	 New	England	Biolabs	NEBNext®	Multiplex	Oligos	for	Illumina®	(Index	Primer	Set	1)	 E7335S	 New	England	Biolabs	Nuclease-free	water	(H2O)	 AM9932	 Life	Technologies	Phenylmethylsulfonylfluorid	5	g	(PMSF)	 6367,1	 Carl	Roth	Protease	Inhibitor	Cocktail	Set	III,	EDTA-Free	-	Calbiochem	 539134	 Merk	Millipore	Proteinase	K	Solution	20	mg/ml	1.25	ml	 AM2546	 Life	Technologies	Qiaquick	PCR	purification	kit		 28104	 Qiagen	Quant-iT	PicoGreen	dsDNA	Assay	Kit	 P7589	 Life	Technologies	Qubit	dsDNA	HS	Assay	Kit	 Q32854	 Life	Technologies	Rabbit	IgG	isotype	control	antibody	100	µg	 GTX35035	 Biozol	Diagnostica	Ribonucleic	acid,	transfer	from	bakers	yeast	(tRNA)	 R5636-1ML	 Sigma-Aldrich	RNA	6000	Pico	kit	 5067-1513	 Agilent	RNase	A	(20	mg/ml)	 12091021	 Life	Technologies	RNeasy	MinElute	cleanup	kit	 74204	 Qiagen	RNeasy	mini	kit		 4104	 Qiagen	SDS	Solution,	20	%	 20768,02	 Serva	Electrophoresis	Sodium	Chloride	 P029.2	 Carl	Roth	Sodium-deoxycholate	 D6750-10G	 Sigma-Aldrich	TRIS	PUFFERAN®	 5429,3	 Carl	Roth	Triton™	X-100	 X100-500ML	 Sigma-Aldrich	TURBO	DNase	2U/µl	1000U	 am2238	 Life	Technologies	
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Microarray	&	RNA	seq	&	RT-PCR	 Article	number	 Vendor	Encore™	Biotin	Module	,	60	pack	 4200-60	 NuGen	GeneChip®	Human	Gene	2.0	ST	Array,	30	arrays	 902113	 Affymetrix	GeneChip®	Hybridization,	Wash,	and	Stain	Kit	 900720	 Affymetrix	NextSeq	500/550	v2	reagent	cartridge,	75x	 FC-404-2005	 Illumina	Ovation®	Pico	WTA	System	V2	,	60	pack	 3302-60	 NuGen	Power	SYBR®	Green	PCR	Master	Mix	 4367659	 Thermo	Fisher	Scientific	RNA	6000	Pico	kit	 5067-1513	 Agilent	RNeasy	MinElute	cleanup	kit	 74204	 Qiagen	RNeasy	Mini	kit		 74104	 Qiagen	SuperScript®	III	First-Strand	Synthesis	System	for	RT-PCR		 18080051	 Life	Technologies	TaqMan®	Gene	Expression	Master	Mix	 4369016	 Thermo	Fisher	Scientific	TruSeq	Stranded	total	RNA	LT	kit	(RiboZero	Gold)	 RS-122-2301	 Illumina		
DNA	methylation	 Article	number	 Vendor	EZ	DNA	Methylation-Lightning™	Kit	 D5030	 Zymo	Research	Infinium	HumanMethylation450	BeadChip	Kit	 WG-314-1003	 Illumina	Wizard	DNA	isolation	kit	 A1120	 Promega		
Immunofluorescence	&	western	blot	 Article	number	 Vendor	2-Mercaptoethanol	 M3148	 Sigma-Aldrich	Clarity	Western	ECL	Substrate,	200	ml	 170-5060	 Bio-Rad	Laboratories	goat	anti-mouse	IgM-HRP	 sc-2064	 Santa	Cruz	Ibidi	mounting	medium	 50001	 Ibidi	Mini-PROTEAN	TGX	Stain	Free	Gels,	4-15%	 456-8086	 Bio-Rad	Laboratories	PhosSTOP™	 4906837001	 Sigma-Aldrich	Powder	Milk,	blotting	grade	 T145.1	 Carl	Roth	ProLong®	Gold	Antifade	Reagent	with	DAPI	 8961	 New	England	Biolabs	Protease	Inhibitor	Cocktail	Set	III,	EDTA-Free	-	Calbiochem	 539134	 Merk	Millipore	TRIS	PUFFERAN®	 5429.3	 Carl	Roth	Triton™	X-100	 X100-500ML	 Sigma-Aldrich	µ-Slide	8	Well,	ibidi-treat	 80826	 Ibidi	
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Genome	editing	 Article	number	 Vendor	Accutase	 A6964-100ML	 Sigma-Aldrich	Boric	acid		 B7901	 Sigma-Aldrich	Doxycycline	hydrochloride	 D9891-1G	 Sigma-Aldrich	GeneJET	Plasmid	Miniprep	Kit,	50	preps	 K0502	 Fermentas	LE	Agarose,	500	g	 840004	 Biozym	Lithium	acetate	dihydrate	 L6883	 Sigma-Aldrich	NEB®	5-alpha	Competent	E.	coli	(High	Efficiency)	 C2987	I	 NEB	P3	Primary	Cell	4D-Nucleofector®	X	Kit	L	(24	RCT)	 V4XP-3024	 Lonza	PureLink	HiPure	Plasmid	Filter	Maxiprep	Kit	 K210017	 Life	Technologies	Quick	Ligation™	Kit	 M2200	L	 NEB	QuickExtract	DNA	Extraction	Solution	1.0	 101098	 Biozym	SYBR®	Safe	DNA	Gel	Stain	 5001208	 Life	Technologies	Taq	PCR	Master	Mix	Kit	(1000	U)	 201445	 Qiagen		
Media	composition		
bFGF	medium	 MEF	medium	400	ml	 DMEM/F12	 500ml	 DMEM	100	ml	 KSR	 50	ml	 FBS	5	ml	 NEAA	 5.5	ml	 NEAA	5	ml	 Glutamax	 5.5	ml	 Glutamax	10	ng/ml	 bFGF	 5	ml	 Penicillin-Streptomycin	1	ml	 2-mercaptoethanol	 	 	5	ml	 Penicillin-Streptomycin	 	 	
	
Diff	medium	1	 Diff	medium	2	400	ml	 DMEM/F12	 49	ml	 RPMI	medium1640	100	ml	 KSR	 1	ml	 B27	Supplement,	minus	insulin	5	ml	 NEAA	 50	ng/ml	 BMP4	(added	fresh	daily)	5	ml	 Glutamax	 	 	1	ml	 2-mercaptoethanol	 	 	5	ml	 Penicillin-Streptomycin	 	 	50	ng/ml	 BMP4	(added	fresh	daily)	 	 	
Tables	IV-1-7:	Reagents	used	in	this	study		
Table	IV-8:	Media	composition	of	bFGF	and	mouse	embryonic	fibroblast	(MEF)	medium		
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mTESR1	mTESR1	was	prepared	by	 adding	100	ml	mTESR1	5x	 Supplement	 to	400	ml	mTESR1	Basal	Medium	and	addition	of	5	ml	Penicillin-Streptomycin.		
1x	Matrigel	(MG)	Matrigel	 was	 prepared	 by	 thawing	 on	 ice	 and	 dilution	 of	 1	 ml	 MG	 in	 50	 ml	 cold	DMEM/F12.	This	mix	was	then	stored	at	4°C	and	used	for	up	to	4	weeks.		
2x	Collagenase	Collagenase	was	prepared	by	addition	of	100	mg	of	collagenase	to	50	ml	of	DMEM/F12.	The	collagenase	was	dissolved	and	sterile	filtered.		
Freezing	medium	Freezing	medium	contained	of	culture	medium	(bFGF	or	mTESR1)	plus	10%	DMSO.		
FACS	medium	FACS	medium	was	prepared	by	addition	of	2-4%	FBS	and	5	mM	EDTA	to	PBS.			
Methods	
Cell	culture		All	centrifugation	steps	were	performed	at	RT	for	4	min	and	1200	RPM	on	a	Megafuge	40R	centrifuge	(Thermo	Fisher	Scientific).		
Human	ESC	lines	used:		For	this	work	I	used	two	different	human	embryonic	stem	cell	lines,	namely	H9	(WA09)	and	HUES9	iCRISPR.	The	H9	cells	were	used	for	the	main	part	of	the	project	(Microarray,	ChIP-Seq,	 DNA-methylation,	 time-course	 RNA-Seq,	 immunofluorescent	 microscopy),	whereas	the	HUES9	iCRISPR	cells	were	used	for	genetic	manipulation	experiments.	The	
Table	IV-9:	Media	composition	Differentiation	(Diff)	medium	1	and	2		
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reason	 for	 this	 is	 that	 the	 HUES9	 iCRISPR	 cells	 were	 genetically	 manipulated	 by	Transcription	 activator-like	 effector	 nucleases	 (TALENs)	 in	 a	 way	 that	 the	 DNA	endonuclease	Cas	9	was	inserted	in	the	AAVS1	locus	of	the	genome	of	HUES9	cells.	The	expression	 of	 Cas	 9	 can	 be	 induced	 by	 addition	 of	 doxycycline.	 This	 system	 allows	editing	 the	 genome	 of	 the	 cells	 just	 by	 introducing	 guide	 RNAs	 and	 addition	 of	doxycycline.	Thus	it	represents	a	fast	and	easy	way	to	perform	gene	editing	experiments	with	high	efficiency	(Gonzalez	et	al,	2014).				
Culture	conditions		
Maintenance:			
H9	cells	H9	cells	were	cultured	on	a	 layer	of	 irradiated	mouse	embryonic	fibroblasts	(MEFs)	in	bFGF	medium.	 The	 feeder	 layer	 is	 used	 because	 it	 produces	 different	 factors	 that	 are	important	for	the	maintenance	of	pluripotency.	Passaging	of	these	cells	was	performed	every	3-4	days	when	cells	were	70-80%	confluent.	Therefore	one	day	prior	to	passaging,	the	irradiated	feeders	were	plated	on	gelatin	coated	plates	and	left	to	attach	for	one	day	in	MEF	medium.	For	splitting,	the	H9	cells	were	incubated	for	45	min	to	1	hour	with	2x	collagenase.	After	the	colonies	detached	the	cells	were	collected	with	bFGF	medium	and	allowed	to	settle	by	gravity.	When	the	majority	of	cells	were	settled,	the	excess	medium	was	sucked	off,	cells	were	resuspended	in	bFGF	medium	and	pipetted	up	and	down	for	5	times	with	a	10	ml	pipette	to	break	the	colonies	into	smaller	clumps	of	cells.	Then	cells	were	passaged	1:6	on	the	MEF	plates	in	bFGF	medium.		For	 RNA-Seq	 experiments,	 which	 were	 performed	 in	 collaboration	 with	 Dr.	 Dmitry	Shaposhnikov,	H9	 cells	were	 adapted	 to	mTESR1	medium	and	 cultured	on	MG	coated	plates	in	feeder-free	conditions.	Passaging	was	performed	as	for	cells	in	bFGF	medium,	except	that	mTESR	was	used	instead	of	bFGF	and	cells	were	plated	on	MG-coated	plates	instead	of	feeder	layers.		
HUES9	iCRISPR	cells	(Gonzalez	et	al.,	2014)	HUES9	iCRISPR	cells	were	maintained	 in	mTESR1	medium	and	cultured	on	MG	coated	plates	 in	 feeder-free	 conditions,	 as	 this	 provided	 beneficial	 for	 further	 nucleofection	
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experiments.		Passaging	was	performed	as	described	for	H9	cells.		Freezing	Freezing	of	 cells	was	performed	by	addition	of	 collagenase	as	described	above,	except	cells	were	not	plated	on	plates,	but	resuspended	in	freezing	medium	and	transferred	to	cryotubes.	 Then,	 cells	 were	 cooled	 down	 in	 Mr.	 Frosty	 freezing	 containers	 (Thermo	scientific)	 at	 -80°C.	 The	 freezing	 containers	 allow	 the	 cells	 to	 cool	 down	 for	 1°C	 per	minute,	 the	 optimal	 speed	 to	 conserve	 cells.	 After	 24	 hours	 cells	were	 transferred	 to	liquid	nitrogen.		Thawing	Cells	 were	 taken	 from	 liquid	 nitrogen,	 quickly	 thawed	 in	 the	 water	 bath	 at	 37°C,	resuspended	 in	 culture	medium,	 centrifuged	and	 the	 supernatant	was	discarded.	Cells	were	 taken	 up	 in	medium	 and	 plated	 in	 the	 respective	medium,	 either	 on	MEFs	 (for	bFGF	cultured	cells)	or	on	MG-coated	dishes	(for	mTESR1	cultured	cells).			
BMP	directed	differentiation		H9	in	bFGF	Cell	culture	plates	were	coated	with	MG	for	30	min.	Cells	were	dissociated	to	single	cells	by	incubation	in	0.25%	Trypsin	for	5	min	at	37°C.	Detached	cells	were	collected	in	MEF	medium	 and	 centrifuged.	 Afterwards,	 cells	 were	 resuspended	 in	 Diff	 medium	 1	 and	plated	 at	 a	 density	 of	 105	 000	 cells/cm2.	 BMP4	 was	 added	 fresh	 every	 day	 at	 a	concentration	of	50	ng/ml.	Medium	was	changed	daily	during	differentiation	and	cells	were	harvested	after	2.5	days	using	0.25%	Trypsin	as	described	above.		H9	in	mTESR1	Cell	culture	plates	were	coated	with	MG	for	30	min.	H9	cells	were	dissociated	to	single	cells	by	 incubation	with	Gentle	cell	dissociation	buffer	 for	10	min.	Cells	were	plated	in	mTESR1	plus	10	µM	ROCK	inhibitor	(Y-27632).	On	the	next	day	cells	were	washed	with	PBS	and	Diff	Medium	2	 including	 freshly	 added	BMP4	 to	 a	 concentration	of	50	ng/ml	was	 added.	 Medium	 was	 changed	 daily.	 For	 time-course	 experiments	 cells	 were	harvested	at	time-points	8	hours,	16	hours,	24	hours,	48	hours	and	72	hours	using	PLB	
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buffer.		HUES9	iCRISPR:	BMP4	directed	differentiation	of	HUES9	cells	was	performed	as	described	 for	H9	cells	cultured	in	bFGF	medium,	except	that	10	µM	ROCK	inhibitor	was	added	for	the	first	24	hours	of	differentiation.		
Human	Chorionic	Gonadotropin	(hCG)	measurement		For	hCG	measurement	cells	were	differentiated	as	described	above	and	1	ml	of	medium	was	collected	per	sample	every	24	hours.	For	initial	testing	pregnancy	test	stripes	were	used	 following	manufacturer’s	 instructions.	 Samples	were	 then	 frozen	 and	 stored	 at	 -80°C	 for	 further	 testing	 with	 the	 AccuLite®	 CLIA	 kit	 according	 to	 manufacturer’s	instructions.			
Fluorescence	activated	cell	sorting	(FACS)		The	following	protocol	was	adjusted	to	2.5	x	105	cells	(¼	of	a	confluent	6	well	plate).	If	more	cells	were	used,	for	example	for	ChIP-Seq,	the	protocol	was	up-scaled	accordingly.	For	FACS	cells	were	incubated	with	1	ml	0.25%	trypsin	per	6	well	until	they	dissociated	as	single	cells.	Trypsin	was	stopped	by	the	addition	of	3	ml	MEF	medium	and	cells	were	centrifuged.	 Cells	 were	 then	 resuspended	 in	 1	 ml	 FACS	 medium,	 distributed	 to	 4	different	tubes	(1x	antibody	staining,	1x	IgG	staining	and	2x	for	RNA	isolation)	and	put	on	ice.	Then	the	appropriate	amount	of	primary	antibody	was	added		(Table	IV-10)	and	stainings	were	performed	for	30	min	on	ice.	Afterwards	cells	were	centrifuged	at	2000	g	for	5	min	at	4°C.	The	supernatant	was	removed	and	the	pellet	was	resuspended	in	200	µl	FACS	medium	containing	secondary	antibody	(1:250).	Cells	were	incubated	in	the	dark	for	 another	 30	min	 on	 ice,	 centrifuged,	 the	 supernatant	 removed	 and	 resuspended	 in	250	µl	FACS	medium	containing	Propidium	 iodide	 (PI,	1:200).	Cells	were	 then	 filtered	through	a	Falcon	40	µm	cell	 strainer	 (BD)	 and	analyzed	on	a	FACS	ARIA	 III	 (BD).	 For	sorting,	 cells	 were	 gated	 using	 FSC-A	 against	 SSC-A	 according	 to	 morphology	 of	 the	population	and	then	doublets	were	excluded	according	to	FSC-A	against	FSC-W.	Next	PI	
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was	 excited	 using	 the	 561	 nm	 yellow-green	 laser	 and	 detected	 using	 a	 610/20	 filter.	Exclusion	 of	 the	 PI-positive	 cells	 diminishes	 dead	 cells	 in	 the	 population.	 Then	 the	respective	dye	of	the	secondary	antibody	was	detected	using	either	the	633	nm	red	laser	to	excite	Alexa	Fluor	647	 that	was	detected	using	a	660/20	 filter,	or	 the	488	nm	blue	laser	to	excite	Alexa	Fluor	488,	where	the	fluorescence	was	detected	via	a	530/30	filter.	For	 sorting	 the	 top	 and	 lowest	 20%	 of	 the	 APA	 population	were	 gated	 and	 sorted	 as	APA+	and	APA-,	respectively.	The	primary	SSEA-5	labeled	antibody	was	detected	using	the	405	nm	violet	laser	for	excitation	and	the	450/40	filter	for	detection.	FACS	data	was	then	analyzed	using	FlowJo	X	10.0.7r2.		
Antibodies	used	for	FACS:	
	
Antibody	 Vendor	 Catalog	Number	
Lot	
Number	
Concentration	
used	Purified	Mouse	Anti-Human	CD249,	Clone	2D3/APA	 BD	Biosciences	 564532	 4197560	 1µg/2,5x105	cells	or	1:200	Mouse	Igg	 eBioscience	 16-4714-85	 E034743	 1µg/2,5x105	cells	or	1:400	SSEA5	Pacific	Blue	 Homemade	 	 	 5µl/2,5x105	cells	Alexa	Fluor(R)	488	goat	anti-mouse	IgG	(H+L)	2	mg/ml	 Life	Technologies	 A11001	 1726530	 1:250	Alexa	Fluor(R)	647	goat	anti-mouse	IgG	(H+L)	2	mg/ml	 Life	Technologies	 A21235	 1383063	 1:250	
	
RNA	isolation	RNA	was	 isolated	using	 the	RNeasy	mini	 kit	 according	 to	manufacturer’s	 instructions.	Isolated	RNA	was	stored	at	-80°C	thereafter.			
Quantitative	real-time	PCR	(RT-PCR)	
Reverse	transcription	
Table	IV-10:	Antibodies	used	for	FACS	analysis		
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RNA	concentration	was	measured	using	the	Nanodrop	ND-1000	system.	For	all	samples	of	 an	 experiment	 similar	 RNA	 concentrations	 were	 reverse	 transcribed	 using	 the	SuperScript®	III	First-Strand	Synthesis	System	for	RT-PCR	according	to	manufacturer’s	instructions.	cDNA	was	amplified	using	oligo	dT	primers.		
RT-PCR	Both,	 SYBR	green	 and	Taq	Man	 reactions	were	performed	using	 the	QuantStudio	12K	Flex	Real-Time	PCR	System	(Thermo	Fisher	Scientific)	in	384	well	plates.		
	
SYBR	green	For	SYBR	green	reactions	the	following	mastermix	and	primers	were	used:			 Volume	in	µl	 Component	5	 Power	SYBR®	Green	PCR	Master	Mix	2.25	 Primer	mix	[4	µM]	1	 DNA	1.75	 H2O	
	
Primers:	
	
Name Forward Reverse 
ELF5 CCTGATGTCGTGGACTGATCTG GCTTAGTCCAGTATTCAGGGTGG 
GAPDH GAGTCAACGGATTTGGTCGT ATGACAAGCTTCCCGTTCTC 
STS GCTGGCAAAAGTCAACACGGAG GTCCGATGTGAAGTAGATGAGGG 
	
	
TaqMan	
	TaqMan	reactions	were	performed	using	the	following	mastermix	and	Taq	Man	assays:			 Volume	in	µl	 Component	5	 TaqMan®	Gene	Expression	Master	Mix	0.5	 TaqMan	Probe	1	 DNA	3.5	 H2O	
Table	IV-11:	Mastermix	used	for	SYBR	green	assay		
Table	IV-12:	Primers	used	for	SYBR	green	assay		
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TaqMan	Assays:	
	
Gene	 Assay	ANKRD1	 Hs00923599_m1	CD13	 Hs00174265_m1	CDX2	 Hs01078080_m1	ENPEP	 Hs00157366_m1	GAPDH	 Hs02758991_g1	GATA2	 Hs00231119_m1	GATA3	 Hs00231122_m1	GCM1	 Hs00961601_m1	MESP1	 Hs00251489_m1	POU5f1	 Hs01895061_u1	ROR2	 Hs00171695_m1	T	 Hs00610080_m1	TFAP2A	 Hs01029413_m1	TFAP2C	 Hs00231476_m1	TP63	 Hs00978343_m1	VGLL1	 Hs00212387_m1		
Microarray	Microarray	was	performed	using	the	GeneChip	Human	Gene	2.0	ST	Arrays	(Affymetrix).	They	were	hybridized	and	scanned	according	to	manufacturer’s	instructions.		
Chromatin	Immunoprecipitation	(ChIP)	
	
Histone	modification	ChIP:		
Antibody	testing	Antibodies	 were	 tested	 for	 specificity	 using	 the	 AbSurance	 Histone	 H3	 Antibody	Specificity	Array	 according	 to	manufacturer’s	 instructions.	 Briefly,	 the	membrane	was	rehydrated	in	methanol	and	blocked	using	5%	milk	powder	in	TBS-T	for	1	hour	at	room	temperature.	 Afterwards	 the	 antibody	 was	 added	 to	 the	 blocking	 solution	 and	 the	
Table	IV-13:	Mastermix	used	for	TaqMan	assay		
Table	IV-14:	Probes	used	for	TaqMan	assay		
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membrane	 was	 incubated	 at	 4°C	 over	 night.	 The	 membrane	 was	 then	 washed	 three	times	with	TBS-T	for	5	min	each.	After	incubation	with	secondary	antibody	for	1	hour	at	room	 temperature	 three	 washing	 steps,	 as	 described	 before,	 followed	 and	 the	membrane	was	incubated	for	1	min	with	Clarity	Western	ECL	Substrate	and	imaged.	Further	antibody	testing	was	performed	using	ChIP-RT-PCR.	Therefore	regions	enriched	and	depleted	for	the	respective	histone	mark	were	determined	using	the	UCSC	genome	browser	and	ENCODE	data.	Primers	were	designed	in	these	regions	using	Primer3	Plus	(http://primer3plus.com/cgi-bin/dev/primer3plus.cgi)	 to	 span	 around	 80-150bp.	(Table	IV-15)	These	primers	were	then	used	to	test	the	specificity	of	the	antibodies	after	the	ChIP	by	RT-PCR	using	the	SYBR	green	mastermix	as	described	above.	For	analysis	of	the	enrichment	or	depletion	the	mean	Ct	of	2	technical	replicates	was	used	per	primer	set	 and	 compared	 to	 the	 adjusted	 input	 values	 (the	 Ct	 values	 of	 the	 input	 need	 to	 be	adjusted	according	to	the	dilution	factor)	with	the	formula:		 %	input	=	100	𝑥	2(Ct	(adjusted	Input)-	Ct	(IP))		Primers	used:	
Name	 Forward	 Reverse	ACTB	 AACGGCAGAAGAGAGAACCA	 AAGATGACCCAGGTGAGTGG	B2M	 GAGGCTATCCAGCGTGAGTC	 GAAGTCACGGAGCGAGAGAG	CCND1	 TGAAGAATCCCTGGATGGAG	 GCCTGGGGTGAGATACAAGA	ESR1	 AGAAAGGCGGGCATTAACTT	 GGCCTTGACTTTCATGGTGT	EVX2	 CTGAGTCTTCGGGGTTTCAA	 GTCAGCGGGAGAAAGAGTTG	GAPDH	#1	 AGTCCCCAGAAACAGGAGGT	 AGAGCGCGAAAGGAAAGAA	GAPDH	#2	 CTCTCTCCCATCCCTTCTCC	 GGGAAGAGGGGAAGCTGTAT	GAPDH	#3	 AGGCAACTAGGATGGTGTGG	 TGGACTCCACGACGTACTCA	HOXD12	 GGAAACCCTACACGAAGCAG	 TCGCTGAGGTTCAGCCTATT	K4neg	 CCAGGCAGATGAATGAGGAT	 CCCTTCCAAGGCTCTCTTCT	NEUROG1	 CTGCAGGTACCCCTGATCTC	 AACTGCCCTTTCCTGAGTGA	SPERT	 GCATTAGAAGCTGGGGTGAA	 CCTTCTCTCTTGCCCATCTG	
		
Sample	preparation:	Cells	 were	 dissociated	 from	 three	 confluent	 10	 cm	 plates	 using	 0.25%	 trypsin	 as	described	 before.	 The	 pellet	 was	 resuspended	 in	 10	ml	 cold	 DMEM/F12	 and	 1	ml	 of	freshly	 prepared	 crosslinking	 solution,	 consisting	 of	 50	 mM	 Hepes/KOH,	 100	 mM	sodium	 chloride,	 1	 mM	 EDTA,	 0.5	 mM	 EGTA,	 11%	 Formaldehyde	 (diluted	 from	 16%	
Table	IV-15:	Primers	used	for	ChIP-RT-PCR		
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Formaldehyde)	was	added.	This	 results	 in	a	1%	 formaldehyde	concentration.	After	10	min	on	the	shaker	the	crosslinking	was	stopped	by	the	addition	of	550	µl	2.5	M	glycine.	Cells	were	centrifuged	at	2000	g	for	5	min	at	4°C.	The	pellet	was	resuspended	in	5	ml	ice	cold	 PBS	 with	 50	 µl	 100	mM	 PMSF	 (in	 ethanol)	 and	 centrifuged	 as	 before.	 Then	 the	pellet	was	 resuspended	 in	 cold	 FACS	medium	 and	 stained	 as	mentioned	 above.	 After	sorting	1x106	cells	per	 tube	cells	were	washed	once	more	with	PBS+PMSF	and	 further	flash	frozen	in	liquid	nitrogen.	Cells	were	stored	at	-80°C	until	ChIP	was	performed.		
ChIP:	All	steps	were	performed	on	ice	unless	noted	otherwise.	For	each	ChIP	reaction	2.5	x	105	cells	were	used.		Pre-clearing	beads	preparation:	For	10	pre-clearing	reactions	200	µl	Dynabeads(R)	Protein	A	 for	 Immunoprecipitation	were	 put	 on	 a	MagnaRack™	Magnetic	 Separation	Rack	 (Thermo	 Fisher	 Scientific)	 and	excess	 liquid	was	 discarded.	 The	 beads	were	 resuspended	 in	 1	ml	 TE	 	 buffer	 and	 for	blocking	 purposes	 100	 µl	 tRNA	 (10	mg/ml)	were	 denaturated	 for	 5	min	 at	 95°C	 and	added	with	4	µl	of	rabbit	IgG	isotype	control	(5	µg/µl)	to	the	beads.	This	mix	was	then	rotated	at	4°C	over	night	and	then	washed	three	times	with	1	ml	wash	buffer	1	(WB1,	50	mM	Tris	 pH	 8.8,	 0.1%	 SDS,	 0.1%	Na-Deoxycholate,	 1%	Triton	 X100,	 150	mM	 sodium	chloride,	1	mM	EDTA,	0.5	mM	EGTA)	 for	5	min	at	a	 rotating	wheel	at	4°C.	Afterwards	beads	were	resuspended	in	200	µl	TE	buffer.		Cell	lysis:	Cell	pellets	(1	x	106	cells)	were	taken	from	-80°C	and	thawed	on	ice	for	45	-	60	min.	500	µl	Lysis	buffer	1	(50	mM	Hepes,	140	mM	NaCl,	1	mM	EDTA,	10%	glycerol,	0.5%	NP-40,	0.25%	Triton	X-100)	were	supplemented	with	protease	inhibitor	(1X)	and	the	pellet	was	resuspended	by	pipetting	up	and	down.	Cells	were	then	rotated	vertically	for	10	min	at	4°C.	 Afterwards	 cells	 were	 centrifuged	 at	 2000	 g	 for	 5	 min	 at	 4°C.	 	 The	 pellet	 was	resuspended	in	500	µl	Lysis	buffer	2	(LB2,	10	mM	Tris,	200	mM	NaCl,	1	mM	EDTA,	0.5	mM	 EGTA)	 supplemented	 with	 protease	 inhibitor	 (1X)	 and	 again	 rotated	 and	centrifuged	as	before.	Afterwards	 the	pellet	was	 resuspended	 in	120	µl	 Lysis	buffer	3	(LB3,	 10	mM	Tris,	 100	mM	NaCl,	 1	mM	EDTA,	 0.5	mM	EGTA,	 0.1%	Na-Deoxycholate,	
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0.5%	N-lauroylsarcosine,	0.1%	SDS)	and	transferred	into	microTUBE	AFA	Fiber	Pre-Slit	Snap-Cap	6x16mm	for	sonication.		Sonication:	Sonication	 was	 performed	 in	 120	 µl	 LB3	 in	 microTUBE	 AFA	 Fiber	 Pre-Slit	 Snap-Cap	6x16mm	with	 a	 Covaris	 E220	 Focused-ultrasonicator	 with	 the	 following	 parameters:	Peak	Incident	Power	=	105,	Duty	Factor	=	10%,	Cycles	per	Burst	=	200,	Treatment	time	(s)	=	480	at	4°C.			IP:	Chromatin	was	diluted	with	900	µl	dilution	buffer	(50	mM	Tris	pH	8.0,	167	mM	sodium	chloride,	1.1%	Triton	X100	and	0.11%	Na-Deoxycholate)	and	a	50	µl	aliquot	(equals	5%)	was	taken	as	input	sample	and	frozen	at	-20°C.	To	the	rest	of	the	sample	80	µl	beads	for	pre-clearing	were	 added	 and	 the	 chromatin	was	 rotated	 for	 2	 hours	 at	 4°C.	 Then	 the	supernatant	was	collected	in	a	new	tube	and	the	pre-clearing	beads	were	discarded.	The	pre-cleared	 chromatin	 was	 then	 aliquoted	 into	 4	 tubes,	 each	 aliquot	 containing	chromatin	from	2.5	x	105	cells.	The	preferred	antibody	was	then	added	to	each	tube	and	the	sample	was	incubated	on	the	rotating	wheel	over	night	at	4°C.	In	parallel,	for	each	IP	reaction	 20	 µl	 Dynabeads(R)	 Protein	 A	 for	 Immunoprecipitation	 per	 sample	 were	blocked	with	10	µl	BSA	(10	mg/ml)	and	20	µl	denaturated	tRNA.	The	beads	where	filled	up	 to	1	ml	with	TE	buffer	and	put	on	a	rotating	wheel	over	night	at	4°C.	Next	day	 the	beads	 were	 washed	 three	 times	 with	 WB1	 as	 described	 for	 the	 pre-clearing	 beads,	resuspended	 in	 20	 µl	 TE	 buffer	 per	 IP	 and	 then	 the	 chromatin	 was	 rotated	 with	 the	beads	for	3	hours	at	4°C.	Next,	two	washing	steps	were	performed	using	WB1	followed	by	one	washing	step	with	wash	buffer	2	(WB2,	50	mM	Tris	pH	8.0,	0.1%	SDS,	0.1%	Na-Deoxycholate,	 1%,	 Triton	 X100,	 500	 mM	 sodium	 chloride,	 1	 mM	 EDTA	 and	 0.5	 mM	EGTA),	 one	 with	 wash	 buffer	 3	 (WB3,	 50	 mM	 Tris	 pH	 8.0,	 250	 mM	 LiCl,	 0.5%	 Na-Deoxycholate,	0.5%	NP40,	1	mM	EDTA	and	0.5	mM	EGTA)	and	two	washing	steps	with	wash	 buffer	 4	 (WB4,	 50	mM	Tris	 pH	8.0,	 10	mM	EDTA	 and	5	mM	EGTA).	 The	 bound	chromatin	was	 then	eluted	 from	 the	beads	by	 incubation	of	130	µl	 elution	buffer	 (EB,	1%	SDS,	 0.1	M	NaHCO3)	 in	 a	 shaker,	with	 full	 speed	 shaking	 for	 15	min	 at	 65°C.	 The	liquid	was	collected	and	transferred	to	a	new	tube.	Then	the	elution	step	was	repeated	with	100	µl	EB	and	the	sample	collected	in	the	same	tube	as	before.	At	this	step	the	input	sample	 was	 thawed,	 filled	 up	 with	 EB	 to	 230	 µl	 and	 treated	 as	 the	 IP	 samples.	 All	
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samples	were	 filled	up	with	TE	buffer	 to	a	volume	of	300	µl.	For	digestion	of	RNA	the	chromatin	was	 incubated	with	 3	 µl	 RNAse	A	 resulting	 in	 a	 final	 concentration	 of	 200	µg/ml	 for	 45	min	 at	 37°C.	 Then	9	 µl	 5M	 sodium	 chloride	 and	3	 µl	 Proteinase	K	were	added	and	the	sample	decrosslinked	in	the	shaker	over	night	at	65°C.	Shaking	was	on	for	15	 min	 every	 hour.	 The	 next	 day	 the	 DNA	 was	 purified	 using	 the	 Qiaquick	 PCR	purification	 kit	 and	 eluted	 in	 30	 µl	 elution	 buffer	 supplied	 by	 the	 kit.	 This	 DNA	 was	tested	 for	 enrichment	 of	 positive	 and	 negative	 regions	 as	 described	 above	 and	 then	frozen	at	-20°C	until	library	preparation.	
	
Transcription	Factor	ChIP:		For	ChIP	of	GATA2,	GATA3,	TFAP2A	and	TFAP2C	1	 x	107	 cells	were	used	and	 treated	according	to	the	ChIP-IT	high	sensitivity	kit.		
Antibodies	used		
Name	 Vendor	 Catalog	number	 Lot	number	
Concentration	
used	H3K4me3	polyclonal	antibody	–	Premium	 Diagenode	 C15410003-50	 A.5051-001P	 1	µg/IP	H3K27me3	polyclonal	antibody	–	Classic	 Diagenode	 C15410069	 A1821D	 1	µg/IP	GATA2	antibody	(H-116)	 Santa	Cruz	 sc-9008	X	 B0514	 5	µg/IP	Purified	Mouse	anti-GATA3,			clone		L50-823	 BD	Biosciences	 558686	 509987	 5	µg/IP	AP-2α	(TFAP2A)	antibody	(C-18)	 Santa	Cruz	 sc-184X	 J1310	 5	µg/IP	AP-2γ	(TFAP2C)	antibody	(6E4/4)	 Santa	Cruz	 sc-12762X	 H2012	 5	µg/IP	
	
Next	generation	sequencing	
ChIP-Seq		Library	preparation	 for	ChIP-Seq	was	performed	using	 the	NEBNext	ChIP-Seq	Library	
Table	IV-16:	Antibodies	used	for	ChIP-Seq	experiments		
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Prep	Reagent	Set	for	Illumina		and	the	NEBNext®	Multiplex	Oligos	for	Illumina®	(Index	Primer	 Set	 1)	 according	 to	 manufacturer’s	 instruction	 with	 15	 cycles	 of	 PCR.	 The	libraries	where	then	multiplexed	and	sequenced	using	the	HiSeq®	Rapid	SBS	Kit	v2	(50	Cycle)	and	HiSeq®	Rapid	SR	Cluster	Kit	v2	on	a	HiSeq	2500	(Illumina).			
RNA-Seq:		The	following	paragraph	was	submitted	to	Developmental	Cell	for	publication	as	Krendl	et	al.	2017:	3	µg	of	RNA	were	treated	with	TURBO	DNase	(Life	Technologies,	am2238)	according	to	manufacturer’s	 instructions	 followed	 by	 Rneasy	 MinElute	 RNA	 cleanup	 kit	 (Qiagen,	74204).	Microcapillary	electrophoresis	on	Agilent	2100	Bioanalyzer	with	RNA	Pico	6000	kit	(Agilent,	5067-1513)	was	used	to	analyze	RNA	quality	(RIN	values	>8).	Per	RNA-seq	library,	 1	 µg	 of	 DNAse-treated	 RNA	 was	 treated	 with	 RiboZero	 Gold	(Human/Mouse/Rat)	 kit	 (Illumina,	 RS-122-2301)	 to	 remove	 rRNAs,	 followed	 by	 RNA	cleanup	using	the	Rneasy	MinElute	RNA	cleanup	kit.	Sequencing	libraries	were	prepared	using	 TruSeq	 Stranded	 total	 RNA	 LT	 kit	 (Illumina,	 RS-122-2301)	 according	 to	manufacturer’s	 instructions	 using	 11	 cycles	 of	 PCR	 followed	 by	 purification	 with	Agencourt	Ampure	XP	beads	(Beckman-Coulter,	A63881).	Libraries	were	evaluated	on	an	 Agilent	 2100	 Bioanalyzer	 using	 the	 DNA	 1000	 kit	 (Agilent,	 5067-1504).	 DNA	concentration	 was	 measured	 using	 a	 Qubit	 dsDNA	 HS	 Assay	 Kit	 (Life	 Technologies,	Q32854).	 Samples	were	 sequenced	using	a	NextSeq	500	 instrument	 to	generate	75-nt	single-end	 reads,	 sequencing	 depth	was	 20–40	Mio	 reads	 per	 library.	Multiplexing	 of	libraries	was	performed	according	to	manufacturer’s	instructions.	
	
Quantification	of	libraries		The	 concentration	 of	 the	 libraries	 was	 measured	 using	 the	 three	 methods	 described	below.	 The	molarity	was	 calculated	 automatically	 for	 the	Bioanalyzer	method,	 for	 the	two	other	methods	it	was	calculated	using	the	following	formula:	nM	=	!"#$%#&'(&)"# !"!"  ! !"""""" !"#$%&'( !"#$ ! !"# 	
	Then	the	mean	value	of	the	three	different	measurements	was	determined	and	libraries	
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diluted	stepwise	to	2	nM.		
	
Bioanalyzer		The	 fragment	 size	 and	 the	 molarity	 of	 the	 sample	 was	 determined	 using	 the	 High	Sensitivity	DNA	Analysis	Kit	 on	 a	 2100	Bioanalyzer	 instrument	 (Agilent)	 according	 to	manufacturer’s	instructions.	
	
Pico	green	concentration	measurement		The	DNA	concentration	was	measured	using	 the	Quant-iT	PicoGreen	dsDNA	Assay	Kit	with	 a	 Safire	 2	 multimode	 microplate	 reader	 (Tecan)	 according	 to	 manufacturer’s	instructions.			
Qubit	concentration	measurement		DNA	concentration	measurement	was	performed	using	the	Qubit	dsDNA	HS	Assay	Kit	on	a	Qubit	2.0	Flourometer	according	to	manufacturer’s	instructions.	
	
DNA	methylation	analysis		In	 order	 to	 identify	 differences	 in	 DNA	 methylation	 levels	 on	 a	 genome	 wide	 level,	genomic	DNA	from	sorted	populations	was	isolated	using	the	Wizard	DNA	isolation	kit	and	 bisulfite	 conversion	 was	 performed	 using	 the	 EZ	 DNA	 MethylationTM	 Kit.	 Three	replicates	 of	 each	 population	 were	 then	 analyzed	 with	 the	 Infinium	HumanMethylation450	 BeadChip	 kit	 according	 to	 manufacturer’s	 instructions.	 Data	analysis	was	performed	using	the	RnBeads	R	package	(http://rnbeads.mpi-inf.mpg.de).		
Immunofluorescent	Microscopy		The	following	paragraph	was	submitted	to	Developmental	Cell	for	publication	as	Krendl	et	al.	2017:	
	
	49	
Cells	 grown	 in	 8-well	 chamber	 slides	 coated	 with	 MG	 were	 fixed	 with	 4%	formaldehyde/PBS	for	15	min	at	room	temperature	and	permeabilized	with	0.3%	Triton	X-100/5%	BSA/PBS	for	30	min	at	room	temperature.	Primary	and	secondary	antibodies	were	 diluted	 to	 working	 concentrations	 in	 1%	 BSA/0.1%	 Triton	 X-100/PBS.	 Primary	antibody	was	 incubated	 overnight	 at	 4°C,	 secondary	 for	 1	 hour	 at	 room	 temperature.	Specimens	were	washed	with	PBS	containing	DAPI	before	applying	mounting	medium.	Images	were	obtained	using	a	Zeiss	Axiovert	200M	epifluorescent	microscope.			
Antibodies	used:	
	
Name	 Vendor	 Catalog	number	 Lot	number	
Concentration	
used	GATA-3	 Biocare	Medical	 CM	405	A	 031915	 1:200	AP-2α	(TFAP2A)	antibody		(C-18)	 Santa	Cruz	 sc-184X	 J1310	 1:200	AP-2γ	(TFAP2C)	antibody	(6E4/4)	 Santa	Cruz	 sc-12762X	 H2012	 1:200	Alexa	Fluor(R)	488	goat	anti-mouse	IgG	(H+L)	2	mg/ml	 Life	Technologies	 A11001	 1726530	 1:1000	
Western	blot		The	following	paragraph	was	submitted	to	Developmental	Cell	for	publication	as	Krendl	et	al.	2017:	
	Cells	 were	 trypsinized	 and	 lysed	 using	 RIPA	 buffer,	 containing	 phosphatase	 and	protease	inhibitors.	After	addition	of	2x	SDS	loading	buffer	supplemented	with	10%	2-Mercaptoethanol	 	 samples	were	heated	at	95°C	 for	5	min.	 Samples	were	 run	on	Mini-PROTEAN	TGX	Stain	Free	Gels,	4-15%	and	blotted	using	the	Mini	Trans-Blot	Cell	 (Bio-Rad	 Laboratories).	 Following	 3	 x	 5	min	 washing	 steps	 with	 TBS-T,	 membranes	 were	blocked	with	5%	milk	powder	in	TBS-T.	Membranes	were	then	incubated	over	night	at	4°C	with	 5%	milk	 powder	 in	 TBS-T	 containing	 the	 primary	 antibody.	 After	 3	 x	 5	min	
Table	IV-17:	Antibodies	used	for	immunofluorescent	microscopy		
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TBS-T	washing	 steps	 the	membrane	was	 incubated	with	 goat	 anti-mouse	 IgM-HRP	 in	5%	milk	 powder	 in	 TBS-T.	 Following	 4	 washing	 steps,	 15	 min	 each,	 with	 TBS-T	 the	membrane	 was	 incubated	 for	 1	 min	 with	 Clarity	Western	 ECL	 Substrate	 and	 imaged	with	ChemiDoc™	MP	System	(Bio-Rad	Laboratories).			Buffers	used:		
RIPA	buffer	 2x	SDS	loading	buffer	
1x	SDS	
running	buffer	
1x	wet	
transfer	
buffer	
TBS-T	50	mM	Tris	HCL	pH	7.5-8	 120	mM	Tris	HCl	pH	6.8	 2.5	mM	Tris	base	 2.5	mM	Tris	base	 2	mM	Tris	base	150	mM	NaCl	 4%	SDS	 19.2	mM	Glycine	 19.2	mM	Glycine	 15	mM	NaCl	1%	Trition	X-100	 20%	Glycerol	 0.01%	SDS	 	 0.1%	Tween	20	0.5%	Na	deoxycholate	 0.02	%	bromophenol	blue	 	 	 Adjust	pH	to	7.5	0.1%	SDS	 	 	 	 	
			Antibodies	used:	
Name	 Vendor	 Catalog	number	 Lot	number	
Concentration	
used	Purified	Mouse	anti-GATA3,			clone		L50-823	 BD	Biosciences	 558686	 509987	 1:700	β-Actin	(8H10D10)	Mouse	mAb	 Cell	signaling	 3700	 	 1:5000	
goat anti-mouse 
IgM-HRP	 Santa	cruz	 sc-2064	 	 1:10000	
	
CRISPR/Cas9	gene	editing	
	
Guide	RNA	design		Guide	 RNAs	 (gRNAs)	 were	 designed	 using	 the	 MIT	 CRISPR	 design	 webpage	
Table	IV-18:	Buffers	used	for	western	blot		
Table	IV-19:	Antibodies	used	for	western	blot		
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(http://crispr.mit.edu)	 according	 to	 Ran	 et	 al	 (Ran	 et	 al.,	 2013)	 instructions.	 For	 the	GATA3	genome	editing	experiment	two	pairs	of	gRNAs	were	designed,	flanking	a	region	at	the	first	exon/intron	boundary,	in	order	to	cut	out	this	genomic	region.	The	following	gRNAs	were	used	for	this	experiment:	
	
Name	 Target	 Sequence	GATA3_gRNA	 GATA3	 CACCGTACTGCGCCGCGTCCATGT	GATA3_gRNA_rev_comp	 GATA3	 AAACACATGGACGCGGCGCAGTAC	GATA3_gRNA_2	 GATA3	 CACCGACACTCTCGCGACGAGCCAG	GATA3_gRNA_rev_comp_2	 GATA3	 AAACCTGGCTCGTCGCGAGAGTGTC		
Vector	construction		gRNAs	were	resuspended	in	TE	buffer	to	a	final	concentration	to	1	µg/µl	and	1	µl	of	each	gRNA	 and	 reverse	 compliment	 fragment	 were	mixed	 in	 100	 µl	 TE	 buffer.	 They	 were	denatured	 in	 a	 Mastercycler	 nexus	 (Eppendorf)	 for	 5	 min	 at	 100°C.	 Then	 the	temperature	 was	 lowered	 for	 5°C/minute	 until	 25°C	 were	 reached.	 This	 allows	annealing	of	 the	 two	complementary	gRNA	fragments.	The	annealed	gRNAs	were	then	ligated	into	a	pBS	U6	Vector	with	the	following	reaction:		
Reagent	 Amount	pBS	U6	vector	 50	ng	gRNA	mix	 4	µl	H2O	 5	µl	2x	Quick	Ligation	Reaction	Buffer	 10	µl	Quick	T4	DNA	Ligase	 1	µl	
	This	mix	was	 then	 incubated	 for	5	min	at	 room	 temperature	and	 further	 transformed	into	 5-alpha	 Competent	 E.	 coli,	 which	 where	 first	 thawed	 on	 ice	 for	 30	 min.	 For	transformation	1	µl	of	the	ligation	was	mixed	with	50	µl	bacteria	and	incubated	for	30	min	on	ice.	After	this	they	were	incubated	for	30	seconds	at	42°C,	put	on	ice	for	2	min	and	 then	 supplemented	 with	 550	 µl	 SOC	 medium.	 The	 mix	 was	 incubated	 at	 a	thermomixer	at	500	rpm	shaking	 for	45	min	at	37°C	and	50	µl	were	 then	plated	on	a	pre-warmed	Agar	plate	 containing	100	µg/ml	ampicillin	 (AMP)	and	 incubated	at	37°C	over	 night.	 The	 next	 day	 colonies	 were	 picked	 and	 incubated	 in	 3	 ml	 LB	 medium	
Table	IV-20:	gRNA	sequences	used	for	genome	editing	experiments		
Table	IV-21:		Composition	of	the	ligation	reaction	of	pBS	U6	vector	and	gRNA		
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containing	AMP	 (100	µg/ml)	and	again	 incubated	at	37°C	over	night.	The	DNA	of	 this	mix	 was	 then	 isolated	 used	 the	 GeneJET	 Plasmid	 Miniprep	 Kit	 according	 to	manufacturer’s	 instructions	 and	 sent	 for	 Sanger	 sequencing	 using	 the	 U6	 forward	primer	to	GATC	Biotech.	Sanger	sequencing	results	were	analyzed	for	proper	integration	of	the	right	gRNA	using	the	Sequencher	5.1	software.	When	sequences	where	right	the	leftovers	of	 the	miniprep	were	 incubated	 in	100	ml	LB	Medium	containing	100	µg/ml	AMP	and	incubated	over	night	at	37°C.	Maxi	prep	was	performed	the	next	day	using	the	PureLink	HiPure	Plasmid	FP	Maxiprep	Kit	according	to	manufacturer’s	instructions.		
Nucleofection		For	 genetic	 modification	 experiments	 the	 HUES9	 iCRISPR	 cell	 line	 was	 used	 and	cultured	as	described	above.	For	nucleofection	a	10	cm	plate	of	70-80%	confluent	cells	was	dissociated	into	single	cells	using	3	ml	Accutase.	After	dissociation	the	Accutase	was	stopped	 using	 3	ml	mTESR1	 and	 cells	 were	 centrifuged.	 Cells	 were	 resuspended	 and	counted	 using	 the	 Neubauer	 cell	 counter.	 1	 x	 106	 cells	 were	 nucleofected	 with	 6	 µg	plasmid	(3	µg	per	target	sequence)	on	a	4D	NucleofectorTM	System	(Lonza)	using	the	P3	Primary	Cell	4D-Nucleofector	X	Kit.	Cells	were	re-plated	on	a	MG	coated	6	well	plate	in	pre-warmed	 mTESR	 and	 doxycycline	 hydrochloride	 (Dox)	 was	 added	 to	 1	 µg/ml.	Additionally	 ROCK	 inhibitor	 was	 added	 to	 a	 concentration	 of	 10	 µM	 for	 the	 first	 24	hours.	 After	 this	 period	 the	 cells	 were	 cultured	 for	 two	 days	 in	 mTESR1	 and	 Dox.	Thereafter	they	were	cultured	as	described	before.			
Identification	of	genetically	edited	clones		When	 cells	 on	 the	6	well	 reached	 confluency	 they	were	passaged	as	 single	 cells	using	Accutase	and	plated	on	MG-coated	10	cm	plates	in	a	low	density	(1:20	-	1:50)	in	order	to	obtain	single	cell	colonies.	For	the	first	24	hours	ROCK	inhibitor	was	added	as	described	above.	The	rest	of	the	cells	were	used	for	DNA	extraction	(explained	below)	and	testing	of	 the	 genome	 editing	 efficiency	 by	 PCR	 (explained	 in	 the	 next	 paragraph).	 gRNA	combinations	that	showed	a	cut	were	used	for	single	clone	picking.	
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After	clones	reached	a	size	that	was	sufficient	for	picking,	they	were	picked	using	the	tip	of	a	200	µl	pipette	and	put	into	one	well	of	a	96	well	plate.	Colonies	were	then	broken	up	and	1/10	of	it	was	taken	for	direct	DNA	isolation.			DNA	isolation	The	DNA	 isolation	was	performed	using	 the	QuickExtract	DNA	Extraction	Solution	1.0	according	 to	manufacturer’s	 instructions.	Briefly,	50	µl	of	 solution	was	added	 to	20	µl	media	 containing	 the	 cells,	 vortexed	 for	 15	 seconds	 and	 then	 incubated	 for	 6	min	 at	65°C.	 After	 this	 cells	were	 vortexed	 again	 for	 15	 seconds	 and	 incubated	 for	 2	min	 at	98°C.			PCR	To	 detect	 the	mutated	 genomic	 DNA,	 I	 designed	 primers	 flanking	 the	 site	 of	 excision	using	Primer	3	plus.	Initially	primers	were	tested	on	genomic	DNA	using	a	gradient	PCR	with	an	annealing	temperature	from	60°C	to	70°C.	The	results	were	then	detected	on	an	agarose	gel	 in	Lithium	Acetate	Borate	(LAB)	buffer	(10mM	Lithium	Acetate	and	10mM	Boric	Acid)	including	Sybr	Safe	(1:20000).	The	percent	of	the	agarose	gel	used	depended	on	 the	 size	 of	 the	 fragment	 that	 should	 be	detected.	 Fragments	 smaller	 than	1500	bp	were	analyzed	on	a	1,5%	agarose	gel,	whereas	 fragments	between	1500	and	5000	bp	were	analyzed	on	a	1%	agarose	gel.	This	testing	resulted	in	the	following	conditions	for	GATA3:	
PCR	
Mastermix	
Volume(μl)	for	1	reaction	for	bulk	
Volume(μl)	for	1	reaction	for	picked	colonies	
	
PCR	program	 Temperature	in	°C	 Time	in	min	
Taq	PCR	Master	Mix	 10	 10	 	 	 94	 3	4µM	Primer	mix		 2	 2	 	 45x	 94	 0.5	DNA	 2	 6	 	 68.2	 1	H2O	 6	 2	 	 72	 1	
Total	
volume	 20	 20	 	 	 72	 10	
	 	 	 	 	 10	 hold	
	Primers	used	
Table	IV-22:		PCR	mastermix	and	program	used	for	detection	of	GATA3	mutated	clones		
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	 Target	 Forward	primer	 Reverse	primer	GATA3	 CGAGGCCATGGAGGTGACGG	 CCCCCACCCCAAAACCTGCA	
	
Data	analysis			Data	 analysis	 was	 performed	 in	 collaborations	 with	 Dr.	 Steffen	 Sass	 (Institute	 of	Computational	 Biology,	 Helmholtz	 Center	 Munich,	 Munich,	 Germany)	 and	 Dr.	 Tobias	Straub	 (Biomedical	 Center	 Munich,	 ZFP	 and	 Bioinformatic	 Unit,	 Planegg-Martinsried,	Germany)		The	 following	 paragraphs	 were	 submitted	 to	 Developmental	 Cell	 for	 publication	 as	Krendl	et	al.	2017:	
Microarray		CEL	files	were	processed	and	normalized	using	the	affy	package	within	the	R	framework	for	statistical	computing.	Normalization	was	performed	using	robust	multiarray	average	(RMA).	 Genes	 with	 low	 variation	 or	 low	 signal	 were	 removed	 by	 applying	 a	 filtering	approach	 that	 is	 implemented	 in	 the	 genefilter	 package	 (Bourgon	 et	 al.,	 2010).	Differential	gene	expression	was	determined	using	limma	(Smyth,	2004).	P-values	were	corrected	for	multiple	testing	using	the	Benjamini	and	Hochberg.	A	gene	was	considered	to	be	differentially	expressed	if	its	corrected	p-value	was	below	a	threshold	of	0.05.	The	resulting	gene	sets	were	subject	to	literature-based	tissue	enrichment	analysis	using	the	GeneRanker	tool	within	the	Genomatix	Software	Suite.		
ChIP-Seq	read	processing		Sequencing	 reads	 were	 aligned	 to	 version	 hg19	 of	 the	 human	 genome	 using	 bowtie	(Langmead	et	al.,	2009)	version	1.1.1	allowing	only	for	single	matches	to	the	reference	(parameter	–m	1).	We	extended	the	matched	reads	to	a	total	of	200	bp	and	calculated	for	each	sample	a	per-base	genomic	coverage	vector	by	cumulating	the	total	spans	of	all	sequenced	fragments.			
Table	IV-23:		Primers	used	for	detection	of	GATA3	mutated	clones		
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Histone	modification	enrichment	at	promoters		Per	gene	for	each	4	kb	window	the	number	of	matching	reads	in	each	replicate	sample	were	 calculated.	 Raw	 read	 counts	 were	 transformed	 by	 𝑟𝑒𝑎𝑑𝑠. 𝑡𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑒𝑑! =𝑎𝑟𝑐𝑠𝑖𝑛 !"#$%!!"!#$ !"#!" ,	where	i	=	promoter	window,	reads	=	number	of	reads	covering	i.	Signal	 enrichment	 was	 analyzed	 by	 subtracting	 the	 normalized	 reads	 of	 the	corresponding	input	samples	from	the	IP	read	values.	Enrichments	across	replicates	of	each	 histone	 modification	 were	 adjusted	 by	 quantile	 normalization	 and	 values	 were	averaged.	 In	 case	 of	 many	 promoters-to-one	 gene	 relationships	 we	 selected	 the	promoter	with	highest	interquartile	range	of	signals	across	all	experimental	conditions.		
	
Peak	calling	and	definition	of	robust	peak	sets		Transcription	 factor	 peaks	were	 called	 using	Homer	 (Heinz	 et	 al.,	 2010)	 findPeaks	 (v	4.7.2)	 with	 parameters	 style=factor,	 size=200,	 fragLength=200,	 inputFragLength=200	and	C=0.	All	 peaks	were	 called	 using	 the	 corresponding	 input	 samples	 as	 control.	We	defined	peaks	 as	 robust	 if	 the	 region	was	 called	 in	 at	 least	 two	biologically	 replicated	samples	except	for	TFAP2C,	for	which	only	one	high	quality	data	set	was	obtained.		
De	novo	motif	discovery	and	genome-wide	motif	searches		We	search	for	enriched	motifs	in	peak	regions	using	MEME	(Bailey	et	al.,	2009)	using	the	zero	or	one	occurrence	per	sequence	(“zoops”)	model.		
RNA-Seq		RNA-Seq	reads	were	mapped	to	the	hg38	genome	using	TopHat	(Trapnell	et	al.,	2009).	The	resulting	alignments	were	overlaid	with	the	UCSC	“known	gene”	track	(Kent	et	al.,	2002)	 to	obtain	exon	read	coverage	 for	every	annotated	gene.	Genes	with	a	maximum	read	 count	 of	 zero	 across	 all	 samples	were	 considered	 to	 be	 non-expressed	 and	 thus	removed	 from	 further	 analysis.	 The	 count	 data	 was	 then	 pre-processed	 using	 voom	(Law	 et	 al.,	 2014)	 including	 quantile	 normalization	 between	 the	 individual	 samples.	Differential	gene	expression	between	time	points	was	then	determined	similarly	to	the	
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microarray	 data.	 For	 illustration	 purposes	 data	 was	 normalized	 using	 the	 igv	 tools	option	normalize	coverage	data.	Time	series	of	selected	TFs	were	clustered	according	to	the	pairwise	Pearson	correlation	coefficients	using	k-means	clustering	analysis	with	k=6	clusters.	Fisher’s	exact	test	was	employed	 to	 test	 whether	 a	 set	 of	 genes	 with	 a	 certain	 histone	 modification	 was	significantly	overrepresented	in	one	of	the	resulting	clusters.		
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V.	Results	
Analysis	of	the	lineage	correspondence	and	heterogeneity	of	
progeny	generated	from	human	ESCs	by	BMP4		There	 is	 still	 controversy	 whether	 the	 trophoblast-like	 progeny	 that	 emerges	 from	human	ESCs	 by	 BMP4	 treatment	 descends	 from	mesoderm	 or	 trophoblast	 precursors	(Aims	 section	 “To	 resolve	 the	 uncertainty	 concerning	 the	 lineage	 correspondence	 of	human	PSC-derived	trophoblast	progeny”).	Furthermore	the	degree	of	heterogeneity	in	this	progeny	population	 is	not	clear.	To	address	these	questions	I	 treated	human	ESCs	plated	 as	 single	 cells	with	BMP4,	 a	 regimen	 that	 promotes	 trophoblast	 differentiation	(Introduction	 section” Transcriptional	 processes	 in	 response	 to	 Bone	 Morphogenic	Protein	(BMP)	4	in	human	ESCs“).	To	determine	the	optimal	time	point	for	purifying	the	cells	by	sorting	I	first	analyzed	the	expression	of	APA	by	flow	cytometry	(Figure	V-1A).	This	 showed	only	~10%	APA+	cells	 in	 the	 first	 two	days,	but	at	day	3	 this	population	increased	to	around	60%	of	the	cells,	which	then	plateaued	(Figure	V-1B).		
	
Based	 on	 this	 analysis,	 I	 elected	 the	 time-point	 of	 2.5	 days	 for	 purifying	 the	 cells	 and	analyzing	their	cell	intrinsic	properties	(as	earlier	time-points	do	not	yield	sufficient	cell	amounts	for	genome-wide	analyses).	I	sorted	the	top	20%	APA+	and	lowest	20%	APA-	cells	 for	 analyzing	 the	 corresponding	 trophoblast	 and	 non-trophoblast	 progenitor	
Figure	V-1:	Time	course	analysis	of	APA+	cells	A.	 Representative	 time-course	 flow	 cytometry	 measurements	 of	 the	 cell	 surface	marker	APA	in	BMP4-treated	human	ESCs	over	a	period	of	6	days.	B.	A	Diagram	showing	the	percentage	of	the	APA+	population	over	a	period	of	6	days.	
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population	 (Figure	 V-2A).	 Residual	 differentiated	 cells	 were	 eliminated	 from	 human	ESCs	 cultures	 by	 staining	 the	 cells	 using	 an	 antibody	 specific	 for	 the	 surface	 marker	SSEA-5	and	sorting	of	the	positive	fraction	(Tang	et	al.,	2011).	An	 important	 characteristic	 of	 trophoblast	 or	 placenta	 cells	 is	 the	 expression	 of	hormones,	 including	 the	 human	 chorionic	 gonadotropin	 (hCG)	 (Introduction	 section	“Human	placental	development”).	Therefore,	 to	validate	 the	 trophoblast	enrichment	of	the	 BMP-4	 treated	 human	 ESC	 cultures,	 I	 tested	 the	 production	 of	 hCG	 initially	 using	pregnancy	“stick”	 tests	and	 later	using	a	quantitative	 immunoencymometric	assay.	My	analysis,	conducted	at	days	0,	2,	4,	6	and	8	confirmed	trophoblast	induction	using	BMP-4,	as	only	cells	of	 these	cultures	produced	the	hormone	starting	at	day	4	and	not	cells	treated	with	KSR	medium	only		(Figure	V-2B).	
	
To	 address	 the	 lineage	 identity	of	 the	APA+	and	APA-	populations,	 I	 initially	 analyzed	these	 populations	 using	 RT-PCR.	 Testing	 the	 expression	 of	 specific	 assays	 for	pluripotency	 (OCT4),	 trophoblast	 (CDX2,	 ELF5,	 ENPEP	 and	 GCM1)	 and	 meso-	 or	mesendoderm	(MESP1,	T,	CD13,	ROR2	and	GSC)	genes	showed	that	both,	the	APA+	and	the	APA-	population	compared	to	sorted	SSEA-5+	cells	exhibited	a	decrease	of	OCT4	and	an	 increase	of	 trophoblast	 genes.	Moreover,	 the	expression	of	ELF5,	ENPEP	 and	GCM1	
Figure	 V-2:	 Flow	 cytometry	analysis	 of	APA	and	hormone	production	 of	BMP4	 treated	
human	ESCs.	A.	A	representative	flow	cytometry	analysis	of	the	cell	surface	marker	APA	in	2.5	day	BMP4-treated	 human	 ESCs.	 Gates	 used	 for	 sorting	 of	 top	 and	 bottom	 20%	 of	 the	population	are	shown.	FL2	=	Fluorescence	2	B.	Time	course	analysis	of	hCG	protein	concentration	produced	by	human	ESCs	treated	with	KSR	based	medium	alone	or	KSR+BMP4	(n=2).		
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was	higher	in	the	APA+	population	compared	to	the	APA-	population.	In	addition	in	the	APA-	 population	 compared	 to	 the	 SSEA-5+	 cells	 I	 observed	 an	 increase	 in	meso-	 and	mesendoderm	gene	expression	(Figure	V-3).	These	data	provided	me	the	confirmation	necessary	 for	 conducting	 further	 analysis	pertaining	 to	 the	 identity	of	 the	 trophoblast	progenitors	and	for	mechanistic	investigation.		
		
Next,	I	analyzed	the	same	samples	(three	replicates	of	SSEA-5+,	APA-	and	APA+	sorted	cells)	 using	 GeneChip	 Human	 Gene	 2.0	 ST	 arrays	 (Affymetrix).	 This	 platform	 allows	quantification	 of	 approximately	 40,000	 RefSeq	 transcripts,	 including	 nearly	 25,000	genes	 and	 11,000	 lincRNAs.	 Analysis	 of	 these	 samples	 according	 to	 gene	 expression	
Figure	V-3:	Targeted	gene	expression	measurements	in	APA-	and	APA+	populations.	Quantitative	 PCR	 analysis	 of	 canonical	 developmental	 TFs	 and	markers,	 involved	 in	pluripotency,	 trophoblast,	 mesoderm	 and	 mesendoderm	 development,	 assayed	 in	sorted	APA-,	APA+,	SSEA-5+	cell	populations.	Expression	amplitudes	were	normalized	to	 the	 SSEA-5+	 cell	 population,	 or	 delta	 Ct	 relative	 to	GAPDH,	 if	 expression	was	 not	detected	 in	 the	 SSEA-5+	 cell	 population.	 Standard	 error	 of	 the	 mean	 of	 two	independent	 experiments	 (sorted	 from	human	ESCs	of	different	passages)	 is	 shown.	ND	refers	to	not	detected.		
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patterns	 showed	 that	 all	 replicates	 of	 the	 respective	 populations	 clustered	 together	(Figure	V-4A).	Furthermore,	this	showed	that	the	APA-	population	is	more	similar	to	the	SSEA-5+	population	than	the	APA+	population	to	the	SSEA-5+	population.	By	applying	a	two-fold	expression	change	cutoff	and	a	false	discovery	rate	(FDR)	cutoff	of	5%	between	biological	 replicates	 I	 found	 around	 720	 decreased	 (Figure	 V-4B)	 and	 around	 1000	increased	 (Figure	V-4C)	 transcripts	between	all	 three	 conditions.	 I	 also	noted	 that	 the	proportion	 of	 transcripts	 differentially	 expressed	 between	 the	 APA+	 vs.	 SSEA-5+	populations	is	much	higher	than	between	the	APA-	vs.	SSEA-5+	populations.	I	presume	the	reason	for	this	is	because	the	replicates	of	the	APA-	population	are	heterogeneous,		and	therefore	many	genes	do	not	reach	the	5%	FDR	threshold.	This	 in	depth	 transcriptomic	approach	corroborated	and	expanded	 the	RT-PCR	data.	 I	found	that	the	pluripotency	downregulation	also	includes	SOX2	and	NANOG	next	to	OCT4	(Figure	 V-4B).	 Furthermore,	 among	 the	 notable	 increased	 transcripts	 I	 identified	 a	trophoblast	 specific	 signature,	 consisting	 of	 GCM1,	 TP63,	 ENPEP,	 GATA3	 and	 TFAP2C	(Introduction	 section	 “The	 transcriptional	 network	 of	 TE	development“)	Among	 these	genes,	 I	 found	VGLL1,	whose	homolog	has	been	shown	to	be	a	co-factor	 for	one	of	 the	primary	TE	formation	factors	in	the	mouse,	Tead4	(Nishioka	et	al.,	2008),	leading	me	to	postulate	that	it	also	may	play	a	role	in	human	TE	development.	
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Next,	 I	 analyzed	 the	 genome-wide	 transcriptome	 data	 in	 the	 respective	 populations	using	Genomatix	GO-term	analysis	of	enriched	 tissue	and	cell	 type	categories.	Starting	with	the	increased	genes	in	the	APA+	vs.	the	SSEA-5+	cell	population	identified	placenta	
Figure	V-4:	Microarray-based	transcript	expression	analysis	of	APA-,	APA+	and	SSEA-5+	
populations.	A.	 An	 hierarchical	 clustering	 of	 Affymetrix	 GeneChip	 Human	 Gene	 2.0	 ST	 Array	triplicate	 APA-,	 APA+	 and	 SSEA-5+	 cell	 population	 data	 calculated	 using	 Pearson	correlation	coefficients	as	measure	of	similarity.	It	shows	sample	clustering	according	to	cell	population	identity.	B.	 -	 C.	 Venn	 diagrams	 exhibiting	 the	 number	 and	 overlap	 of	 decreased	 (B)	 and	increased	(C)	gene	transcripts	 in	APA+	versus	APA-	populations	and	sorted	SSEA-5+	undifferentiated	 human	ESCs.	Transcript	measurements	 performed	using	Affymetrix	Human	 Gene	 ST	 2.0	 arrays.	 Differentially	 expressed	 transcripts	 were	 analyzed	 by	applying	 a	 fold	 change	 cut-off	 of	 2	 and	 a	 false	 discovery	 rate	 (FDR)	 of	 5%	between	biological	repetitions	(n=3).	Two	folds	higher	number	of	differentially	expressed	genes	was	 noted	 comparing	 the	 APA+	 versus	 the	 SSEA-5+	 cell	 population	 than	 the	 APA-	versus	 the	 SSEA-5+	 and	 the	 APA+	 versus	 the	 APA-	 cell	 population,	 because	 fewer	genes	 in	 the	 APA-	 population	 reached	 the	 FDR	 threshold	 of	 5%.	 The	 positions	 of	canonical	pluripotency	and	trophoblast	genes	are	indicated	respectively	in	(B)	and	(C).	
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and	trophoblast	associated	categories	among	the	highest	enriched	(exhibiting	the	lowest	p-values)	(Figure	V-5A).	In	contrast,	comparing	enriched	transcripts	of	the	APA-	vs.	the	SSEA-5+	cell	populations,	the	most	enriched	tissues	were	of	ectoderm,	mesenchymal	or	embryonic	structure	categories	(Figure	V-5B).	Finally,	comparing	the	APA+	vs.	the	APA-	increased	transcripts	we	identified	only	uterus,	trophoblast	and	placenta	tissues	among	the	top	7	enriched	GO-terms	(Figure	V-5C).			
	
After	establishing	the	lineage	correspondence	of	the	APA+	population	to	trophoblasts,	I	next	 analyzed	 the	 similarity	 to	 early	 embryonic	 human	 TE.	 I	 relied	 on	 a	 published	dataset	that	compared	TE	cells	isolated	from	human	blastocysts	to	human	ESCs	(Bai	et	al.,	 2012).	 I	 found	 an	 overlap	 of	 23	 TFs,	 which	 underlie	 the	 classification	 of	trophoblast/placental	 tissues,	whereas	 the	non-overlapping	TFs	were	mostly	enriched	for	 other	 embryonic	 structures	 (Figure	 V-6).	 Taken	 together	 these	 data	 clarify	cell/lineage	 identifies	 pertinent	 to	 my	 primary	 study	 objectives	 and	 questions:	 it	strengthens	 the	 perspective	 that	 the	 trophoblast	 progeny	 of	 human	 ESCs	 is	 of	 a	 TE	
Figure	V-5:	GO-term	analysis	of	enriched	tissues	of	APA-,	APA+	and	SSEA-5+	populations	Genomatix	 GO-term	 analysis	 of	 enriched	 tissue	 and	 cell	 type	 categories	 applied	 to	transcripts	 increased	 in	 the	 APA+	 compared	 to	 SSEA-5+	 (A),	 the	 APA-	 compared	 to	SSEA-5+	(B)	and	the	APA+	compared	to	the	APA-	(C)	cell	populations.	(A)	and	(C)	show	enrichment	for	placenta,	cytotrophoblast	and	others,	while	(B)	shows	enrichment	for	different	–	non-placenta-	categories.	
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origin,	 it	 indicates	 a	 mixed	 lineage	 embryonic	 character	 of	 the	 non-trophoblast	population	that	emerges	during	early	differentiation	of	human	ESCs	using	BMP4,	and	it	reveals	the	correspondence	of	human	trophoblast	progenitors	to	human	embryonic	TE.	Further	it	corroborates	the	use	of	APA+	cells	that	emerge	from	human	ESCs	in	vitro	by	treatment	using	BMP-4	as	a	differentiation	system	that	enables	to	study	differentiation	mechanisms	towards	human	extraembryonic	tissues.			
	
	
Histone	modification	turnover	during	BMP4-mediated	
human	ESC	differentiation	to	trophoblast	progenitors		Mechanisms	of	epigenetic	regulation	produce	the	phenotypic	diversity	of	our	cells	and	tissues	that	harbor	the	same	genetic	information.	The	histone	composition	and	specific	modifications	of	histones	establish	the	grounds	for	differential	gene	expression	among	
Figure	V-6:	Comparison	of	in	vitro	generated	trophoblasts	to	TE	from	human	embryos	A	 VENN	 diagram	 exhibiting	 the	 correspondence	 in	 upregulation	 of	 TFs,	 co-transcriptional	 regulators	 and	 ENPEP	 (APA)	 (extracted	 using	 the	 Genomatix	bioinformatics	 tool)	 between	 a	 published	 dataset	 (Bai	 et	 al.,	 2012)	 (comparing	 TE	versus	 human	 ESCs)	 and	 my	 list	 of	 genes	 in	 the	 APA+	 versus	 the	 SSEA-5+	 cell	population.	 A	 5	 and	 2	 fold-change	 cut-off	 were	 applied	 to	 the	 published	 and	 my	dataset,	 respectively.	 Middle	 pane	 shows	 Genomatix	 GO-term	 analysis	 of	 enriched	tissues	 of	 the	 respective	 group	 of	 genes.	 Right	 pane	 shows	 the	 extracted	 TFs	 plus	
ENPEP	from	the	group	of	overlapped	genes.		
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cell	types	(Introduction	section	“Chromatin	associated	histone	turnover	in	development	and	 differentiation”).	 To	 gain	 understanding	 of	 the	 mechanisms	 that	 regulate	 the	establishment	 of	 the	 trophoblast	 fate	 I	 therefore	 used	 my	 human	 ESC	 BMP4	differentiation	system.	I	focused	on	identifying	the	locations	of	the	activating	H3K4me3	and	the	repressing	H3K27me3	 in	 the	sorted	SSEA-5+,	APA-	and	APA+	cell	populations	using	 chromatin	 immunoprecipitation	 (ChIP)	 in	 conjunction	 to	 next	 generation	sequencing	 (ChIP-Seq).	 The	 reason	 for	 analyzing	 these	 marks	 is	 to	 identify	 the	reshuffling	of	histone	modifications	and	to	establish	its	correlation	with	gene	expression	changes	during	the	differentiation	process	on	a	genome	wide	level.	
	
Optimization	of	protocols	and	reagents		I	first	established	a	histone	H3K4me3	and	H3K27me3	ChIP	protocol	that	is	suitable	for	small	cell	populations	that	I	could	readily	purify	by	FACS.	I	tested	different	protocols	till	the	ChIP	yielded	 the	 lowest	background	and	highest	enrichment	 for	 specific	 sites,	 and	DNA	 fragments	 of	 around	 150	 and	 500	 bps	 for	 maximizing	 the	 resolution	 of	 the	sequencing	(Methods	section	“Chromatin	Immunoprecipitation”).		In	addition,	I	have	tested	the	specificity	of	the	ChIP	antibodies,	because	binding	to	other	histone	modifications	 could	produce	 false	positive	hits.	 I	 verified	 the	 specificity	of	 the	antibodies	 using	 a	 membrane	 blotted	 with	 modified	 histones.	 This	 showed	 that	Diagenode	 antibodies	 exhibited	 the	 highest	 specificity	 (for	 example	 compare	 with	membranes	reacted	with	H3K27me3	antibodies	from	Millipore	and	Active	Motif	which	exhibited	unspecific	binding	to	H3K4me3,	H3K9me3	and	Millipore	also	to	H3K36me3	in	Figure	V-7).	
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		Furthermore,	 I	have	tested	the	quality	of	 the	ChIP	by	RT-PCR	using	primers	that	were	designed	 for	 genomic	 regions	 that	 harbor	 the	 respective	 H3K27me3	 and	 H3K4me3	modifications	 in	 human	 ESCs	 and	 negative	 control	 regions	 where	 these	 marks	 were	previously	 found	 to	 be	 absent.	 The	 percent	 of	 input	 DNA	 was	 used	 to	 calculate	 the	enrichment	 or	 depletion	 of	 the	 histone	marks.	 These	 experiments	 have	 validated	 that	the	 Diagenode	 antibodies	 produced	 the	 highest	 enrichment	 (Figure	 V-8).	 Finally,	 I	adjusted	the	amount	of	antibody	that	was	optimal	for	the	ChIP	of	2.5	x	105	sorted	cells.		
Figure	V-7:	Testing	of	H3K27me3	antibody	specificity	for	ChIP	AbSurance	Histone	H3	Antibody	Specificity	Arrays	reacted	with	Millipore,	 ,	Active	Motif	 and	Diagenode	antibodies.	 The	 red	 rectangle	 represents	 the	 sector	 spotted	with	H3K27me3	histones.	The	signal	 in	 the	 lower	right	corner	 corresponds	to	an	internal	positive	control	that	detects	the	secondary	antibody.		
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Global	analysis	of	H3K4me3	and	H3K27me3	positions	during	trophoblast	
specification		To	analyze	histone	modification	positions	that	are	relevant	to	the	transcriptome	profiles	of	the	sorted	APA+,	APA-	and	undifferentiated	SSEA-5+	cell	populations,	I	used	the	same	preparations	for	ChIP-Seq	as	were	used	for	microarray	analysis.	I	analyzed	the	DNA	fragments	by	Illumina	HiSeq2500	instrument	providing	at	least	20	million	50bp	single	end	reads	per	sample,	and	mapped	these	to	the	hg19	human	genome	annotation	(Methods	section	“ChIP-Seq	read	processing“).	Mapping	the	reads	to	the	human	genome	showed	statistically	significant	positions	of	the	H3K4me3	mark	 in	narrow	peaks	around	 transcription	 start	 sides,	 and	 the	H3K27me3	mark	 exhibited	 coverage	 over	 broader	 regions	 in	 general	 and	 in	 gene	 bodies.	 These	results	are	consistent	with	the	functions	of	H3K4me3	and	H3K27me3	in	gene	activation	and	 repression,	 respectively	 (Introduction	 section	 “Epigenetic	 profiles	 of	 PSCs“).	
Figure	V-8:	Testing	of	H3K4me3/K27me3	antibody	specificity	by	RT-PCR	A.	RT-PCR	analysis	of	regions	within	ACTB,	GAPDH,	B2M,	HOXD12,	ESR,	and	SPERT	loci	using	 template	 DNA	 derived	 from	 ChIP	 of	 sorted	 SSEA-5+	 cells	 with	 H3K4me3	Diagenode	 premium	 polyclonal	 antibody	 (Cat.	 Nr.	 C15410003-50,	 LotNr:	 A.5051-001P).	Matched	IgG	control	was	used,	and	percentage	of	enrichment	over	the	input	is	shown.	B.	 RT-PCR	 analysis	 of	 regions	within	HOXD12,	EVX2,	NEUROG1,	GAPDH,	CCND1,	 and	
B2M	 loci	 using	 template	 DNA	 derived	 from	 ChIP	 of	 sorted	 SSEA-5+	 cells	 with.	H3K27me3	 Diagenode	 standard	 polyclonal	 antibody	 (Cat.	 Nr.	 C15410069,	 LotNr:	A1821D).	Matched	IgG	control	was	used,	and	percentage	of	enrichment	over	the	input	is	shown.		
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Following	 these	 validations,	 I	 focused	 on	 the	 biological	 functions	 of	 the	 respective	histone	modifications	to	the	process	of	trophoblast	specification,	and	therefore	analyzed	the	 differentially	 expressed	 genes	 in	 the	 APA+	 vs.	 the	 SSEA-5+	 cell	 population	 in	 this	respect.	Analyzing	 first	 the	 histone	modification	 turnover	 of	 the	 increased	 genes,	 I	 discovered	that	 more	 than	 half	 of	 these	 genes	 harbor	 the	 activating	 H3K4me3	 mark	 in	 their	respective	promoter	regions	already	in	the	SSEA-5+	undifferentiated	cell	population.	In	addition	 22%	 of	 genes	 exhibit	 bivalency	 marks	 (H3K4me3	 and	 H3K27me3	colocalization),	and	18%	do	not	harbor	both	marks	(no	Mod).	Only	a	very	small	fraction,	around	2%,	of	the	increased	genes,	is	marked	by	H3K27me3	in	SSEA5+	cells	(Figure	V-9).	 In	 the	 SSEA-5+	 to	 APA+	 transition	 I	 registered	 a	 high	 degree	 of	 turnover	 in	 the	bivalent	genes	to	H3K4me3,	and	hardly	any	gene	in	the	H3K4me3	monovalent	group	in	SSEA5+	 cells	 change	 their	 histone	mark	 configuration	 during	 differentiation	 to	 APA+,	which	 is	 expected	 because	 H3K4me3	 marks	 have	 been	 found	 to	 be	 a	 key	 feature	 at	active	gene	promoters.	Conversely	and	unexpectedly,	only	a	small	fraction	of	the	genes	in	the	no	Mod	category	change	their	histone	mark	configuration	during	differentiation	to	APA+	 trophoblast	 progenitors.	 This	 is	 surprising	 because	 in	 many	 cases	 active	transcription	 is	 accompanied	 by	 H3K4me3	 marks	 in	 the	 promoter	 region	 of	 the	respective	gene.	
		
Figure	V-9:	Histone	modification	turnover	of	
increased	transcripts	in	the	APA+	vs.	SSEA-5+	
cell	populations	Transcripts	 were	 assigned	 to	 four	 histone	modification	 classes,	 H3K27me3,	 H3K4me3,	bivalent	double	positive	and	no	modification	(no	Mod)	based	on	enrichments	of	H3K4me3	and	 H3K27me3	 signals	 in	 a	 4	 kb	 window	around	 their	 TSS	 (n=3).	 Analysis	 included	870	 increased	 genes	 from	 lists	 of	differentially	 expressed	 transcripts	 in	 the	APA+	 versus	 the	 SSEA-5+	 cell	 population.	Presented	 are	 the	 changes	 in	 the	 histone	classes	 between	 the	 SSEA-5+	 and	 the	 APA+	cell	population.		
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Analyzing	the	histone	modification	landscape	of	the	decreased	transcripts	with	respect	to	their	configuration	in	SSEA-5+	undifferentiated	cells	revealed	that	the	majority	of	the	genes	 harbor	 monovalent	 H3K4me3	 marks.	 Interestingly,	 although	 they	 were	transcriptionally	downregulated,	most	monovalent	H3K4me3	genes	maintain	the	mark,	and	 this	 indicates	 that	 these	 genes	 are	 still	 active	 in	 APA+	 cells,	 just	 at	 a	 lower	 level.	Interestingly,	we	find	the	pluripotency	gene	NANOG	in	a	small	group	of	genes	where	the	H3K4me3	 monovalent	 mark	 is	 removed	 upon	 differentiation,	 and	 this	 indicates	 a	distinct	mode	of	reducing	transcriptional	activity	(Figure	V-10).			
	
	
H3K4me3	and	H3K27me3	turnover	in	TFs	during	trophoblast	specification		Because	TFs	and	transcriptional	co-factors	are	critical	drivers	of	cell	fate,	I	next	focused	the	 analysis	 on	 them	 for	 understanding	 the	 mechanisms	 of	 trophoblast	 progenitor	specification.	 Interestingly,	 these	 fell	 into	 two	categories	containing	classical	early	and	late	mouse	/	human	trophoblast	genes,	e.g.	GATA3,	TFAP2C	and	CDX2,	and	ELF5,	GCM1,	
VGLL1	 and	TP63,	which	belonged	 to	 the	bivalent	 and	no-mod	 categories,	 respectively.	Furthermore	 I	 noted	 an	 enrichment	 of	 placenta-associated	 non-TFs	 in	 this	 no	 Mod	category	 (Figure	 V-11).	 This	 indicates	 that	 bivalent	 TFs	 in	 SSEA5+	 cells	 could	 be	activated	faster	than	the	ones	carrying	none	of	the	H3K4me3	or	H3K27me3	marks.		
Figure	V-10:	Histone	modification	turnover	of	
decreased	transcripts	in	the	APA+	vs.	SSEA-5+	
cell	population	Transcripts	 were	 assigned	 to	 four	 histone	modification	 classes,	 H3K27me3,	 H3K4me3,	bivalent	double	positive	and	no	modification	(no	Mod)	based	on	enrichments	of	H3K4me3	and	 H3K27me3	 signals	 in	 a	 4	 kb	 window	around	 their	 TSS	 (n=3).	 Analysis	 included	592	 decreased	 genes	 from	 lists	 of	differentially	 expressed	 transcripts	 in	 the	APA+	 versus	 the	 SSEA-5+	 cell	 population.	Presented	 are	 the	 changes	 in	 the	 histone	classes	 between	 the	 SSEA-5+	 and	 the	 APA+	cell	population.	The	position	of	pluripotency	genes	NANOG	and	OCT4	is	indicated.		
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	Figure	V-11:	Histone	modifications	of	APA+	enriched	TFs	A	 heatmap	 display	 of	 APA+	 versus	 SSEA-5+	 increased	 genes	 and	 their	 respective	histone	mark	 enrichments	 at	 gene	 promoters	 analyzed	 in	 APA-,	 APA+,	 and	 SSEA-5+	cell	 populations.	 Genes	 are	 grouped	 according	 to	 their	 histone	 modification	configurations	 in	 SSEA-5+	 cells.	 Right	 pane	 displays	 TFs	 isolated	 of	 the	 respective	groups.	 Additional	 placenta	 associated	 genes	 (non	 TFs)	 of	 the	 no-mod	 category,	identified	via	GO	term	analysis	(Genomatix)	are	displayed.		
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Representative	examples	of	bivalent	(GATA3),	H3K4me3	monovalent	(ARID3A),	H3K27me3	monovalent	(TFAP2B)	and	no	Mod	(GCM1)	genes	in	SSEA-5+	cells	and	their	histone	modification	turn-over	to	the	APA-	and	the	APA+	population	are	shown	in	Figure	V-12.		
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For	the	downregulated	TF	OCT4	a	representative	example	of	the	histone	mark	positions	in	the	three	purified	populations	is	shown	in	Figure	V-13.			
	
Taken	 together,	 the	 changes	 in	 the	 histone	modification	 that	 I	 characterized	 indicate	that	 the	network	of	 the	TFs	 that	govern	TE	differentiation	consist	 of	 a	 cascade,	which	begins	 with	 bivalent	 genes	 that	 are	 transcriptionally	 poised	 and	 therefore	 loose	 the	H3K27me3	 mark	 when	 transcribed,	 continues	 with	 genes	 that	 harbor	 neither	 the	modification	and	have	slower	activation	kinetics	and	is	accompanied	by	the	silencing	of	pluripotency	genes	that	loose	the	activating	H3K4me3	mark	during	differentiation.		
Identification	of	a	putative	human	trophoblast	gene	network	
Time-course	transcriptomic	analysis	of	BMP4-treated	human	ESCs			While	 the	analysis	of	purified	APA+	progenitors	brought	a	 further	 step	 to	 identify	 the	intrinsic	 properties	 of	 cells	 committing	 to	 the	 human	 trophoblast	 lineage,	 to	 gain	 a	
Figure	V-12:	Representative	histone	mark	maps	of	SSEA-5+,	APA-	and	APA+	increased	
genes	Representative	histone	mark	maps	of	genes	with	characteristics	of	bivalent	(GATA3),	monovalent	H3K4me3	(ARID3A)	and	H3K27me3	(TFAP2B)	and	modification	deficient	(GCM1)	 loci	 in	 SSEA-5+	 cells.	 Histone	 coverage	 (y-scale)	 of	 one	 out	 of	 three	experiments	is	displayed	in	SSEA-5+,	APA-	and	APA+	cell	populations.	
Figure	V-13:	Turn	over	of	histone	marks	in	the	OCT4	gene	Histone	 coverage	 (y-scale)	 of	 one	 out	 of	 three	 experiments	 is	 displayed	 in	 SSEA-5+,	APA-	and	APA+	cell	populations.		
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holistic	perspective	of	this	process	I	had	to	add	another	layer	of	information	that	refers	to	processes	that	precede	the	emergence	of	the	progenitors	at	day	3	of	differentiation.	I	have	therefore	performed	in	collaboration	with	Dr.	Dmitry	Shaposhnikov	a	time-course	RNA-Seq	analysis	of	human	ESCs	treated	with	BMP	until	72	hours,	the	time	point	when	the	APA+	progenitors	appear.		To	 corroborate	 the	 results	 acquired	 by	 the	 different	 transcriptomic	 approaches,	microarrays	for	analyzing	the	progenitors	and	RNA-sequencing	for	the	time	course	bulk	human	ESCs	analysis,	I	analyzed	the	overlap	in	the	differentially	regulated	genes.	I	found		a	trend	of	increasing	overlap	that	included	over	90%	of	the	genes	after	48	and	72	hours	of	 differentiation	 (Figure	 V-14).	 These	 data	 therefore	 indicate	 that	 the	 network	 of	trophoblast	genes	consist	of	several	layers,	and	this	confirms	our	lists	of	involved	genes.		
		To	 identify	 the	 sequence	 of	 activation	 of	 the	 genes	 in	 the	 TE	 network	 I	 analyzed	 the	expression	 pattern	 (e.g.	 trajectory)	 of	 the	 TFs	 that	 are	 upregulated	 during	 the	 time-course	bulk	RNA-seq	measurements		(Figure	V-15).	
Figure	V-14:	Analysis	of	trophoblast	genes	by	
microarray	and	RNA-seq	A	 bar	 plot	 exhibiting	 the	 number	 of	transcripts	 overlapping	 at	 each	 of	 the	respective	 time-point	 of	 bulk	 human	 ESCs	BMP4	 treatment	 (8,	 16,	 24,	 48	 and	 72	 hrs;	transcript	levels	in	undifferentiated	cells	were	used	as	a	reference)	with	genes	increased	and	repressed	in	the	APA+	versus	the	SSEA-5+	cell	population.	 Green,	 orange	 and	 grey	 sectors	correspond,	 respectively,	 to	 the	 increased,	repressed	genes	and	no	overlap.	A	FDR	of	less	than	 5%	 between	 replicates	 (n=2)	 was	 used	to	 annotate	 differentially	 expressed	 genes	between	the	respective	time	points	and	0	hrs.		
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	I	identified	6	main	cohorts	of	which	3,	termed	early,	intermediate	and	late,	are	the	most	relevant	 for	 my	 purposes	 because	 they	 could	 provide	 clear	 separation	 of	 time	 wise	activation	 of	 several	 group	 of	 trophoblast	 TFs.	 The	 genes	 registered	 in	 these	 clusters,	numbered	 1,	 3,	 and	 6	 respectively,	 are	 presented	 in	 Table	 V-1.	 I	 have	 validated	 the	expression	of	some	of	these	early	genes	by	immunohistochemistry	(Figure	V-16).	
early	 intermediate	 late	
CRTC3	 ANKRD1	 MED12L	 ARID3A	 GRHL1	 PPARG	
DLX5	 ARID5B	 MED13L	 ASXL1	 HIC2	 RARB	
DLX6	 CDX2	 NR2F2	 BARX2	 HIPK3	 RCOR1	
EGR1	 CHD3	 NRIP1	 BCL6	 HOXB2	 SETD7	
FOS	 CITED2	 PPARGC1A	 BHLHE40	 JUP	 SMARCA2	
GATA2	 DLX3	 RREB1	 BNC1	 KDM6B	 SMYD2	
GATA3	 ELF2	 RYBP	 CALCOCO1	 KLF6	 SOX9	
HEY1	 ELF4	 SATB1	 CEBPA	 KLF8	 TEAD3	
JUN	 GRHL2	 SERTAD2	 CREB3L2	 LCP1	 TFAP2B	
LEF1	 HAND1	 TBX3	 ELF1	 MAFB	 THRB	
MSX2	 IKZF2	 TEAD1	 EPAS1	 MED12	 TLE4	
TFAP2A	 ISL1	 TFAP2C	 EYA2	 MEIS1	 TP63	
TLE3	 KAT2B	 ZNF117	 FOXO4	 MEIS2	 VGLL1	
	 MAGED1	 ZNF436	 GCM1	 NFIL3	 ZFHX3	
	 	 ZNF83	 	 	 ZNF440		
Figure	V-15:	Gene	expression	trajectories	of	increased	TFs	Clusters	 of	 increased	 TFs	 (Microarray	 APA+	 versus	 SSEA-5+)	 extracted	 from	 time-course	 RNA-seq	 analysis	 of	 human	 ESCs	 treatment	 by	 BMP4	 exhibiting	 6	 primary	cohorts	 of	 expression	 trajectories.	 Clustering	 was	 performed	 according	 to	 pairwise	Pearson	correlation	coefficients	using	k-means	clustering	analysis	with	k=6	clusters.	
Table	V-1:	TFs	in	early,	intermediate	and	late	clusters	The	TFs	of	clusters	1,	3	and	6	deduced	from	Figure	V-15.	
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	These	indicate	that	BMP4	exposure	activates	an	early	panel	of	TFs,	which	subsequently	targets	additional	 layers	of	TFs	 in	 the	 intermediate	or	 late	 trajectories.	Representative	RNA-Seq	read	profiles	of	an	early	(GATA3),	intermediate	(CDX2)	and	late	(GCM1)	gene	of	the	respective	groups,	and	one	decreased	gene	(OCT4)	are	shown	in	Figure	V-17.	
Figure	V-16:	Immunohistochemistry	of	selected	TFs	of	the	early	trajectory	TFs	Representative	immunohistochemistry	staining	of	GATA3,	TFAP2A	and	TFAP2C	in	undifferentiated	and	2.5	days	BMP4	treated	human	ESCs.	DAPI	is	shown	in	blue,	primary	antibodies	were	detected	by	Alexa	488	labeled	secondary	antibody.	
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	Figure	V-17:	Representative	RNA-Seq	read	count	profiles	Representative	diagrams	exhibiting	expression	(RNA-Seq)	of	genes	during	time-course	treatment	of	human	ESCs	by	BMP4.	Genes	included	are	GATA3,	CDX2,	GCM1	(representing	the	early,	intermediate	and	late	clusters)	and	the	downregulated	pluripotency	gene	OCT4	(n=2).	Presented	are	normalized	expression	values.	
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The	 same	clustering	approach	was	also	performed	 for	 the	decreased	TFs,	but	 this	did	not	help	to	separate	and	produce		cohorts	that	are	meaningful	for	understanding	stages	of	gene	repression	(Figure	V-18).		
	
	In	order	to	detect	the	drivers	of	trophoblast	commitment	within	the	early,	intermediate	and	 late	 upregulated	 gene	 clusters,	 I	 focused	 on	 the	 genes	 above	 a	 log2	 fold-change	cutoff	of	5.	The	time-points,	where	this	cutoff	was	applied,	were	chosen	according	to	the	expression	 patterns	 of	 the	 respective	 groups.	 As	 the	 early	 group	 exhibits	 a	 steep	increase	already	after	8	hours	the	cutoff	was	applied	at	this	time	point,	whereas	for	the	intermediate	 and	 late	 groups	 24	 and	 48	 hour	 time-points	 were	 chosen,	 respectively,	because	then	the	steepest	increase	in	expression	was	observed	(Figure	V-15).	The	 corresponding	 TFs	 are	 presented	 in	 Figure	 V-19.	 The	 TFs	 exhibiting	 the	 highest	degree	of	activation	already	after	8	hours	of	BMP-4	treatment	in	the	early	trajectory	are	
GATA2,	MSX2,	GATA3	 and	TFAP2A.	 In	 the	 intermediate	 trajectory	 I	 noted	 trophoblast	
Figure	V-18:	Gene	expression	trajectories	of	decreased	TFs	Clusters	 of	 decreased	 TFs	 (Microarray	 APA+	 versus	 SSEA-5+)	 extracted	 from	 time-course	 RNA-seq	 analysis	 of	 human	 ESCs	 treatment	 by	 BMP4	 exhibiting	 3	 primary	cohorts	 of	 expression	 trajectories.	 Clustering	 was	 performed	 according	 to	 pairwise	Pearson	correlation	coefficients	using	k-means	clustering	analysis	with	k=3	clusters.		
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regulators	 including	 HAND1,	 CDX2	 and	 TFAP2C	 (Introduction	 section	 “The	transcriptional	network	of	TE	development“	and	(Riley	et	al.,	1998)).	Finally,	in	the	late	cluster	I	noted	15	TFs,	including	the	TFs	VGLL1,	TP63	and	GCM1.		
	
Genome	wide	mapping	of	GATA2/3	and	TFAP2A/C	bound	loci	during	BMP4-
mediated	human	ESC	differentiation		As	 I	 have	 hypothesized	 that	 early	 activated	 TFs	 propel	 the	 trophoblast	 specification	network,	I	next	focused	in	this	regard	on	the	functions	of	primary	candidates	in	the	early	gene	cluster	group.	I	performed	ChIP-Seq	experiments	in	collaboration	with	Dr.	Dmitry	Shaposhnikov	using	antibodies	that	are	specific	for	human	GATA2,	GATA3,	TFAP2A	and	TFAP2C.	The	reason	that	I	chose	TFAP2C	instead	of	MSX2,	which	is	in	the	early	cluster	while	 TFAP2C	 is	 in	 the	 intermediate,	 is	 that	 other	work	 in	 our	 lab	 has	 indicated	 that	MSX2	is	redundantly	expressed	in	other	early	lineages,	and	because	TFAP2C	is	involved	in	mouse	 TE	 specification	 and	 it	 is	 a	 member	 of	 the	 AP2	 family.	 As	 the	 TF	 ChIP-Seq	typically	 requires	 more	 cells	 than	 histone	 modification	 ChIP-Seq,	 these	 experiments	were	performed	using	bulk	cell	preparations.	By	performing	de-novo	motif	detection	of	the	sequenced	reads	I	discovered	that	the	GATA-motif	is	overrepresented	in	the	GATA2	and	 GATA3	 ChIP-Seq	 experiments.	 Furthermore,	 same	 analysis	 of	 the	 TFAP2A	 and	TFAP2C	ChIP	sequenced	reads	showed	the	consensus	motif	for	the	TFAP	family	(Figure	V-20).	This	 is	 reassuring	 that	my	TF	ChIP	 readouts	 are	 specific	 for	 their	bound	 target	loci.	
Figure	V-19:	Highest	induced	TFs	of	early,	intermediate	and	late	clusters	Exhibited	 are	 TFs	 of	 the	 respective	 early,	 intermediate	 and	 late	 transcript	 groups	increased	above	a	threshold	of	5	fold	change	(log2)	at	8,	24	or	48	hrs,	respectively.	FC	=	fold	change;	h	=	hours			
	78	
	
	Next	I	focused	on	identifying	the	genes	exhibiting	peaks	of	TF	binding	within	a	region	of	3.5	kb	up-	and	5	kb	downstream	of	the	TSS.	By	analyzing	the	cooperative	binding	of	the	TFs,	I	discovered	five	categories	where	0,	1,	2,	3	or	4	TFs	are	bound	in	the	same	region.	To	 find	 out	 whether	 increased	 or	 decreased	 expression	 during	 trophoblast	differentiation	could	be	explained	by	the	binding	of	the	genes	by	the	TFs,	I	analyzed	the	correlation	 between	 the	 TF	 bound	 sites	 and	 the	 induced/repressed	 genes	 noted	following	72	hours	of	differentiation	compared	with	undifferentiated	cells.	As	a	result	I	observed,	that	multiple	TF	binding	correlate	with	the	upregulation	of	genes	rather	than	the	downregulation,	with	several	important	exceptions	that	are	discussed	below	(Figure	V-21).		
	
Figure	V-20:	De-novo	motif	analysis	of	TF	ChIP-Seq	Motifs	enriched	in	the	genomic	fragments	isolated	by	transcription	factor	ChIP-Seq	of	GATA2,	GATA3,	TFAP2A	and	TFAP2C.	
Figure	V-21:	Correlation	of	TF	binding	
and	gene	expression	A	 bar	 plot	 exhibiting	 the	 correlation	between	 the	 number	 of	 the	 bound	GATA2,	 GATA3,	 TFAP2A	 and	 TFAP2C	TFs	(either	0,	1,	2,	3	or	all),	in	3.5kb	up-	and	 5kb	 down-stream	 of	 gene’s	 TSS,	and	 their	 direction	 of	 regulation:	 up-	(green)	 and	 down-	 (red)	 regulated,	or	unchanged	 (blue),	 comparing	differentially	expressed	genes	at	the	72	hour	 time-point	 BMP4	 treatment	versus	 undifferentiated	 cells	 as	determined	 by	 global	 RNA-Seq	analysis.		
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In	total	I	found	204	genes	that	are	bound	by	the	all	4	TFs	in	the	region	of	3.5	kb	up-	and	5	kb	downstream	of	the	TSS	(Table	V-2-4).		
upregulated	
AADACL3	 C8orf31	 DOCK9	 HRH1	 LINC00518	 MPZL1	 OPN3	 S100A16	 TRIL	
ABCA4	 CA12	 DOPEY2	 INADL	 LINC00936	 MTUS1	 ORAI3	 SLC20A2	 TRIML2	
ACVR1	 CDH10	 ELMO1	 ITGA2	 LMOD2	 MYLK-AS1	 P2RY6	 SLC7A2	 TTLL7	
ADAM18	 CDX2	 ENPEP	 ITGB6	 LOC100130476	 MYO6	 PDE10A	 SLCO2A1	 USP43	
AMOT	 CMTR2	 ENTPD4	 KALRN	 LOC100507346	 NEDD9	 PDZD2	 SMTNL2	 VTCN1	
ANKRD1	 COLEC12	 FAM89A	 KCNC3	 LOC729739	 NKX2-3	 PIK3C2G	 SPARC	 YPEL2	
ANXA3	 CRIP1	 FOXC1	 KCNN4	 LPP	 NOS2	 PPFIBP2	 STS	 YPEL5	
ANXA4	 CSF1R	 FRS2	 KIAA1456	 LPP-AS2	 NPC2	 PRTG	 SVOPL	 ZAP70	
ARHGAP24	 CSGALNACT1	 GADD45G	 KIAA1551	 LTBR	 NPNT	 PTPN14	 SYNPO	 ZFPM1	
BACE1	 CTSL3P	 GAS7	 KMO	 MAB21L3	 NR2F2	 PTPN3	 TACC1	 ZNF358	
BACE1-AS	 CYP1B1	 GNLY	 KRT18	 MAP3K8	 NR2F2-AS1	 PTTG1IP	 TBX3	 	
C10orf10	 DGKD	 GRHL1	 KRT19	 MBNL3	 NRK	 RALBP1	 TINCR	
	C1QTNF6	 DIAPH3	 GSTO1	 KRT8	 MBOAT2	 NTAN1	 RHOBTB2	 TMBIM1	
	C21orf2	 DLX4	 HAPLN1	 LGR5	 MIR205	 NTRK1	 RRBP1	 TNFAIP3	
		
unchanged	
ACOT2	 FAM65B	 LSM4	 PPP1R26-AS1	 SLC16A9	 TLE3	 ZFX	 ZNF853	
ALDH4A1	 GLG1	 MESDC2	 PPP1R9A	 SLC44A1	 TMEM254	 ZMIZ2	 ZSWIM6	
ATRAID	 GMEB1	 MRS2	 RABGGTB	 SLC5A10	 TMEM254-AS1	 ZNF175	
	
C14orf80	 IQGAP2	 MYO1B	 RBL2	 SLC7A6	 TMEM44	 ZNF280D	
	
CHML	 ISCA2	 NENF	 RBM15	 SNX13	 UBR5	 ZNF343	
	
DCP1A	 IVNS1ABP	 PDS5A	 RPL13AP20	 SOCS2	 WDR74	 ZNF587	
	
DTNA	 LETMD1	 PGS1	 SETD4	 SSBP3	 WDR91	 ZNF593	
	
ECH1	 LINC00339	 PLS3	 SLBP	 TGIF1	 YTHDF1	 ZNF826P	
		
downregulated	
ARTN	 CERKL	 HSD17B4	 LDLR	 PDK1	 PTPRD	 SCNN1A	 UNQ6494	
ASPRV1	 FDFT1	 IL17RD	 LOC440600	 POU5F1	 PTPRG	 SLC45A4	 USP44	
CA14	 GJA1	 JADE1	 LRRC9	 PRTFDC1	 QSOX2	 TMEM55A	
		
	
Tables	V-2-4:	Gene	loci	bound	by	all	4	TFs	Tables	showing	up-,	downregulated,	and	unchanged	transcripts	 that	are	bound	by	all	four	 TFs	 (GATA2,	 GATA3,	 TFAP2A	 and	 TFAP2C)	 3.5kb	 up-	 and	 5kb	 down-stream	 of	their	TSS.	Lists	are	derived	from	the	analysis	shown	in	Figure	V-21.	
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By	further	analyzing	the	different	combinations	of	three	of	the	TFs,	I	found	that	GATA3	exhibits	 the	 broadest	 co-occupancy	 with	 the	 other	 TFs	 (Figure	 V-22)	 indicating	 that	GATA3	may	be	the	most	important	driver	of	this	developmental	process.		
	
	Of	 the	204	bound	genes	 I	 found	 that	122	genes	were	upregulated	at	 the	72	hour	 time	point	of	BMP4	treatment.	(Table	V-2).	Among	these	were	11	TFs	e.g.	CDX2	and	ANKRD1,	which	were	identified	in	the	group	of	genes	that	exhibited	an	intermediate	upregulation	behavior.	Other,	non	TF	genes,	 in	 this	group,	 include	trophoblast	associated	genes	 like	
STS,	VTCN1,	KRT8	or	KRT18.			The	decreased	 list	 consisting	of	 the	 genes	 that	 are	bound	by	 all	 four	TFs,	 didn’t	 show	enrichment	 for	 specific	 tissues,	 but	 importantly	 included	 the	 TF	 OCT4	 and	 the	transcriptional	co-activator	JADE1	(Figure	V-23).		
Figure	V-22:	The	number	of	transcripts	bound	by	either	3	or	4	TFs	A	 graph	 showing	 the	 numbers	 of	 genes	 that	 are	 bound	 either	 by	 4	 or	 different	combinations	of	3	TFs	extracted	from	GATA2/3	and	TFAP2A/C	ChIP-Seq	data.		
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			 Figure	V-23:	Transcripts	bound	by	all	4	TFs	An	overview	of	genes	that	are	bound	by	GATA2,	GATA3,	TFAP2A	and	TFAP2C	TFs	(all	4)	 and	 the	 cellular	 location	 of	 the	 respective	 proteins	 as	 annotated	 by	 Genomatix.	Increased	 and	 decreased	 genes	 during	 the	 BMP4	 time	 course	 are	 exhibited	 in	 the	upper	 (green)	and	 lower	 (red)	 sections.	Transcriptional	 regulators	are	marked	bold,	and	representative	placenta	enriched	non-TFs	(GO	terms	analysis)	are	shown.	OCT4	is	the	 only	 down-regulated	 TF	 bound	 by	 all	 four	 TFs.	 The	 rest	 of	 the	 down-regulated	genes	were	not	associated	with	specific	developmental	processes.		
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Interestingly,	 I	 found	 that	 the	 TFs	 bind	 in	 the	 first	 intron	 of	 CDX2	 and	 OCT4,	 while	typically	the	four	exhibit	binding	upstream	or	in	the	near	vicinity	of	TSS,	for	example	as	in	ANKRD1.	 For	GCM1,	 I	 observed	binding	of	GATA2,	GATA3	and	 to	 a	 lesser	 extend	of	TFAP2A	(Figure	V-24).	
	
Taken	 together	 I	 took	 these	 data	 as	 an	 indication	 that	 the	 four	 TFs,	 namely	 GATA2,	
GATA3,	 TFAP2A	 and	 TFAP2C,	 collectively	 underlie	 human	 trophoblast	 specification.	 I	therefore	 next	 set	 to	 functionally	 test	 the	 importance	 of	 these	 four	 TFs,	 whom	 I	operationally	 named	 the	 TEtra	 (the	 TrophEctoderm	 four),	 for	 this	 differentiation	pathway.	
	
Functional	analysis	of	the	trophoblast	TF	network			
Figure	V-24:	Examples	of	TF	binding	events	by	the	four	TFs	Genomic	 maps	 of	 representative	 genes,	 CDX2,	 ANKRD1,	 GCM1	 and	 OCT4,	 and	 the	corresponding	 reads	 extracted	 from	 the	 ChIP-Seq	 of	 GATA2,	 GATA3,	 TFAP2A	 and	TFAP2C.		
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As	mentioned	above,	 I	 found	 that	GATA3	exhibits	 the	broadest	 co-occupancy	with	 the	other	 members	 of	 the	 TEtra.	 Therefore,	 I	 decided	 to	 focus	 on	 this	 TF	 for	 functional	validation	 of	 the	 network	 that	 I	 identified.	 I	 used	 a	 human	 ESC	 line	 that	 harbors	 an	inducible	 form	of	 the	CRISPR-Cas	system	(HUES9	 iCRISPR,	 (Gonzalez	et	al.,	2014))	 for	knocking-out	 (KO)	 GATA3.	 My	 readout	 for	 the	 function	 of	 GATA3	 included	measurements	 of	 the	 APA+	 cell	 population	 by	 FACS,	 targeted	 gene	 expression	measurements	 by	 RT-PCR	 and	 detection	 of	 hCG	 levels	 by	 the	 immunoencymometric	assay.	To	knockout	GATA3	 I	used	two	pairs	of	guide	RNAs	(gRNAs)	that	were	designed	to	cut	out	a	region	of	325bp	from	the	second	exon	and	the	downstream	intron.	This	resulted	in	a	 premature	 stop	 codon	 in	 this	 intron	of	GATA3.	 I	 have	derived	 two	 clones	 harboring	such	 mutations	 in	 both	 alleles,	 which	 were	 verified	 as	 knockouts	 by	 Western	 blot	analysis	after	exposure	of	GATA3	KO	human	ESCs	to	BMP4	(Figure	V-25).	
		The	impact	on	differentiation	as	tested	by	flow	cytometry	indicated	that	the	formation	of	the	APA+	cell	population	 is	severely	 impaired,	noting	a	decrease	of	 the	cell	population	from	~60%	in	the	wild-type	cells	to	5%	in	the	GATA3	KO	cell	clones	(Figure	V-26).	This	validates	 that	 GATA3	 indeed	 is	 one	 of	 the	 primary	 drivers	 of	 the	 APA+	 trophoblast	differentiation	in	human	ESCs.	
	
Figure	 V-25:	 Western	 blot	 analysis	 of	 GATA3	
knock-out	in	the	CRISPR-CAS	inducible	ESC	system	A	Western	 blot	 analysis	 of	wild-type	 and	GATA3	KO	iCRISPR	human	ESC	clones	exposed	for	3	days	to	BMP4	treatment.			
Figure	V-26:	Flow	cytometry	analysis	of	APA	in	human	ESCs	and	GATA3	knock-out	Representative	APA	flow	cytometry	plots	exhibiting	analysis	of	wild-type	and	GATA3	KO	iCRISPR	clones	following	3	days	of	BMP4	differentiation.	FL2	=	Fluorescence	2		
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To	measure	the	effect	of	GATA3	on	its	assumed	targets	that	were	identified	by	TF	ChIP-Seq,	 I	 measured	 the	 expression	 of	 candidate	 genes	 in	 the	 network	 by	 RT-PCR	 and	compared	to	the	wild-type	cells.	I	found	that	the	expression	of	several	key	genes	in	the	network,	 including	GATA2,	GCM1,	VGLL1	 and	STS	 decreases	 in	 comparison	 to	 the	non-modified	 cells	 and	 as	 anticipated	 from	 my	 ChIP-Seq	 data,	 which	 have	 indicated	 that	
OCT4	is	inhibited	by	the	TEtra,	this	gene	shows	a	transcriptional	increase.	Surprisingly,	however	several	genes	exhibited	trends	that	are	opposite	the	anticipated.	This	includes	
TFAP2A,	TFAP2C,	CDX2	and	TP63	that	were	increased	in	the	GATA3	KO	clones	relative	to	the	 control	 (Figure	V-27).	 I	 hypothesize	 that	TFAP2A	 and	TFAP2C	 partially	 counteract	and	 compensate	 the	 GATA3	 KO	 on	 the	 transcriptional	 level	 by	 upregulation	 of	 CDX2.	However,	 it	 is	 also	 likely	 that	 CDX2	 is	 regulated	 by	 additional	 ways	 that	 are	 GATA3	independent.		
	
Finally	to	validate	the	effect	of	GATA3	on	placenta	hormone	production,	I	compared	the	hCG	 production	 in	 the	 GATA3	 KO	 clones	 to	 unmodified	 cells	 using	 an	immunoencymometric	 assay.	 In	 line	with	 the	previous	data,	 I	 found	 that	 also	 the	hCG	production	is	severely	impaired	during	differentiation	of	GATA3	KO	cells	to	trophoblast	by	treatment	with	BMP4	(Figure	V-28).		
Figure	V-27:	Analysis	of	trophoblast	candidate	genes	after	GATA3	KO	in	human	ESCs		The	 relative	 expression	 fold	 change	 of	 a	 set	 of	 pluripotency	 and	 early	 trophoblast	genes	was	analyzed	 by	RT-PCR	comparing	GATA3	 KO	and	wild-type	 iCRISPR	human	ESCs	 following	 3-day	 of	 BMP4	 treatment.	 Standard	 error	 of	 the	mean	 (SEM)	 of	 two	independent	experiments	is	shown.	
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Identification	of	developmental	epigenetic	signatures	
Correlation	of	histone	modification	turnover	and	temporal	regulation	of	TFs	
during	BMP4-mediated	human	ESC	differentiation		To	 identify	 epigenetic	 mechanism	 that	 underlie	 human	 trophoblast	 differentiation,	 I	analyzed	the	correlation	between	transcription	and	changes	of	the	histone	modification	patterns	 in	 the	 early,	 intermediate	 and	 late	 groups	 of	 TFs	 detected	 by	 bulk	 RNA	sequencing.	For	that	I	tested	if	any	of	the	histone	modification	marks	and	combinations	is	overrepresented	 in	 the	populations	of	SSEA-5+,	APA-	and	APA+	sorted	cells.	 I	noted	that	bivalency	is	enriched	in	the	SSEA-5+	fraction	with	respect	to	the	genes	with	early	induction	 trajectory,	 that	 H3K27me3	 and	 to	 a	 lesser	 extent	 H3K4me3	 and	 bivalent	categories	characterize	the	genes	exhibiting	the	intermediate	trajectory	in	SSEA-5+	cells,	and	that	the	no	Mod	and	bivalent	categories	are	most	prevalent	in	the	group	of	the	genes	that	exhibit	 latest	 induction	behavior	with	 respect	 to	all	 cell	populations.	Of	note,	 this	distribution	 of	 histone	mark	 enrichment	 is	 similar	 in	 the	 APA-	 cell	 population.	 In	 the	APA+	cell	population,	however,	there	is	a	shift	to	the	H3K4me3	category	in	the	early	and	intermediate	 cluster,	 whereas	 in	 the	 late	 cluster	 no	 Mod	 and	 bivalent	 marks	 persist	(Figure	V-29).	Taken	together,	these	data	indicate	that	distinct	patterns	of	histone	marks	characterize	 TFs	 that	 are	 activated	 at	 different	 stages;	 bivalent	 TFs	 go	 first,	 than	bivalent/H3K27me3	marked	TFs	and	finally	no	Mod	TFs,	such	as	GCM1.	
Figure	V-28:	Placental	hormone	production	of	human	ESCs	harboring	GATA3	KO	Time	course	analysis	of	hCG	concentration	produced	by	wild-type	or	GATA3	KO	human	iCRISPR	ESCs	treated	with	KSR+BMP4	(n=2).		
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	Key	genes	of	the	early,	intermediate	and	late	cohorts	and	their	corresponding	histone	modification	status	in	SSEA-5+	cells	is	shown	in	Figure	V-30.			
	
Figure	V-29:	Trophoblast	gene	expression	kinetics	and	histone	mark	turnover	The	 left	 panel	 exhibits	 the	 trajectories	 of	 early,	 intermediate	 and	 late	 increased	 TF	cohorts	over	a	time-course	of	72	hrs	where	human	ESCs	were	treated	by	BMP4.	Only	APA+	versus	SSEA-5+	cell	population	induced	TFs	are	plotted.	The	right	panes	exhibit	the	overrepresented	histone	modification	categories	of	these	TFs	in	SSEA-5+,	APA-	and	APA+	cell	populations,	classified	as	bivalent,	monovalent	and	TFs	where	these	histone	modifications	were	not	detected.	P-values	were	calculated	by	applying	Fisher’s	exact	test	 for	 the	 observed	 number	 of	 overlaps	 between	 the	 group	 of	 genes	 with	 the	respective	histone	modifications	and	the	genes	in	the	three	cohorts.		
Figure	V-30:	Histone	marks	of	TFs	from	early,	intermediate	and	late	cohorts	TFs	of	the	early,	intermediate	and	late	cohorts	exhibiting	>	log2	5	fold	change	at	8,	24	or	 48	 hrs,	 respectively.	 Font	 color	 labels	 correspond	 to	 the	 histone	 modification	categories	 in	 SSEA-5+	 undifferentiated	 cells	 (extracted	 from	 Figure	 IV-19):	 bivalent	(blue),	H3K4me3	monovalent	(green),	H3K27me3	monovalent	(red)	and	H3K27me3,	H3K4me3	modification	negative	(grey).		
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DNA	methylation	changes	during	human	trophoblast	differentiation		As	DNA	methylation	changes	play	an	important	role	in	developmental	gene	regulation,	I	investigated	 the	 5-Methylcytosine	 status	 of	 hundreds	 of	 thousands	 of	 CpG	 loci	 in	 the	SSEA-5+,	APA-	and	APA+	cell	population.	For	consistency,	 this	analysis	was	conducted	using	the	same	batch	of	samples	used	for	microarray	and	histone	modification	analyses.	As	a	background	for	explaining	the	results	below,	it	should	be	mentioned	that	in	human	ESCs	 bivalent	 genes	 are	 typically	 CpGs	 rich,	 often	 harboring	 CpG	 islands	 at	 their	promoters,	and	do	not	exhibit	DNA	methylation	marks	in	this	region.	In	line	with	previous	observations,	I	did	not	observe	CpG	methylation	in	CpG	islands	at	promoters	 of	 early	 bivalent	 TFs	 neither	 in	 undifferentiated	 cells	 not	 in	 progenitor	populations,	where	they	are	H3K4me3	monovalent	e.g.	GATA2	(Figure	V-31).	TFs	of	the	no	Mod	category,	e.g.	GCM1	exhibited	CpG	methylation	in	SSEA-5+	cells,	but	surprisingly	although	 they	were	 induced	 in	 the	 APA+	 progenitor	 population,	 they	 did	 not	 show	 a	significant	removal	of	methylated	CpGs	(Figure	V-31).		
	
	In	 fact	 I	 identified	 only	 few	 instances	 where	 significant	 changes	 in	 CpGs	methylation	could	 be	 observed	 at	 induced	 trophoblast	 genes,	 always	 in	 the	 direction	 of	 de-methylation	 comparing	 the	 APA+	 to	 SSEA-5+	 cell	 populations.	 I	 found	 that	 this	 de-methylation	in	fact	takes	place	in	the	sites	of	TEtra	binding,	the	most	notable	of	which	I	observed	 in	VTCN1	 (Figure	 V-32).	 I	 noted	 a	 similar	 trend	 of	 CpG	 de-methylation	 and	
Figure	V-31:	Representative	CpG	sites	in	promoter	regions	of	early	and	late	TFs	Displayed	are	the	TSS	of	 the	GATA2	and	GCM1	genes,	and	positions	of	 the	respective	CpG	 island	and	 the	CpG	poor	 region.	Bottom,	 the	DNA-methylation	 state	of	 analyzed	CpGs	 at	 the	 corresponding	 genomic	 positions	 in	 the	 SSEA-5+,	 APA-	 and	 APA+	 cell	populations.	DNA-methylation	analysis	was	conducted	in	triplicates	and	classification	was	 performed	 as	 follows:	 unmethylated:	 0-20%,	 intermediate:	 21-60%	 and	 highly	methylated:	61-100%.	
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TEtra	 co-localization	 in	 several	 other	 structural	 genes	 that	 are	 induced	 in	 APA+	trophoblast	progenitors	(highlighted	with	an	asterisk	in	Figure	V-23)		
	
	 	
Figure	V-32:	TF	binding	and	developmental	changes	of	DNA	methylation	in	VTCN1	A	genomic	map	of	the	low	CpG	gene	VTCN1,	which	is	induced	in	the	APA+	versus	the	SSEA-5+	 cell	population,	 exhibiting	 binding	 of	 GATA2,	 GATA3,	 TFAP2A	 and	TFAP2C.	Bottom,	 the	DNA-methylation	 status	of	 analyzed	CpGs	at	 the	 corresponding	genomic	positions	in	the	SSEA-5+,	APA-	and	APA+	cell	populations.	Analysis	was	conducted	as	indicated	in	Figure	V-31.		
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VI.	Discussion	
My	 results	 break	 grounds	 in	 general	 understanding	 of	 trophoblast	 progenitor	differentiation	 and	 in	 particular	 in	 the	 human.	 This	 is	 because	 I	 was	 able	 to	 prove	lineage	 correspondence	 and	 analyze	 cell	 intrinsic	 properties	 of	 human	 trophoblast	progenitors	 using	 purified	 populations	 of	 progenitors	 during	 their	 process	 of	differentiation	from	human	pluripotent	ESCs.	I	discovered	the	TEtra	TFs	that	are	at	the	basis	of	this	differentiation	pathway,	and	proved	functionally	that	it	is	a	critical	part	of	the	 network	 that	 drives	 human	 trophoblast	 specification.	 This	 circumvents	 ethical	limitations	on	 studying	human	embryogenesis	 trophoblast	development,	 and	provides	critical	grounds	to	explore	mechanisms	of	placental	disease	that	have	long-term	effects	on	 child’s	 and	 mother’s	 health.	 Moreover,	 I	 discovered	 key	 modes	 of	 epigenetic	regulation	 that	 govern	 human	 trophoblast	 specification,	 and	 these	 modes	 may	 have	implications	to	understanding	human	development	to	various	cell	types.		
Resolving	the	uncertainty	concerning	the	lineage	
correspondence	of	human	PSC-derived	trophoblast	progeny	
As	 a	 foundation	 for	 my	 doctoral	 thesis,	 I	 began	 my	 investigation	 of	 the	 progenitor	population	 that	 emerges	 from	 human	 ESCs,	 termed	 here	 the	 APA+	 progenitors,	 by	analyzing	their	lineage	correspondence.	I	have	obtained	several	lines	of	evidence,	which	in	my	opinion,	remove	the	doubts	that	the	progeny	of	human	PSCs	treated	with	BMP4	is	of	 a	 trophoblast	 origin	 (Introduction	 section	 “BMP4-mediated	 trophoblast	differentiation	of	human	ESC”).	This	includes:		1.	 I	 have	 shown	 that	 the	 progeny	 of	 human	 ESCs	 treated	 by	 BMP-4	 includes	 other	lineages	and	possibly	residual	undifferentiated	cells	in	the	APA-	population.			I	have	demonstrated	this	by:			a.	RT-PCR	analysis	of	the	APA-	population	indicates	heterogeneity	of	this	population,	as	in	 parallel	 to	 trophoblast	 genes	 also	 genes	 of	 other	 lineages	 (e.g.	 meso-	 and	
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mesendoderm	 represented	 by	MESP1	 and	 T)	 are	 induced.	 Further	 I	 saw	 lower	OCT4	expression	in	the	APA+	compared	with	the	APA-	population	indicating	that	there	are	still	cells	with	pluripotency	characteristics	in	the	APA-	population.		b.	 The	 increase	 of	 trophoblast	 genes	 was	 less	 pronounced	 in	 the	 APA-	 population,	indicating	lower	numbers	of	trophoblast	cells	in	this	population.	ELF5	for	example	was	not	 detected	 in	 APA-	 population	 and	 GCM1	 expression,	 which	 is	 important	 for	syncytiotrophoblast	development,	was	very	low	in	the	APA-	population.	c.	 Global	 gene	 expression	 analysis	 and	 GO-term	 bioinformatics	 showed	 that	 the	 APA-	population	 is	 enriched	 for	 lineages	 including	 ectoderm	 and	 mesenchyme	 and	 not	trophoblast	or	placenta.		2.	I	have	shown	that	the	purified	APA+	population	has	a	trophoblast	correspondence.			I	have	demonstrated	this	by:			a.	 RT-PCR	 analysis	 of	 purified	 APA+	 cells	 demonstrated	 that	 trophoblast	 associated	genes	 (CDX2,	 ELF5,	 GCM1	 and	 ENPEP)	 and	 not	 genes	 of	 meso-	 and	 mesendoderm	(MESP1,	T,	CD13,	ROR2	and	GSC)	are	expressed	in	this	population.	Further	I	showed	that	the	pluripotency	gene	OCT4	is	downregulated	more	in	this	population	compared	to	APA-	cells.	b.	 Global	 gene	 expression	 analysis	 and	 GO-term	 bioinformatics	 comparing	 the	 APA+	population	 to	 both,	 the	APA-	 	 and	 the	pluripotent	 population	 	 showing	 that	 the	APA+	population	is	enriched	for	tissues	of	trophoblast	and	placental	nature.	c.	 Using	 existing	 transcriptomic	 datasets	 of	 human	 blastocyst-stage	 TE	 as	 a	 basis	 for	comparison	 to	 the	 in	 vitro	 generated	 trophoblast	 progenitors.	 Comparison	 of	 the	datasets	 led	 me	 to	 the	 conclusion	 that	 the	 core	 transcriptional	 TFs	 in	 my	 system	correlate	with	the	in	vivo	dataset.		A	recent	study	pointed	out	that	BMP4	differentiated	human	ESCs	fulfill	some,	but	not	all	criteria	 of	 in	 vivo	 first	 trimester	 trophoblasts	 (Introduction	 section	 “BMP4-mediated	trophoblast	 differentiation	 of	 human	ESC”).	 This	 study	 shows	 for	 example	 that	 only	 a	portion	of	the	in	vitro	differentiated	cells	expresses	GATA3	and	TFAP2C,	in	vivo	markers	for	 trophoblasts.	However,	 they	have	utilized	clumps	of	cells	as	a	starting	material	 for	differentiation,	which	 in	my	opinion	 represent	 the	physiology	of	 ICM	cells	 rather	 than	
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polar	 TE	 cells	 and	 could	 then	 lead	 to	 a	 less	 efficient	 BMP4	 mediated	 differentiation	process.	 Our	 protocol,	 which	 is	 based	 on	 seeding	 human	 ESCs	 as	 single	 cells	 before	differentiation,	 can	 overcome	 at	 least	 partially	 this	 heterogeneity	 as	immunohistochemistry	 identified	 GATA3	 and	 TFAP2C	 expression	 in	 a	majority	 of	 the	cells.		Despite	of	 this,	 Lee	and	colleagues	noted	 that	CpGs	at	 the	ELF5	promoter	become	de-methylated,	resembling	the	state	of	 the	 in	vivo	 first	 trimester	trophoblast.	My	analysis,	however,	 did	 not	 show	 de-methylation	 of	 this	 trophoblast	 specific	 promoter,	 but	 as	mentioned	 before	we	 look	 at	 a	 very	 early	 time-point	 and	 generally	 identify	 very	 few	changes	in	DNA	methylation	over	the	entire	genome.		Heterogeneity	during	differentiation	is	in	my	opinion	the	source	of	debate	on	the	lineage	correspondence	of	the	trophoblast	progenitors	that	emerge	from	human	PSCs.		For	example,	Bernardo	and	colleagues	showed	that	human	ESCs	treated	with	BMP4	in	chemically	 defined	 medium	 express	 both,	 trophoblast	 and	 mesoderm	 genes	 and	conclude	 that	 these	 are	 of	 extraembryonic	 mesoderm	 therefore	 challenging	 the	trophoblast	 nature	 of	 these	 cells	 (Introduction	 section	 “BMP4-mediated	 trophoblast	differentiation	 of	 human	 ESC”).	 However,	 the	 experimental	 system	 used	 by	 Bernardo	and	colleagues	harbors	important	limitations:		a.	They	apply	a	different	cultivation	and	differentiation	protocol	than	all	studies	before	by	using	chemically	defined	medium	on	gelatin	membranes	 soaked	 in	FBS	and	do	not	state	whether	they	started	the	differentiation	using	single	cells	or	cell	clumps.		b.	The	differentiation	performed	with	BMP4	only	results	in	4-8%	KRT7+	cells.	Compared	with	studies	performed	later	by	several	groups	this	does	not	reflect	their	findings,	where	at	least	40%	(Amita	et	al.,	2013)	and	in	other	cases	most	of	the	BMP4	treated	cells	were	KRT7+	(Telugu	et	al.,	2013;	Lee	et	al.,	2016).	Still	it	is	important	to	mention	that	Lee	and	colleagues	utilized	an	Activin	A	inhibitor	and	ALK	and	FGF	receptor	inhibitors,	which	suppress	mesoderm	differentiation	in	combination	with	BMP4	for	differentiation.		c.	They	analyze	these	4-8%	of	KRT7+	cells	and	although	they	state	that	the	KRT7+	cells	express	both	trophoblast	genes	(GCM1,	ELF5	and	HCGA)	and	mesoderm	genes	(ISL1	and	FLK1),	the	amount	of	genes	characterized	limit	the	assignment	of	these	cells	to	a	certain	lineage.	Genome	wide	analysis	of	this	KRT7+	population	could	have	shed	light	into	the	nature	of	these	KRT7+	cells.		
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d.	There	is	still	the	possibility	of	heterogeneity	in	this	KRT7+	population	that	can	lead	to	expression	of	these	mesoderm	and	trophoblast	genes	in	different	subpopulations	of	cells	similar	to	what	we	saw	analyzing	the	APA+	and	APA-	population.			It	 has	 been	 repeatedly	 shown	 that	 cell	 purification	 is	 an	 imperative	 paradigm	 for	determining	the	intrinsic	properties	of	stem	cells	and	progenitors	(Hoppe	et	al.,	2014).	Because	previous	studies	were	not	based	on	purified	progenitors	their	conclusions	may	have	 derived	 on	 the	 basis	 of	 co-existing	 populations,	 including	 a	 mes/mesendoderm	population.	 Further,	 one	 mechanism	 of	 the	 emerging	 heterogeneity	 during	 BMP4	treatment	of	human	ESCs	was	discovered	as	BMP4	can	also	activate	components	of	the	WNT	 pathway	 leading	 to	 induction	 of	 mesoderm	 genes	 and	 further	 a	 mesoderm	subpopulation	 in	 the	 culture	 (Introduction	 section	 “BMP4-mediated	 trophoblast	differentiation	of	human	ESC”).		In	conclusion	our	data	show	that	this	differentiation	approach	represents	a	promising	experimental	method	to	follow	cells	from	a	precursor	state	to	defined	trophoblast	cell	types	during	human	development	with	the	ability	to	eliminate	unwanted	side	products	of	the	BMP4	mediated	differentiation	process.		Taken	together	the	data	obtained	from	the	gene	expression	analysis	allowed	me	to	successfully	address	the	first	aim	of	my	study.		
The	TF	circuit	of	human	APA+	trophoblast	progenitors	
I	 took	 a	 combined	 approach	 for	 identifying	 the	 network	 of	 genes	 that	 govern	 human	trophoblast	 specification.	 I	 relied	 on	 purified	 populations	 of	 the	 BMP4	 driven	differentiation,	as	I	have	proved	that	these	progenitors	recapitulate	most	of	the	human	TE	 and	 trophoblast	 progenitor	 characteristics	 (section	 above),	 in	 conjunction	 with	global	transcriptional,	epigenetic	mark,	and	time-course	RNA-seq	analyses.	In	addition,	I	used	TF	ChIP-seq	and	functional	assays	to	prove	my	finding	of	the	network	(Figure	VI-1).	
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			The	following	evidence	support	the	outline	of	this	network	including:		a.	We	showed	that	the	four	TFs,	i.e.	the	TEtra	-	GATA2,	GATA3,	TFAP2A	and	TFAP2C	are	highly	upregulated	at	the	earliest	time	point	analyzed	(8	hrs	BMP-4	treatment),	and	bind	to	the	promoters	of	intermediate	and	late	differentiation	genes	(Figure	VI-1).	Additional	evidence	 supporting	 the	 classification	 of	 the	 TEtra	 TF	 as	 drivers	 of	 TE	 differentiation	include	 that	Gata3	 and	Tfap2c	 are	known	key	players	of	early	mouse	TE	development	(Introduction	section	“The	transcriptional	network	of	TE	development”).	b.	The	targets	of	the	TEtra	 include	a	very	well	known	mouse	TE	marker	-	CDX2,	of	 the	intermediate	 TF	 cohort,	 and	 GCM1,	 a	 key	 syncytiotrophoblast	 TF	 of	 the	 late	 cohort	(Introduction	section	“Mouse	placental	development”).		c.	 The	 TEtra	 TFs	 bind	 to	 the	 first	 intron	 of	 OCT4	 leading	 to	 repression	 of	 this	 key	pluripotency	gene.	I	have	shown	this	by	genome	wide	TF	binding	analysis	of	the	Tetra	using	 ChIP-Seq	 and	 subsequent	 knock-out	 of	 GATA3.	 This	 links	 the	 progression	 to	 a	trophoblast	fate	with	the	inhibition	of	the	pluripotency	network.		Importantly,	the	logic	of	the	TEtra	TF	network	is	built	in	away	that	the	binding	sites	of	these	two	families	are	in	may	cases	overlapping.	This,	in	my	opinion,	confers	robustness	to	this	differentiation	pathway	by	redundancy.	The	human	network	in	this	regard	seems	to	have	features	that	are	dissimilar	to	the	mouse	including	the	rewiring	of	the	network;	
Figure	 VI-1:	 Regulatory	
network	 of	 human	
trophoblast	development	A	 summary	 of	 the	observed	 time-course	increased	 (green)	 and	decreased	 (red)	trophoblast	 and	pluripotency	 genes	following	BMP4	 treatment	of	human	ESCs.	Reciprocal	interactions	 (binding	 in	the	 promoter	 regions)	within	 the	 cohort	 of	 the	early	 four	 TFs,	 the	 TEtra	factors,	 are	 outlined	according	 to	 ChIP-seq	analysis.	
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while	 in	 the	human	GATA2,	GATA3,	TFAP2A	and	TFAP2C	 seem	to	regulate	CDX2,	 in	 the	mouse	 it	 is	 Cdx2	 that	 regulates	 Tfap2c	 and	 Gata3	 (Introduction	 section	 “The	transcriptional	network	of	TE	development”).	 In	 line	with	our	observations	are	recent	single	cell	analysis	 studies	of	human	blastocyst	derived	TE	cells,	which	have	 indicated	that	in	the	human	GATA2	and	GATA3	are	expressed	earlier	than	CDX2	(Petropoulos	et	al.,	2016).	 This	 was	 further	 confirmed	by	 another	 group	 using	 an	 in	 vitro	 3D	 assay	 that	mimics	 early	 human	 development	 (Deglincerti	 et	 al.,	 2016).	 Nevertheless,	 the	 full	picture	seems	to	be	more	complex	as	recent	studies	have	placed	mouse	Gata3	in	parallel	to	Cdx2	 (Ralston	et	al.,	2010)	and	Tfap2c	upstream	of	Cdx2	 (Cao	et	al.,	2015).	Also	my	discoveries	 indicate	 that	 the	TEtra	network	 is	 auto-regulatory	 to	 some	extend	as	 they	are	 found	to	be	bound	at	 their	respective	promoters	during	differentiation	and	GATA3	depletion	leads	to	upregulation	of	TFAP2A	and	TFAP2C,	which	could	indicate	a	possible	compensation	mechanism	(Figure	V-27).	One	additional	difference	between	mouse	and	human	development	 is	 that	EOMES	was	not	detected	upregulated	 in	our	data,	while	 in	the	mouse	 it	 plays	 a	 critical	 role	 (Russ	 et	 al.,	 2000;	 Strumpf	 et	 al.,	 2005).	 Again,	 our	observations	are	in	line	with	in	vivo	measurements	(Petropoulos	et	al.,	2016).		Furthermore,	 our	 identified	 TF	 network	 could	 partly	 explain	 why	 mouse	 fibroblasts,	when	 treated	with	 a	 combination	 of	 4	 TFs,	 including	Gata3	 and	Tfap2c	 but	 not	Cdx2,	reprogram	 to	 a	 trophoblast	 stem-like	 state	 (Benchetrit	 et	 al.,	 2015;	 Kubaczka	 et	 al.,	2015).		What	 is	 perplexing	 is	 that	 KO	 of	 GATA3	 alone	 seems	 to	 severely	 impair	 human	trophoblast	 commitment	 (Figure	 V-26).	 I	 would	 not	 expect	 this	 severe	 phenotype	because	of	the	putative	TF	redundancies,	but	still	I	have	not	analyzed	time	points	earlier	than	 8	 hrs	 and	 the	 direct	 targets	 of	 the	 Smads	 transducers	 and	 therefore	 additional	studies	are	necessary	to	understand	in	detail	the	function	of	GATA3.		The	 fact	 that	 there	 is	 redundancy	 in	 the	 key	 players	 of	 the	 early	 human	 trophoblast	development	 by	 GATA2	 -	 GATA3	 and	 TFAP2A	 -	 TFAP2C	 could	 add	 stability	 to	 this	developmental	 step.	 This	 suggests	 that	 this	 early	 cell	 fate	 decision	 is	 controlled	 in	 a	similar	way	as	the	second	wave	of	development,	where	the	epiblast	separates	from	the	primitive	 endoderm,	 as	 the	 factors	 involved	 in	 this	 process	 have	 been	 shown	 to	 be	
GATA4	–	GATA6	and	SOX7	–	SOX17	(Niakan	et	al.,	2010;	Blakeley	et	al.,	2015).	Although	this	hypothesis	needs	further	validation	this	could	mean	that	very	critical	early	cell	fate	
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decisions	 in	 the	 human	 embryo	 are	 controlled	 by	 a	 mechanism	 that	 relies	 on	 the	redundancy	of	TFs.	Taken	together,	these	data,	obtained	by	time-course	gene	expression	analysis	and	TF	ChIP-Seq	analysis	of	TEtra,	allowed	me	to	address	the	second	aim	of	my	study.		
Regulation	 of	 CDX2	 and	 OCT4	 during	 human	 trophoblast	
differentiation	
My	 discoveries	 include	 novel	 features	 of	 regulation	 of	 trophoblast-pluripotency	bifurcation.	 This	 began	with	my	 finding	 that	CDX2	 is	 up-	 and	OCT4	 is	 downregulated	during	 differentiation	 from	 human	 ESCs	 to	 APA+	 trophoblast	 progenitors.	 Then	 I	observed	 that	 the	 TEtra	 TFs	 bind	 novel	 sites	 in	 the	 first	 introns	 of	 these	 genes.	Furthermore,	I	found	that	in	these	sites	the	four	TFs	overlap.	This	indicates	the	presence	of	 a	 regulatory	 element	 at	 this	 site	 and,	 according	 to	 the	 expression	 direction,	 I	hypothesized	that	CDX2	and	OCT4	are	positively	and	negatively	regulated,	respectively.	In	the	case	of	CDX2,	there	has	been	a	previous	indication	that	this	 intronic	site	plays	a	role	 in	mouse	 trophoblast	 development.	 It	 has	 been	 shown	 that	 binding	 of	 Gata3	 and	Tfap2c	to	this	site	can	regulate	Cdx2	expression	in	mouse	TSCs	(Home	et	al.,	2009;	Cao	et	al.,	 2015).	 Another	 study	 showed	 that	 the	 Cdx2	 promoter	 region,	 as	 well	 as	 the	 first	intron,	are	 targets	of	Nanog	and	Oct4	 in	mouse	ESCs	and	 that	during	 the	 transition	of	pluripotency	 to	 TSCs	 this	 region	 is	 bound	 by	 Cdx2	 itself,	 which	 could	 lead	 to	 an	autoregulation	feedback	loop	(Chen	et	al.,	2009).	In	mouse	blastocysts	Cdx2	expression	is	controlled	by	a	TE-specific	enhancer	 (TEE)	 that	 lies	upstream	of	 the	Cdx2	promoter	(Rayon	et	al.,	2014),	but	this	regulatory	element	is	not	essential	for	Cdx2	expression	in	mouse	 TSCs.	 Taken	 together	 this	 indicates	 that	 two	 sites	 regulate	 Cdx2	 expression	sequentially:	 the	 TEE	 in	 early	 development	 and	 the	 intronic	 site	 later	 during	development.	However,	the	intronic	region	was	ruled	out	as	an	extraembryonic	specific	enhancer	 as	 it	 is	 also	 active	 in	 mouse	 ESCs,	 shown	 by	 reporter	 assays.	 Yet,	 the	explanation	for	the	activity	of	the	reporter	assay	in	mouse	ESCs	could	be	that	Nanog	and	Oct4	 bind	 this	 fragment	 in	 mouse	 ESCs,	 therefore	 leading	 to	 a	 positive	 result	 in	 the	reporter	assay.	The	mechanism	behind	this	could	be	that	Nanog	and	Oct4	silence	Cdx2	in	mouse	ESCs.		
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In	 human	 ESCs	 CDX2	 is	 also	 bound	 by	NANOG	 and	OCT4	 in	 the	 promoter	 region	 and	together	 they	 have	 been	 proposed	 to	 silence	 the	 gene	 in	 ESCs	 (Boyer	 et	 al.,	 2005).	Furthermore,	by	reviewing	the	published	ENCODE	datasets	of	NANOG	and	OCT4	ChIP-Seq	I	 found	that	the	same	intronic	region	of	CDX2,	which	 is	bound	by	the	Tetra	TFs,	 is	also	bound	and	possibly	regulated	by	NANOG	and	OCT4	in	human	ESCs.	Taken	together,	this	has	led	me	to	propose	a	model	for	human	CDX2	regulation	(Figure	VI-2)	 that	 takes	 into	 account	 previous	 findings	 and	 my	 data.	 It	 proposes	 mutual	exclusive	regulation	of	CDX2,	either	in	the	direction	of	repression	in	pluripotent	cells	or	in	the	direction	of	induction	when	OCT4/NANOG	are	replaced	by	the	TEtra	TFs.			
 
An	unexpected	finding	is	that	following	differentiation	of	the	GATA3	KO	cells	with	BMP4	I	 have	not	 noted	 reduced	 levels	 of	CDX2	 compared	 to	 control.	 Surprisingly	 I	 noted	 an	opposite	effect	-	CDX2	is	upregulated	when	GATA3	is	absent	during	BMP4	treatment	of	human	 ESCs.	 One	 explanation	 for	 this	 phenomenon	 could	 be	 the	 before	 mentioned	compensation	 by	 TFAP2A/C	 or	 another	 compensatory	 route	 that	 effects	 the	 level	 of	
CDX2	in	this	case.			
Figure	VI-2:	Proposed	regulation	mode	of	CDX2		Shown	 is	 the	 genetic	 structure	 of	 the	CDX2	 locus	with	 its	 three	 exons.	 Left	 (yellow)	indicates	the	regulation	of	CDX2	 in	human	ESCs.	Right	(blue)	shows	the	regulation	in	trophoblast	progenitors.	Green	indicates	activation	and	red	indicates	repression.		
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Although	 the	 regulation	 of	 Oct4	 /	 OCT4	 was	 rather	 extensively	 studied	 and	 several	regulatory	 regions	 were	 identified,	 including	 promoter	 upstream	 proximal	 and	 distal	enhancers,	I	am	not	aware	of	a	prior	discovery	of	regulatory	elements	in	the	first	intron	as	I	have	made	(Figure	VI-3).		
	
		The	 functional	 importance	 of	 the	 TEtra	 binding	 to	 the	 first	 intron	 of	 OCT4	 requires	functional	validation.	I	have	begun	this	by	using	the	GATA3	KO	cell	 line,	which	verified	the	direction	of	negative	regulation	of	OCT4	by	the	TEtra	TFs,	because	the	levels	of	OCT4	increased	in	this	cell	line	compared	to	control	(Figure	V-27).	Removal	of	the	GATA	and	TFAP2	binding	sites	should	be	performed	in	the	endogenous	 locus	or	using	a	reporter	assay.	My	hypothesis	is	that	without	GATA	and	TFAP2	binding	sites	OCT4	levels	will	be	maintained.	One	reason	why	I	did	not	perform	such	experiments	is	that	I	noted	several	
Figure	VI-3:	Proposed	regulation	mode	of	OCT4		Shown	is	the	genomic	assembly	of	the	OCT4	locus	with	its	five	exons	(blue),	the	distal	and	 the	proximal	 enhancer.	 Upper	and	 bottom	panes	outlines	 the	modes	 of	positive	and	negative	regulation	in	human	ESCs	and	trophoblast	progenitors,	respectively.	TSS	=	 transcription	 start	 site;	 green	 indicates	 activating	 and	 red	 indicates	 repressing	factors.	
	98	
tandem	GATA	and	TFAP2	motifs	and	several	bound	regions	within	the	intron.	Therefore,	a	thorough	mutational	screen	is	necessary,	and	this	was	beyond	the	scope	of	my	thesis.			
Epigenetic	regulation	of	trophoblast	differentiation	
My	study	shows	that	the	early	and	many	intermediate	key	regulators	of	the	trophoblast	differentiation	 have	 CpG	 rich	 promoters	 and	 are	 marked	 with	 both,	 the	 activating	H3K4me3	 and	 the	 repressing	 H3K27me3	 marks	 concomitantly	 in	 undifferentiated	human	 ESCs.	 I	 further	 showed	 that	 these	 bivalent	 TFs	 are	 upregulated	 very	 rapidly	during	 differentiation	 and	 loose	 the	 repressing	 H3K27me3	 mark	 within	 2.5	 days	 of	differentiation.	 In	 contrast	 to	 this,	 I	 observed	 that	 some	 of	 the	 key	 trophoblast	regulatory	 TFs,	 which	 are	 upregulated	 later	 during	 differentiation,	 are	 CpG	 poor	 and	harbor	no	activating	or	repressing	marks	in	undifferentiated	cells.	In	this	group	I	found	
GCM1,	TP63	and	VGLL1.	 In	the	progenitors	only	TP63	acquires	 low	levels	of	H3K4me3,	while	GCM1	 and	VGLL1	 remain	 unmarked.	 This	 suggests	 that	 in	 genes	 harboring	 CpG	poor	 promoters,	 transcriptional	 activation	 precedes	 the	 acquisition	 of	 activating	H3K4me3	marks.	Furthermore,	very	little	changes,	if	any,	take	place	in	methylated	CpG	islands	 during	 the	 transition	 from	pluripotent	 to	APA+	 trophoblast	 cells.	 The	 changes	that	I	did	observe	were	mainly	de-methylation	of	CpGs	in	CpG	poor	genes,	which	become	activated	 during	 differentiation.	 Interestingly,	 the	 site	 of	 de-methylation	 often	 co-localizes	with	 the	TEtra	peak	sites	 (Figure	V-32),	 indicating	 that	binding	of	TFs	either	leads	 to	active	de-methylation	or	 interferes	with	 the	maintenance	of	CpG	methylation.	The	epigenetic	characteristics	of	the	genes	activated	in	the	trophoblast	progenitors	fits	with	 their	order	of	 induction.	 It	has	been	shown	 that	bivalent	CpG	rich	promoters	are	typically	developmental	regulators,	and	that	CpG	poor	genes,	which	are	not	marked	with	histone	 modifications,	 typically	 encode	 for	 structural	 proteins	 (Introduction	 section	“Epigenetic	profiles	of	PSCs”).	However,	I	found	a	novel	feature	in	this	regard	-	also	late	trophoblast	specific	TFs	included	in	this	group,	indicating	that	I	discovered	a	novel	form	of	developmental	regulation.	Additionally,	 it	was	shown	that	gene	expression	and	DNA	methylation	 negatively	 correlate	 during	 differentiation	 (Xie	 et	 al.,	 2013),	 but	 in	 our	relatively	 early	 time-point	 of	 analysis	 we	 did	 not	 observe	 this	 phenomenon	 as	 I	 still	detect	DNA-methylation	marks	at	many	CpG	poor	promoters	of	expressed	genes	in	the	APA+	population.	Therefore	I	conclude	that	the	transcriptional	activation	of	these	genes	
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happens	 before	 the	 erasure	 of	 DNA	 methylation	 marks	 at	 their	 promoters.	 All	 these	observations	allow	me	to	successfully	address	the	third	aim	of	my	study.		
Biomedical	relevance	of	the	discovery	of	the	TEtra	TFs	
My	 identification	 of	 the	 TF	 circuit	 that	 underlies	 human	 trophoblast	 differentiation	opens	a	path	to	understand	developmental	pathologies	of	the	placenta.	This	is	because	it	provides	 a	 platform	 to	 discover	 their	 molecular	 etiology	 that	 may	 in	 many	 cases	originate	 from	 misregulation	 of	 early	 transcriptional	 networks.	 Breaking	 grounds	 in	understanding	 placental	 impairments	 and	 disorders	 causing	 miscarriages	 or	preeclampsia	is	important	for	offspring	and	mother’s	health.	Preeclampsia	 for	 example	 is	 a	 hypertensive	 disorder,	 which	 is	 usually	 diagnosed	 by	proteinurea	 and	 hypertension	 after	 the	 20th	 week	 of	 gestation	 (Bulletins--Obstetrics,	2002).	Importantly	the	link	between	preeclampsia	and	members	of	the	TEtra	has	been	made	already,	although	 it	was	almost	unnoticed.	Published	evidences	 include	datasets	showing	that	GATA2	and	TFAP2A	are	both	downregulated	in	preeclampsia	compared	to	placentas	 from	 normal	 pregnancies.	 Furthermore,	 a	 strong	 enrichment	 of	 the	 AP2	(TFAP2)	 binding	 motif	 was	 noted	 at	 many	 downregulated	 genes	 in	 preeclampsia	placentas	(Sober	et	al.,	2015).			Finally,	 our	 findings	 could	 also	 be	 pertinent	 for	 reproductive	 therapies	 by	 artificial	reproductive	 technologies	 (ART)	 such	 as	 in	 vitro	 fertilization	 (IVF).	 A	 study	 in	 mice	found	 that	 ART	 increases	 the	 chances	 for	 maldevelopment	 and	 dysfunction	 of	 the	placenta,	 which	 is	 linked	 to	 reduced	 weight	 of	 the	 fetal	 mice	 (Chen	 et	 al.,	 2015).	Examining	 this	 data	 they	 found	 misregulation	 of	 GCM1	 following	 IVF	 compared	 to	normal	 pregnancies,	 which	 we	 found	 to	 be	 a	 target	 of	 GATA2	 and	 GATA3	 during	trophoblast	differentiation.	Taken	together,	this	provides	an	initial	 indication	that	by	discovering	the	TEtra,	I	have	made	a	first	crucial	step	in	the	direction	of	understanding	early	placental	and	pregnancy	defects,	 that	 this	 could	 translate	 to	 improve	 ARTs	 and	 treatment	 of	 conditions	 with	impaired	placental	development.	
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IX.	Abbreviations	
%	 Percent	
°C	 Degree	Celsius	
3D	 Three	Dimensional	
APA	 Aminopeptidase	A	
bFGF	 Basic	Fibroblast	Growth	Factor	
BMP	 Bone	Morphogenic	Protein	
BMPRI	 Bone	Morphogenic	Protein	Receptor	1	
BMPRII	 Bone	Morphogenic	Protein	Receptor	2	
bp	 Base	Pair	
Cat.Nr.	 Catalog	Number	
cDNA	 Complementary	DNA	
ChIP	 Chromatin	Immunoprecipitation	
ChIP-Seq	 Chromatin	Immunocprecipitation	paired	with	Next	Generation	Sequencing	
cm2	 Square	Centimeter	
CpG	 Cytosine-phosphate-Guanine	
CRISPR/Cas	 Clustered	Regularly	Interspaced	Short	Palindromic	Repeats/CRISPR	associated	protein	9	
Ct	 Cycle	threshold	
DAPI	 4’,	6-Diamidino-2-Phenylindole	
DMEM	 Dulbecco's	Modified	Eagle's	Medium	
DMSO	 Dimethyl	Sulfoxide	
DNMT1	 DNA	Methyltransferase	1	
DNMT3A	 DNA	Methyltransferase	3A	
DNMT3B	 DNA	Methyltransferase	3B	
Dox	 Doxycycline	
E	 Embryonic		
EB	 Elution	Buffer	
EDTA	 Ethylenediaminetetraacetic	Acid	
EGTA	 Ethylene	Glycol-bis(β-aminoethyl	ether)-N,N,N',N'-Tetraacetic	Acid	
ENCODE	 Encyclopedia	of	DNA	Elements	
ESC	 Embryonic	Stem	Cell	
ExE	 Extraembryonic	Ectoderm	
FACS	 Fluorescence-Activated	Cell	Sorting	
FBS	 Fetal	Bovine	Serum	
FDR	 False	Discovery	Rate	
FGF2	 Fibroblast	Growth	Factor	2	
FSC-A	 Forward	Scatter-Area	
FSC-W	 Forward	Scatter-Width	
g	 Gramm	
GC	 Guanine-Cytosine	
GO-term	 Gene	Ontology	term	
gRNA	 Guide	RNA	
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H3K27	 Histone	3	Lysine	27	
H3K4	 Histone	3	Lysine	4	
H3K9	 Histone	3	Lysine	9	
H3S28	 Histone	3	Serine	28	
H9	 WA09	Embryonic	Stem	Cells	
HAT	 Histone	Acetyl	Transferase	
hCG	 Human	Chorionic	Gonadotropin	
HDAC	 Histone	Deacethylase	
ICM	 Inner	Cell	Mass	
IgG	 Immunoglobulin	G	
IP	 Immunoprecipitation	
IVF	 In	Vitro	Fertilization	
kb	 Kilo	Bases	
KO	 Knock-Out	
KSR	 Knockout	Serum	Replacement	
LB	 Lysis	Buffer	
lincRNA	 Long	Intergenic	Non-Coding	RNA	
log2	 Log	Base	2		
Lot	Nr.	 Lot	number	
M	 Molar	
me1	 Mono-Methylation	
me2	 Di-Methylation	
me3	 Tri-Methylation	
MEF	 Mouse	Embryonic	Fibroblasts	
MG	 Matrigel	
mg	 Milligram	
min	 Minutes	
Mio	 Million	
ml	 Milliliter	
MM	 Mastermix	
MNase	 Micrococcal	Nuclease	
mRNA	 Messenger	RNA	
NaCl	 Sodium	Chloride	
ND	 Not	Detected	
NEAA	 Non	Essential	Amino	Acids	
ng	 Nano	Gramm	
nm	 Nano	Meter	
nM	 Nano	Molar	
no	Mod	 No	Modification	
nt	 Nucleotide	
PBS	 Phosphate-buffered	saline	
PE	 Primitive	Endoderm	
PGC	 Primodial	Germ	Cell	
pH	 Potential	of	Hydrogen	
PI	 Propidium	Iodide	
PMSF	 Phenylmethane	Sulfonyl	Fluoride	
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PSC	 Pluripotent	Stem	Cell	
PTM	 Photomultiplier	Tube	
RefSeq	 Reference	Sequence	
RIN	 RNA	Integrity	Number	
RNA-Seq	 RNA	Sequencing	
ROCKi	 Rho-	associated,	Coiled-Coil	Containing	Protein	Kinase	Inhibitor	
RPM	 Revolutions	Per	Minute	
rRNA	 Ribosomal	RNA	
RT	 Room	Temperature	
RT-PCR	 Real-Time	PCR	
SDS	 Sodium	Dodecyl	Sulfate	
SSC-A	 Side	Scatter-Area	
TALEN	 Transcription	Activator-Like	Effector	Nuclease	
TBS-T	 Tris-Buffered	Saline	with	Tween20	
TE	 Trophectoderm	
TE	buffer	 Tris-EDTA	Buffer	
TEE	 TE-specific	Enhancer	
TET	 Ten-Eleven	Translocation	Methylcytosine	Dioxygenase		
TF	 Transcription	Factor	
tRNA	 Transfer	RNA	
TSC	 Trophoblast	Stem	Cell	
TSS	 Transcription	Start	Side	
UCSC	 University	of	California,	Santa	Cruz	
WB1	 Wash	Buffer	1	
WT	 Wild	Type	
µg	 Micro	Gram	
µl	 Micro	Liter	
µM	 Micro	Molar	
µm	 Micro	Meter			 	
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